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This study investigated the synergistic effect of fluorapatite (FA) coatings and 
platelet-rich plasma (PRP) on cell adhesion, proliferation, differentiation and 
mineralisation with a view to the use of this combination in enhancing 
osseointegration of dental implants. Stainless steel (SS) discs tilted at 45° were 
hydrothermally coated with FA crystals. PRP was extracted from human blood 
and the release of platelet growth factors (IGF-1 and PDGF-AB) from non-
activated and activated PRP loaded on FA coatings into PBS was measured. 
Cytotoxicity of FA/PRP combinations and their effect on G292 cell proliferation 
was tested. Osteogenic differentiation of human dental pulp stem cells 
(hDPSCs) cultured on FA/PRP was investigated using osteogenic marker 
expression and histochemical stains. The results showed that FA crystals were 
disorganised on upper disc surfaces and organised on the under surfaces. 
Organised FA coatings stimulated greater and more sustained release of IGF-1 
from non-activated PRP compared to the control (SS/non-activated PRP). The 
greatest release of PDGF-AB was triggered by thrombin from PRP loaded on 
organised FA. FA crystals showed good biocompatibility that was enhanced by 
PRP. Organised FA coatings induced a high cell proliferation when combined 
with PRP gel compared to the control (SS/FBS). There was a clear PRP donor 
variability in ALPL and RUNX-2 gene expression by hDPSCs when PRP used 
in combination with uncoated SS or FA coated surfaces compared to the control 
(SS/FBS). Organised FA when combined with FBS or PRP didnot enhance 
OCN expression but increased OPN expression compared to the control. 
Organised FA induced less ALP activity but high calcium deposition by hDPSCs 
compared to uncoated SS when both were combined with FBS or PRP, 
indicative of osteogenic differentiation. Therefore, it can be concluded that PRP 
in combination with organised FA coating may offer a promising strategy for 
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Chapter 1: Literature Review 
 
1.1 General introduction 
The use of dental implants for the correction of tooth and tissue loss caused by 
trauma, disease or genetic disorders has increased exponentially around the 
world. They have proved to be successful with failure rates of approximately 8 
% in the maxilla and 5 % in the mandible (Moy et al., 2004). However, it takes 
about 4–6 months for dental implants to integrate with the surrounding bone 
before the functional loading of the dental prosthesis (Adell et al., 1981). Some 
medical conditions such as osteoporosis and diabetes (Elsubeihi and Zarb, 
2002), as well as the need for immediate implant loading to reduce the anxiety 
of the patient (Gapski et al., 2003), have led to the search for factors that can 
improve and accelerate dental implant osseointegration.  
The capability of the implant surface to stimulate the osteogenic differentiation 
of cells is a critical factor for osseointegration (Lavenus et al., 2011). A great 
deal of research has been carried out to modify the physical and chemical 
properties of the implant surface to better promote this process. One such 
modification is the coating of implants with fluorapatite (FA). FA coatings are 
chemically and mechanically stable and offer a high level of biocompatibility. 
They stimulate hard tissue regeneration with low bio-resorption rate (Bhadang 
and Gross, 2004; Fathi and Zahrani, 2009). The desirable properties of FA have 
resulted in many studies focusing on its synthesis. For example, Chen et al. 
(2006b) described a hydrothermal method to produce aligned FA films with well-
organized crystals. However, there is little literature reporting this novel method 
nor the role of FA coatings on osseointegration of dental implants.   
In addition to implant surface quality, growth factors are known to stimulate 
tissue healing around the implant (Anitua, 1999). However, growth factors, 
currently delivered as recombinant proteins, are expensive and high doses may 
be required to achieve any therapeutic effect. And so, an easy and cost-
effective way to obtain high concentrations of appropriate growth factors at the 
implant site has been proposed using platelet-rich plasma (PRP). PRP is a 
valuable source for many growth factors involved in hard and soft tissue repair 






improvements in tissue healing and bone formation using PRP around the 
dental implant (Anitua, 2006), others did not observe any improvements (Garcia 
et al., 2010). Nevertheless, some investigators reported that using PRP in 
combination with other biomaterials may hold some promise for tissue 
engineering purposes (Okuda et al., 2005; Yamamiya et al., 2008). 
 
1.2 Dental implants 
The dental implant is an inert, alloplastic surgical component used to provide 
permanent support for a dental prosthesis (crown, fixed bridge or denture) when 
the bone itself cannot provide sufficient support (Mupparapu and Beideman, 
2000). When the implant is surgically placed within the jaw bone by the dentist, 
the surgical sites should be undisturbed and new bone is allowed to grow 
around and fuse with the implant for at least 3- 6 months before the artificial 
prosthesis is attached (Mosby, 2009). 
Implant supported prostheses, compared to the traditional removable and fixed 
restorations exhibit a remarkable capacity to preserve the bone and adjacent 
teeth which allows the patient to recover normal masticatory function, 
aesthetics, speech and self- confidence (Misch, 2014). 
Dental implants are commonly constructed from commercially pure titanium or 
titanium alloy because of their excellent biocompatibility, corrosion resistance 
and desirable physical and mechanical properties. However, materials such as 
ceramics and other alloys (gold and nickel-chrome-vanadium) are also used for 
dental implants. These materials are generally selected on the basis of their 
biocompatibility, strength and corrosion resistance. Nowadays, endosseous 
dental implants are coated with plasma-sprayed titanium or hydroxyapatite to 
enhance early bone integration with the implant surface (Mupparapu and 
Beideman, 2000). 
There are three types of dental implants (figure 1) that have been developed:  
A. Subperiosteal implants which are metal frameworks that attach on top of the 
jawbone underneath the gum tissue and the periosteum (a dense layer of 






B. Transosteal implants (mandibular staple) which are either metal pins or U-
shaped frames that pass through the jaw bone and the gum tissue into the 
mouth. 
C. Endosteal (endosseous) implants which consist of a distinct, single implant 
unit (screw- or cylinder-shaped) placed in a drilled hole within the alveolar bone.  
Endosseous implants are the most commonly used implants due to their long-
term clinical success (Searson et al., 2005). 
 
 
Figure 1: Types of dental implants: A) Subperiosteal implants which are 
frameworks that attach on top of the jawbone underneath the gum tissue. B) 
Transosteal implants which are either metal pins or U-shaped frames that pass 
through the jaw bone into the mouth. C) Endosteal implants which are single 
implant units that placed in a drilled hole within the alveolar bone (Adapted from 









Endosseous implants were discovered by Professor Brånemark in the late 
1960s when he observed a firm anchorage between a piece of titanium 
implanted into the bone and the bone itself without any sign of inflammation. He 
called this new attachment mechanism "Osseointegration" (Brånemark, 1969; 
Brånemark, 1983). Following the introduction of the Brånemark system of dental 
implants, the number of endosseous dental implants placed annually worldwide 
was increased reaching about one million with more than 220 implant brands 
produced by about 80 manufacturers (Jokstad et al., 2003). 
The amount of bone-to-implant contact (BIC) is an important determining factor 
in osseointegration and the long-term success of endosseous dental implants. 
Thus, maximizing the BIC and osseointegration has become a key goal of the 
treatment (Soskolne et al., 2002). 
 
1.3 Osseointegration 
Osseointegration is the direct structural and functional contact between ordered, 
living bone and the surface of a load-carrying implant without the interposition of 
a fibrous tissue (Brånemark et al., 1969). Osseointegration could also refer to 
an anchorage mechanism which persists under normal loading conditions and 
provides a long-term stable prosthesis (Worthington et al., 2003). 
Despite the high success rates, implant failure may occur and is defined as the 
inadequacy of the host tissue to establish or maintain osseointegration. The 
reported failure rates for Brånemark dental implants were 7.7% over five years 
(Esposito et al., 1998). Certain criteria have been determined for a successful 
integration of dental implants such as the lack of implant mobility which is of 
prime importance, as implant loosening is the most often reported reason for 
implant removal (Albrektsson et al., 1981).  
There are some systemic conditions that are believed to be associated with 
increased risk of implant failure and may preclude the patient from undergoing 
implant treatment such as diabetes, osteoporosis, tobacco smoking, 
radiotherapy, chemotherapy and possibly advanced age. These conditions are 
generally associated with impaired vascularisation and protein synthesis which 
seem to compromise soft and hard tissue healing (Searson et al., 2005; Marco 






In addition to the systemic factors, six local factors have been suggested to 
influence the osseointegration including; implant material, implant design, 
surface conditions, bone quality, surgical technique and implant loading 
conditions (Albrektsson et al.,1981). There are some controversies in the 
literature concerning early implant loading with prosthesis. Some studies 
suggest that loading should be applied 4-6 months after implant placement to 
avoid fibrous capsule formation around the implant caused by functional forces 
impacting at the implant-bone interface during wound healing (Adell et al., 
1981). Conversely, others advocated immediate or early loading (within 6 
weeks of implant placement) as long as the implant is of a roughened (plasma 
or hydroxyapatite coated implant), threaded design and inserted in good quality 
bone with good force management (e.g. cross-arch stability) (Salama et al., 
1995; Bijlani and Lozada, 1996; Piattelli et al., 1997).  
The long-term clinical success of endosseous implants depends mainly on rapid 
healing with safe integration into the bone. Therefore, the biology of the bone 
and its healing response to the implant surface has been widely studied. 
 
1.4 Bone structure 
Bone is a viable, cellular, highly mineralised connective tissue that maintains 
some degree of elasticity due to its structure and composition. Bone matrix is 
comprised of 70 % inorganic component, 20 % organic component and 10% 
water. The inorganic (mineral) component of bone is composed of carbonated 
calcium phosphate mineral in the form of hydroxyapatite crystals that are 3 to 
29 nm length and 2-3 nm width laid down in the organic matrix (Weiner and 
Traub, 1992, Rey et al., 2009). The organic part is composed mainly of collagen 
fibres which form approximately 95 % of the total protein in bone while the rest 
is non-collagenous proteins including, proteoglycans and glycoproteins (alkaline 
phosphatase, osteocalcin, osteonectin and bone sialoprotein) (Rodan, 1992). 
The repetitive nature of the amino acid sequences of the collagen fibres allows 
the protein to assemble into triple helical structures referred to as tropocollagen 
molecules (see schematic in figure 2). The elastic collagen matrix is hardened 
by the binding of the hydroxyapatite crystals through the bone mineralization 







Figure 2: Structure of bone tissue. Bone is divided into a hard compact bone and 
spongy bone. Bone is formed by overlapping cylindrical units (osteons) which 
contain blood vessels, lymphatic vessels, nerves and osteocytes along with the 
calcified matrix. The organic part of the bone is mainly elastic collagen fibres in 
which protein is assembled into triple helical structures (tropocollagen 
molecules). The collagen is hardened by binding of inorganic hydroxyapatite 
crystals. The bone is filled with bone morrow containing multipotent 





The bone has two surfaces; the internal (endosteal) and external (periosteal) 
surfaces, and are each lined with cellular layers called the endosteum and 
periosteum respectively. The mature bone (Lamellar bone) is characterized by 
regular and parallel alignment of collagen fibres into concentric sheets 
(lamellae) and osteocytes embedded within the calcified matrix. 
Morphologically, lamellar bone is classified into 2 types, cortical bone (compact 
or dense bone) and trabecular bone (cancellous or spongy bone). Cortical bone 






units called osteons or Haversian systems. Osteons contain blood vessels, 
lymphatic vessels, nerves and osteocytes along with the calcified matrix. 
Trabecular bone is sponge-like manner bone found principally at the ends of 
long bones, and in the vertebral bodies and the flat bones. It is composed of a 
meshwork of trabeculae with intercommunicating spaces for blood vessels and 
bone marrow. The differences in bone structure are related mainly to bone 
function. Cortical bone provides mechanical and protective functions while 
trabecular bone provides metabolic function (Marks and Odgren, 2002). 
However, differences in their protein contents was also shown (Ninomiya et al., 
1990).  
The bone is filled with bone marrow which is a loose vascular connective tissue 
that exists in direct contact with the endosteal surfaces. The connective tissue 
network of the bone marrow is called stroma. The stroma itself is a 
heterogeneous mixture of cells including adipocytes, reticulocytes, endothelial 
cells, and fibroblastic cells which are in direct contact with the hematopoietic 
elements (Jaiswal et al., 1997). Bone marrow contains multipotent stem cells 
localised in a determined micro-environment in which synthesis of blood cells 
take place (Yin and Li, 2006). These stromal cells are capable of differentiating 
along multiple mesenchymal and hematopoietic lineages. 
The mesenchymal stem cells (MSCs) differentiate into various cell types 
including osteoblasts, chondroblasts, fibroblasts, adipocytes and myoblasts 
(Aubin, 1998b) while, the hematopoietic stem cells differentiate into erythrocytic, 
leukocytic and thrombocytic lineages in addition to osteoclasts. 
Bone mesenchymal stem cells (BMSCs) differentiate toward an osteogenic 
lineage under the control of specific growth and transcriptional factors involving 
a number of developmental stages, beginning with transformation into 
osteoprogenitor cells through to preosteoblasts and osteoblasts and finally 
osteocytes (Long, 2001). During the early stages, osteoprogenitors maintain a 
certain degree of plasticity allowing de- and trans-differentiation to other 
mesenchymal lineages whereas osteoblasts and osteocytes are regarded as 
specialised functional cells that represent a terminal stage of cell differentiation 






Osteoblasts are the bone forming cells which after several stages of 
differentiation become osteocytes trapped in mineralised matrix (Acquavella 
and Owen, 1990). The differentiation of mesenchymal stem cells to osteoblasts 
is mainly stimulated by Cbfa1/RUNX2 expression which induces the expression 
of other genes encoding matrix proteins such as osteocalcin, type I collagen 
and bone sialoproteins (Karsenty, 1999, James et al., 2006). The main function 
of osteoblasts is production and secretion of bone matrix proteins such as type I 
collagen and non-collagenous proteins (Rodan, 1992). Production and secretion 
of many cytokines and signalling proteins such as bone morphogenetic proteins 
(BMPs) transforming growth factor beta (TGF-β) and bone matrix proteins were 
also mediated by osteoblasts (Marks and Popoff, 1988, Fu et al., 2007). 
 
1.5 Osteoblast gene expression profile 
 Three differentiation stages were described for BMSCs entering the osteoblast 
lineage; cell proliferation, extracellular matrix (ECM) formation and 
mineralization. Each of these stages is regulated by specific osteoblast gene 
expression profiles (Owen et al., 1990).  
 
 COL1 gene is highly expressed by osteoblasts during the proliferation phase 
(8-12 days for osteoblasts cultured in vitro) (Jaiswal et al., 1997) and becomes 
down regulated when extracellular matrix mineralisation begins (Dunn et al., 
1995). Therefore, the regulatory role for the COL1 gene is predominant during 
the osteoblast proliferation phase. 
 
 Alkaline phosphatase (ALPL) is an early post proliferative osteoblastic marker 
gene that is thought to be associated with the mineralisation procedure. 
However, the expression of ALPL gene is ultimately decreased in highly 
mineralised mature bone matrix (Shalhoub, 1992; Jaiswal et al., 1997). It 
represents an early marker of BMSCs osteogenic differentiations in vitro, and 
bone formation in vivo. ALPL gene encodes alkaline phosphatase (ALP) 
glycoprotein which is a hydrolase co-enzyme that is responsible for hydrolysing 
phosphate groups from various organic and inorganic biological molecules. As 






its phosphohydrolytic activity, which can increase local concentrations of 
inorganic phosphate and destroy pyrophosphate (a local inhibitor of mineral 
crystal growth). It has been reported that ALP protein levels begin to be 
detectable between days 12 to 18 in monolayer culture of human primary 
osteoblasts (Wessinger and Owens, 1990, Jaiswal et al., 1997). 
 
 RUNX-2 gene is an important transcription factor for bone formation (Komori 
et al., 1997). It is a member of the Runt domain proteins that play a crucial role 
in early stages of pluripotent mesenchymal cells differentiation to osteoblasts 
(Yamaguchi et al., 2000). RUNX-2 regulates bone development by promoting 
the up-regulation of ALPL, osteopontin (OPN), osteocalcin (OCN), bone 
sialoprotein (BSP) and type I collagen alpha chains (COL1A1) (Teplyuk et al., 
2008). In addition, RUNX-2 triggers the expression of major bone matrix protein 
genes during early osteoblast differentiation but does not play a major role in 
the maintenance of the expression of collagen I or OCN in mature osteoblasts 
(Komori, 2009). RUNX-2 was shown to modulate RANKL gene expression by 
the osteoblasts, hence indirectly affect osteoclast differentiation (Mori et al., 
2006). Moreover, RUNX-2 has been shown to negatively control osteoblast 
proliferation by acting on pathways associated with cell cycle (Yoshida et al., 
2004).  
 
 OCN gene is a post proliferative expressed gene that encodes the matrix 
protein osteocalcin (Shalhoub et al., 1992, Dunn et al., 1995). The regulatory 
role for the OCN gene is expressed predominantly during mineralised nodule 
formation in in vitro cultures and during the mineralisation of the bone matrix 
(Owen et al., 1990). It is considered to be a marker of mature osteoblast 
differentiation since it is expressed at the later stages of differentiation (Frenkel 
et al., 1997, Jaiswal et al., 1997).  
 
 OPN gene encodes osteopontin which is a cell-matrix adhesion protein. OPN 
and bone sialoprotein (BSP) were described as major sialoproteins in the 
extracellular matrix of bone (Zhang et al., 1990). OPN is a member of the 






(Denhardt et al., 2001). In addition, OPN protein has the potential to serve as a 
bridge between cells and hydroxyapatite through its cell binding amino acid 
RGD sequences (Oldberg et al., 1986). It was revealed that OPN is produced 
by osteoblastic cells at various stages of differentiation (Zohar et al., 1997). 
 
1.6 Biology of bone healing following implant placement  
During and following implantation, blood components come into contact with the 
implant surface resulting in a cascade of biological processes that take place at 
the bone-implant interface until the implant surface becomes covered with 
newly formed bone (Mavrogenis et al., 2009). Bone healing around dental 
implants is similar to fracture healing with the hallmark cascade of hemostasis, 
inflammation, regeneration and remodelling. However, the presence of a foreign 
implant surface may influence these phases (Larsson et al., 2001). Healing 
around the implant ends in a distinctive continuous layer of mature bone in 
intimate contact with the implant surface, while fracture healing ends in 
reproduction of the original bone shape and its associated tissues. Further, the 
process of bone formation at the bone-implant interface is not preceded by 
obvious chondrogenic activity (Cooper, 1998), which represents a prominent 
phase during fracture healing. Figure 3 shows the cellular reaction at the 
implant- bone interface during the peri-implant healing process. 
 
The biological cascade of peri-implant healing process includes: 
1. Protein deposition and adsorption onto the implant surface:  
Within few seconds of blood-implant contact, a monolayer of specific blood 
proteins is adsorbed on the implant surface. The composition of the protein 
layer is highly determined by the surface properties of the implant and these 
adsorbed proteins determine the host response to the material and the resultant 
peri-implant healing (Kuzyk and Schemitsch, 2011). For example, proteins like 
fibronectin and vitronectin contain peptide sequences that are responsible for 
mediating cell adhesion for many different kinds of cells (Kieswetter et al., 
1996). Fibrinogen, complement and IgG proteins are important for platelet 
activation, coagulation and inflammatory response (Kuzyk and Schemitsch, 






mesenchymal stem cells (BMSCs) recruitment into the implant surface arriving 
as early as the first day and stimulate cell differentiation in the healing process 
(Mavrogenis et al., 2009). 
 
Figure 3: Diagram showing the biological cascade at implant- bone interface 
during the healing process. Platelets initiate the coagulation cascade and release 
inflammatory cytokines and growth factors that lead to migration and 
proliferation of phagocytic cells. Neutrophils peaking at the first three days 
remove the residues of bacterial extracellular matrix. Macrophages remove the 
necrotic debris and express more cytokines, inducing further recruitment of 
osteogenic and endothelial progenitors that initiate the angiogenesis. The 
formed fibrin matrix acts as a scaffold for attachment and differentiation of the 
migrating stem cells into osteoblasts. Osteoblasts deposit osteoid, followed by 
woven bone formation and mineralisation. Then the immature woven bone starts 
remodelling at the second week and becomes replaced by mature lamellar bone 






2. Coagulation and platelet activation:  
Platelets are the first cells to arrive at the implant surface. Subsequent platelet 
activation is triggered by tissue injury or through interacting with foreign 
materials like an implant surface or in response to factors such as thromboxane 
A2 and thrombin which are released by other platelets or cells (Kanagaraja et 
al., 1996). Platelet activation induces the platelets to aggregate, form a blood 
clot and release cytokines and growth factors (GFs) (Kuzyk and Schemitsch, 
2011). GFs  such as platelet-derived growth factor (PDGF), transforming growth 
factor β (TGF- β) and insulin-like growth factor I (IGF-1) serve as signalling 
molecules for recruitment and differentiation of mesenchymal stem cells at the 
implant surface (Gaβling et al., 2009; Zhang et al., 2013). 
 
3. Inflammatory response:  
Inflammation is the early tissue response to implant surgery and the presence 
of the implant (Marco et al., 2005). The inflammatory response is facilitated by a 
number of leukocytes (neutrophils and monocytes) which migrate into the peri-
implant space after platelets followed by phagocyte macrophages. Leukocytes 
peak at the first three days following surgery to remove the dead cells and 
residues of bacterial extracellular matrix. They become activated in response to 
platelets cytokines (e.g., β-thromboglobulin and PDGF) resulting in the release 
of many inflammatory cytokines which are the first signalling molecules to 
initiate bone formation (Kuzyk and Schemitsch, 2011). Macrophages remove 
necrotic debris created by the drilling process of implantation surgery. 
Moreover, macrophages replaces the platelets as the primary source of growth 
factors after the third day of the surgery and begin to express some cell surface 
proteins and growth factors such as fibroblast growth factors (FGF-1,2,4), TGF-
α and β, epithelial growth factor (EGF), bone morphogenetic proteins (BMPs) 
and growth & differentiation factors (GDFs) (Canalis et al., 1989). These 
osteoinductive factors have been shown to enhance bone formation at the 
surgical site (Anil et al., 2011). Macrophages also produce numerous cytokines, 
growth and angiogenic factors that are important in the regulation of fibro-






Angiogenesis (formation of new blood vessels) is required to supply the 
osteogenic cells with blood. It is regulated by some growth factors like PDGF, 
angiopoietin, FGFs and vascular endothelial growth factor (VEGF) which may 
also modulate osteoblast function (Carmeliet, 2000).  
 
4. Woven bone formation:   
The complex collaboration of the signalling molecules within the peri-implant 
space exhibits osteoconductive and osteoinductive potential leading to 
recruitment, migration and differentiation of mesenchymal cells into osteoblastic 
(osteoprogenitor) cells that participate significantly in the formation of a woven 
bone (Marco et al., 2005). The osteoblasts start to deposit non-collagenous 
bone matrix proteins on the implant surface (e.g.osteocalcin, osteopontin and 
bone sialoprotein) that have nucleation sites for calcium phosphate 
mineralisation. The mineralisation process is regulated by the alkaline 
phosphatase enzyme secreted from osteoblasts by increasing localised 
inorganic phosphate levels, leading to formation of calcified layer on the implant 
surface (Marco et al., 2005; Mavrogenis et al., 2009). Few days after 
implantation, osteoblasts begin to deposit collagen matrix directly on the early 
formed mineralised layer on the implant surface. This process of osteogenesis 
results in immature woven bone formation (characterised by haphazard 
organization of collagen fibres) around the implant that eventually remodels into 
a mature lamellar bone (characterised by regular parallel alignment of collagen) 
Bone remodelling starts at the second week following the surgery and becomes 
replaced by mature lamellar bone within three months (Marco et al., 2005). The 
final remodelling results in mature bone in direct contact with most of the 
implant surface (i.e. proper implant osseointegration) (Davies, 2003; Marco et 
al., 2005). 
 
1.7 Influence of implant surface properties on osseointegration 
Histological and biomechanical data indicated that bone cells respond 
differently when interfacing to different implant surfaces (Larsson et al., 2001; 
Albrektsson and Wennerberg, 2004). Moreover, it was indicated that the 






the chemical, physical, mechanical and topographical properties of the implant 
surface (Figure 4), which in turn have great impact on the speed and strength of 
the osseointegration (Marco et al., 2005; Grassi et al., 2006). 
 
 
Figure 4: Effect of surface characteristics of the implant on the osteogenic 
response. Chemical properties including hydrophilicity, surface energy and 
composition of the implant surface affects ionic interactions, protein adsorption 
and cell attachment. Surface physical properties such as surface topography 
and roughness (macroscopic and microscopic features) play an important role in 
the biomechanical fixation of dental implants by enhancing protein adsorption 
and the consequent osteoblastic cell migration, adhesion, proliferation and 
differentiation as well as collagen synthesis leading to better bone deposition 








1.7.1 Chemical properties of implant surface: 
Albrektsson et al. (1981) pointed to the hydrophilicity (wettability) and surface 
energy as the most important factors influencing bone-implant contact. Previous 
in vivo evidence has supported the modification of implant surface chemistry to 
enhance implant osseointegration (Schliephake et al., 2005). The chemical 
composition of the implant surface affects ionic interactions, protein adsorption, 
cell attachment and the hydrophilicity of the surface. Highly hydrophilic surfaces 
seem more desirable than hydrophobic ones in view of their interactions with 
biological fluids, tissues and cells (Le Guéhennec et al., 2007). Furthermore, the 
expression of bone-specific differentiation factors is reported to be higher on 
hydrophilic surfaces (Le Guéhennec et al., 2007; Anil et al., 2011).  
 
1.7.2 Physical properties of implant surface: 
Surface physical properties such as surface topography (macroscopic and 
microscopic features of the implant surface) and roughness play an important 
role in the biomechanical fixation of dental implants (Cochran et al., 2002). The 
osseointegration process can be affected by the surface roughness of the 
implants because the cells react differently to smooth and rough surfaces. For 
example, epithelial cells and fibroblasts adhere more strongly to smooth 
surfaces (Wennerberg and Albrektsson, 2000; Boyan et al., 2001). While rough 
implant surfaces have a positive influence on osteoblastic cell migration, 
adhesion, proliferation and differentiation as well as collagen synthesis leading 
to better bone deposition adjacent to the implant (Wennerberg and Albrektsson, 
2000; Boyan et al., 2001; Novaes Jr et al., 2002; Cochran et al., 2002). 
Depending on the dimension of the measured surface features, implant surface 
roughness is divided into macro, micro, and nano-roughness. When macro 
roughness is appropriate, it can enhance the primary implant fixation and long-
term mechanical stability by promoting the mechanical interlocking between the 
macro rough features of the implant surface and the surrounding bone. Macro 
roughness comprises features in the range of millimetres to tens of microns. 
This scale of roughness directly relates to implant geometry, with threaded 
screw and macro porous surface treatments (Wennerberg et al., 1996, Shalabi 






This range of roughness increases the interlocking between mineralised bone 
and implant surface. Micro roughness resulted in greater bone deposition at the 
implant surface according to some clinical studies (Shalabi et al., 2006, Junker 
et al., 2009). Nano-sized surfaces provided with nanoscale topographies are 
widely used in recent years. Nanotechnology involves materials are composed 
of nano-sized materials with a size range between 1 and 100 nm. Brett et al. 
(2004) proved that nanoscale roughness plays an important role in the 
adsorption of proteins, adhesion of osteoblastic cells and thus the rate of 
osseointegration. Roughness of the implant surface can be induced by different 
methods including: titanium plasma-spraying (TPS), acid-etching, anodisation 
and grit-blasting with hard ceramic particles like alumina (Al2O3), titanium oxide 
(TiO2) and calcium phosphate (CaPO4) (Anil et al., 2011). 
 
1.8 Surface modifications of dental implants 
Even though the reported success rate of implant osseointegration is higher 
than 90% after 5 years and more than 78% after 15 years (Adell et al., 1981), 
some important conditions remain to be a challenge in dental implant 
applications such as the long latency period between implant placement and 
loading with dental prosthesis and the poor bone quality in medically 
compromised patients including diabetics, osteoporotic, oncology patients and 
smokers (Elsubeihi and Zarb, 2002). Therefore, surface modification of the 
dental implant using ceramic coatings has been extensively proposed to 
improve the clinical survival rates of the implant, to reduce the healing period 
and to enhance bone anchorage to the implant. It involves improving the 
surface chemistry, morphology and bio-mechanical properties (Anil et al., 2011). 
There are 2 types of ceramic coating; bioactive such as calcium phosphates 
and bioinert such as aluminium oxide and zirconium oxide.  
 
1.8.1 Modification of implant surface by coating with calcium phosphate  
Coating implants with calcium phosphate Ca3(PO4)2 ceramic materials has been 
extensively studied since these compounds have relatively similar chemical 
composition to the mineral matrix of the bone (hydroxyapatite; Ca5 (PO4)3 OH). 






do not exhibit any unsatisfactory tissue response such as local or systemic 
toxicity or immune response (Muddugangadhar et al., 2011). 
Following implantation, the release of calcium ions (Ca2+) and phosphate ions 
(PO43-) from the coating into the peri-implant region precipitates a biological 
apatite layer onto the surface of the implant. The apatite layer stimulates the 
adsorption of specific blood proteins serving as a matrix for osteogenic cell 
attachment and growth. This allows direct bone-implant contact without an 
intervening connective tissue layer leading to a better and faster biomechanical 
fixation of dental implants compared to uncoated surfaces (Le Guéhennec et 
al., 2007). The dental implants are usually coated with ceramics by using 
plasma or flame spray techniques. Various calcium phosphate materials were 
used as coatings for dental implants with different degradability depending on 
calcium/phosphorus (Ca/P) ratios, such as bioglasses, tricalcium phosphates 
(TCP) and tetra- calcium phosphates (Klein et al., 1994). However, the most 
extensively investigated material is hydroxyapatite (HA) and recently 
fluorapatite (FA). It has been found that HA (Ca/P ratio of 1.67) and tetra-
calcium phosphate (Ca/P ratio of 2) induce an intimate bone- implant contact 
with lower bone remodelling activity around the implant surface compared to 
uncoated and tricalcium phosphate coated implants (Klein et al., 1991). The in 
vitro solubility reports indicated that solubility of tetra- calcium phosphates and 
tricalcium phosphates is much higher than HA (Klein et al., 1990), while FA has 
better solubility than HA (Dhert et al., 1991). 
 
1.8.1.1 Hydroxyapatite 
HA [Ca5(PO4)3OH] is similar in composition and structure to natural bone 
(Pullen and Gross, 2005), but has low strength and toughness which precluded 
its clinical use (De Aza et al., 2005). However, using HA as a coating on 
metallic substrate can combine the good biological properties of the HA layer 
while retaining the mechanical superiority of the metallic substrate (Yang et al., 
2010). In vivo studies of HA coated implants revealed good fixation to the 
surrounding bone and a greater amount of new bone formation (McPherson et 
al., 1995). Therefore, HA coated implants were recommended in areas with 






Different coating processes were used for the dental implants with HA such as 
plasma spraying methods, vacuum deposition techniques, sol-gel coating, 
electrophoresis and electrolytic deposition (Muddugangadhar et al., 2011). 
However, plasma spraying is the most commonly used method to produce the 
commercial HA coatings (Strnad et al., 2000). To coat a dental implant with HA 
using a plasma spray coating process, the implant surface is first roughened to 
increase the surface area available for mechanical bonding with HA. Then a 
plasma is created by an electric arc between an anode and cathode that ionizes 
HA particles. A carrier gas (argon or nitrogen) blows a stream of HA powder 
through the very high temperature plasma flame that melts the powder. When 
the molten powder hits the implant surface, it condenses and forms a glossy 
and crystalline ceramic coating (Thornton and Bunshah, 1982; Groot et al., 
1987). A robotic technique is usually used to build up a thin layer of HA coating 
of usually 40-50 µm on a roughened titanium or alloy surface (Groot et al., 
1987). Major shortcomings of plasma-sprayed HA coatings have been 
recognised when used for bone regeneration including lack of mechanical 
strength, cracking and separation from the metallic substrates which results in 
loss of a firm fixation between the implant and surrounding bone tissue (Sun et 
al., 2001; Yang et al., 1997). Recently, many studies suggested the 
incorporation of inorganic materials (strontium, zinc, magnesium, sodium, silver, 
silicon and yttrium) into HA to promote the bone formation and to enhance bone 
mineral characteristics such as crystallinity, degradation behaviour and 
mechanical properties (Sato et al., 2006; Xue et al., 2008; Boanini et al., 2010; 
Yang et al., 2010; Yang et al., 2012a). HA thermal sprayed coatings have been 
modified with zirconia (Chou and Chang, 2002) and alumina (Kim et al., 1998) 
to increase the strength and fracture toughness of the coatings. Moreover, in 
vivo studies indicated that strontium-substituted hydroxyapatite prepared using 
electrochemical deposition process showed higher and faster bone to implant 
contact compared to HA coated implant (Fu et al., 2012; Yang et al., 2012b). It 
has been found previously that strontium enhances preosteoblast differentiation 
and inhibits osteoclast differentiation (Canalis et al., 1996). However, the limited 










Fluorapatite crystals [Ca5(PO4)3F] are hexagonal crystals known to have the  
highest symmetry found among the apatite minerals (Bayliss et al., 1986). The 
structure of FA crystal is composed of calcium ions (Ca2+) and phosphate ions 
(PO43-) arranged around fluoride ions F- which extends throughout the crystals 
in the c-axis direction forming the central column of the crystals (Brown and 
Constantz, 1994). In the last few decades, FA coating has been studied 
extensively in order to be used in tissue engineering applications. The excellent 
biocompatibility of FA is closely related to its chemical and biological similarities 
with hydroxyapatite based human hard tissues.  
Naturally, fluoride ions from the blood accumulate in the bone forming fluoride 
containing HA. Fluoride is the most electronegative element. Its small ionic 
diameter and high charge density enable the fluoride to have a great capacity to 
form strong ionic and hydrogen bonds and to have a high potential for 
interacting with mineral phases and organic macromolecules (Robinson et al., 
2004). Fluoride ions substitute the hydroxyl ions (OH-) within the apatite lattice 
creating a tighter lattice structure [Ca5(PO4)3F] (Figure 5) with higher stability 
and lower solubility than HA because this substitution leads to reduction in (a) 
and (b) lattice parameters of the crystal lattice and a consequent reduction in 
the crystal energy. This, in turn dramatically decreases the acid solubility of the 
crystals and generates a more stable crystal structure (Robinson et al., 2017). 
This could also improve the mechanical strength, decrease the dissolution rate 
of HA and enhance bone tissue growth (Fathi and Zahrani, 2009). Moreover, 
fluoride is believed to stimulate bone growth and mineralisation by suppressing 
osteoclast maturation, inhibiting phagocyte activity and minimizing fibroblast 
proliferation (Sakae et al., 2000, Cooper et al., 2006). These properties have 
encouraged the use of FA coatings for dental and orthopaedic implants. In vivo 
studies have observed a direct bone apposition at the interface of FA coatings 
with no signs of degradation of the coatings compared to the partial resorption 







Figure 5: Schematic diagram for hydroxyapatite and fluorapatite. The hydroxyl 
group of HA is substituted with high charge density fluoride creating tighter 
lattice structure with higher stability and lower solubility than HA as this 
substitution leads to reduction in (a) and (b) lattice parameters of the crystal 
lattice and a consequent reduction in the crystal energy. This, in turn 
dramatically decreases the acid solubility of the crystals and generates a more 





FA coatings have been applied to implants by plasma spraying (Ranz et al., 
1997). FA is the most stable plasma-sprayed calcium phosphate coating as to a 
large part, it retains its stability, its fluorine content and its crystallinity during the 
high temperature process. However, the rapid cooling process does cause a 
change in the orientation of the FA crystals (Klein et al., 1994). In general, all 
coating processes are likely to alter the composition of the coating materials, 






the materials (Yang et al., 1997, Sun et al., 2001). Therefore, new coating 
methods have been introduced and studied. 
Chen et al. (2006a) demonstrated and compared two novel methods to 
synthesize FA crystals. One produced short crystals under ambient pressure in 
which the synthetic crystals prepared at pH 6 -11 and aged at 70°C for 5 days 
had a length of 20–50 nm and a cross section of about 10 nm. The synthetic 
nanorods have a typical apatite crystalline structure with a Ca/P ratio between 
1.6–1.7, which approaches the theoretical ratio of FA (Ca/P = 1.67). The 
second method synthesised longer and very well aligned or ordered FA 
nanorods, by simply controlling pH and using etheylenedeiaminetetraacetic acid 
(EDTA) as a stabiliser in the precipitation solution under mild hydrothermal 
conditions (121°C, 2 atm for 6 hours). The FA crystals were of 1–5 µm in length 
and 30–100 nm in cross section. They are approximately similar to those seen 
in human enamel but of different shapes and sizes. Chen et al. (2006a) 
reported that the formation of FA crystals is determined by two processes, one 
is the initiation of nucleation and the other is the continued growth of the 
nucleate. The EDTA chelates strongly with Ca2+ and this chelating ability 
depends on the pH of the solution. EDTA can exist in several ionic forms (in up 
to 7 different acid-base forms) depending on the solution pH. When the pH 
value of the solution is high (7-12), the more negative anions of EDTA will 
predominate and provide the strongest EDTA-Ca complexing ability (Liu et al., 
2004), thus Ca2+ is not released resulting in prevention of FA crystal formation. 
Whereas, at low pH (pH 4), the chelated Ca2+ is not stable under hydrothermal 
conditions, resulting in explosive release of Ca2+ which produces a large 
quantity and size of nucleates. These nucleates aggregate together and adopt a 
spherical structure in order to minimise their surface energy. Each spherical 
structure will have many active growth sites, and with the continuous release of 
Ca2+ will result in the growth of the FA crystals from these sites. The large size 
of each nucleate on the spherical aggregate induces the formation of many 
defects during the fast growth, that will produce small branches at the end of the 
crystal. However, the stability of Ca-EDTA complex is enhanced by increasing 
the pH to 5 which will result in the formation of smaller spherical structures 






with no branching structures. When the pH is increased to 6, a stronger 
chelating of Ca2+ to EDTA is produced, leading to the formation of small 
nucleates in size and quantity, and because each individual nucleate will 
develop into individual single nanorods, individual well-separated and long 
nanorods are synthesized. The FA crystals may grow faster in one of the polar 
directions. The fastest growth direction will form the leading tip due to diffusion-
limited growth, which results in a spear-like crystal formation with one end of the 
crystal being sharper than the other (Liu et al., 2004). 
Chen et al. (2006b) demonstrated another hydrothermal technique to grow a 
layer of well aligned FA crystals on metal substrates at 121oC and 2 atm for 10 
hours using EDTA to stabilise the release of Ca2+. This direct growth method 
was able to produce fluorapatite dental enamel prism like structures (10–30 µm 
in cross section) on iron substrates. The crystal structure was very similar in 
chemical composition to natural tooth enamel, the crystals are of 1–3 µm in 
cross section and approximately 50 µm in length. Other metal substrates may 
support the growth and orientation of the FA crystals but do not produce the 
closely aligned prism-like structures. The morphology of the synthetic FA 
crystals developed from amorphous deposits to hollow balls and finally to well-
defined crystals as the autoclave time increased from 5 min to 10 hours as 
shown in figure 6. The FA rod- like structures have the tendency to aggregate 
side by side to form a bundle because of the stronger van der Waals attraction 
along the long axis of the rods. Then, a long FA nanorod that undergoes rapid 
growth may act as a leader crystal in the centre of the bundle while some 
shorter nanorods become closely aligned parallel to the surface of the leader 
crystal resulting in a shuttle-like structure of a large well-defined hexagonal 
crystal. With increasing autoclave time, all the Ca2+ from the EDTA-Ca complex 
are diminished and the bundles stop growing longer (Chen et al., 2006b). Chen 
et al. (2006b) proposed that it might be possible to induce dentin and pulp 
formation on the synthetic enamel layer in vitro and to regenerate teeth for 









Figure 6: Growth of FA crystals as the autoclave time increased from 5 minutes 
to 10 hours using a hydrothermal technique. The morphology of the synthetic FA 
crystals developed from amorphous deposits to hollow balls and to well-defined 
crystals as the autoclave time increased. At pH 6, Ca2+ dissociate slowly from the 
EDTA-Ca complex and react with phosphate and fluoride ions leading to the 
formation of small nucleates in size and quantity and because each individual 
nucleate will develop into individual single nanorods, individual well-separated 
and long nanorods are synthesized. The FA rod- like structures have the 
tendency to aggregate side by side to form a bundle of crystals. Then, a long FA 
nanorod that undergoes rapid growth may act as a leader crystal in the centre of 
the bundle while some shorter nanorods become closely aligned parallel to the 
surface of the leader crystal resulting in a shuttle-like structure of a large well-








Czajka-Jakubowska et al. (2009a) have successfully changed the surface 
morphology of the FA crystals from ordered to disordered when produced 
individually on the under surfaces and upper surfaces of the substrate 
respectively. They also attempted to grow FA on different substrates; they found 
that only etched stainless steel and titanium substrates could produce surfaces 
completely covered with FA crystals of uniform composition, alignment, size, 
shape and structure (Czajka-Jakubowska et al., 2009b). 
Interestingly, some in vitro studies revealed that the well aligned FA crystals 
grown by the mild hydrothermal method appeared to promote cell differentiation 
and mineralization process better than the disordered crystals. This would 
suggest that ordered FA crystals may enhance osseointegration of dental 
implants (Liu et al., 2010; Liu et al., 2011; Liu et al, 2012). However, more 
research is required to develop the understanding of the exact effect of 
fluoroapatite as a dental implant coating.  
 
1.8.2 Modification of implant surface by coating with platelet-rich plasma  
Recent tissue engineering developments have improved the osseointegration of 
dental implants through stimulating the regeneration of new bone by using 
growth factors (GFs), plasma proteins and stem cells (Anil et al., 2011). The 
potential effects of GFs in the repair and regeneration of bone have been well 
documented. GFs are secreted locally during blood clotting by activated 
platelets at the site of implantation and stimulate a series of events that leads to 
the wound-healing response. They promote proliferation, chemotaxis and 
differentiation of cells which are essential to osteogenesis and angiogenesis 
(Kanno et al., 2005) (Figure 7). Thus, they have been suggested as bio-
coatings for endosseous implants to accelerate and enhance bone growth 
(Anitua et al., 2008; Anitua et al., 2009b; Albanese et al., 2013).  
Coating implants with bone morphogenetic protein-2 (BMP-2) has been 
suggested as a means of inducing local bone formation (Liu et al., 2007; 
Wikesjӧ et al., 2008) and platelet-derived growth factor (PDGF) accelerated soft 
tissue attachment (Bates et al., 2013). However, the clinical application of 
commercial GFs is problematic due to their short shelf life and high cost. 






Alternatively, an easy and cost-effective way to obtain high concentrations of 
GFs for tissue healing and regeneration has been achieved by using autologous 
platelet concentrates (Nikolidakis and Jansen, 2008). Pure platelet concentrates 
were developed for topical use as an additional application of the classical 
transfusion platelet units and were first used for maxillofacial surgery by 
Whitman et al. (Whitman et al., 1997). Platelet concentrates were prepared and 
used in different forms and platelet-rich plasma (PRP) is one of the forms that 
were extensively used as a substitution for the commercial GFs.   
 
Figure 7: The role of platelets and some GFs in bone healing. After 10 minutes of 
platelets aggregation induced by tissue injury, platelets begin releasing GFs into 
the injury site. GFs such as PDGF, TGF- β and IGF-1 serve as signalling 
molecules for recruitment and differentiation of mesenchymal stem cells into 
different lineage to initiate different activities including angiogenesis and 
osteogenesis. Platelets GFs also activate the macrophages that replaces the 
platelets as the primary source of growth factors after the third day of the 







Platelet-rich plasma (PRP) is safe because it is an autologous preparation (i.e 
prepared from the patient’s own blood), and thus, poses no risk of infection, 
disease transmission or immunogenic reaction. It is easily obtainable and not 
time-consuming to use for the patient and the clinician (Albanese et al., 2013). 
Such advantages have increased the interest in the application of PRP to 
promote tissue healing in dental and orthopaedic applications (Anitua, 1999) 
and as a dental implant coating for improving the osseointegration of dental 
implants (Anitua et al., 2004; Kanno et al., 2005).  
PRP is defined as a high concentration of autologous platelets in a small 
volume of autologous plasma. A concentration of 1,000,000 platelets/µL in a 
5mL volume of plasma or approximately 5 times higher than that of whole blood 
was proposed to be the working definition of PRP (Marx, 2001). PRP is effective 
in the early stage of bone healing process, because the life of a platelet is only 
about 5–7 days. Within 10 minutes of platelets aggregation, platelets begin 
releasing GFs into the injury environment with full release within an hour 
(Pietrzak and Eppley, 2005). Although proteins can be released for an hour, the 
half-life of the GFs and other cell factors last just a few minutes. However, 
macrophages aggregated by PDGF released by platelets, might play a more 
important role in the following stage of healing process.  
 
1.8.2.1 Preparation procedures of PRP 
To prepare PRP, blood samples should be drawn into a tube containing 
anticoagulation factors. There are several choices of anticoagulants such as 
citrate dextrose-A, which is the preferable agent. The citrate binds with calcium 
and subsequently prevents blood coagulation, whereas the dextrose and other 
ingredients support platelet metabolism and viability. Citrate phosphate 
dextrose anticoagulant has fewer supportive ingredients and therefore may be 
less effective at maintaining platelet viability (Marx, 2001). 
Ethylenediaminetetra-acetic acid (EDTA) is also used as an anticoagulant to 
chelate calcium but is potentially more harmful than citrate to the platelets 
(Landesberg et al., 2000). While, trisodium citrate solution was used as an 






PRP is prepared by centrifugation using several automated systems and 
manual protocols. However, each method results in a different PRP product 
with different biological properties and uses (Marx, 2001).  
 
1) Automated protocols of PRP preparation 
The first automated method of producing platelet concentrates was called 
plasmapheresis, in which the patient stays connected to a cell separator and 
the blood filtering continues until the desired quantity of platelets has been 
collected (Weibrich et al., 2003).  
The ideal cell separator must use a double centrifugation technique. The blood 
sample is drawn into a tube containing an anticoagulation factor and spun in 
double centrifuge cycles. The first spin (hard spin) separates the red blood cells 
at high force (3000 g in general) from the plasma that contains the platelets and 
white blood cells (buffy coat). Then the buffy elements in the plasma are 
detected by an optical reader and automatically collected into a separate bag 
using a soft spin as a platelet concentrate (PRP) (Weibrich et al., 2003; Pietrzak 
and Eppley, 2005). The platelet collection is interrupted when the optical reader 
detects elements of RBCs, thus RBCs mixed with leucocytes and some residual 
platelets are directed towards a third collection bag and re-infused in to the 
donor blood. Recently, newer systems have been introduced that can be used 
more easily, both for auto-transfusion during surgery and for topical application 
e.g. the Electa cell separator (Sorin group, Italy). 
Another automated system called PCCS (Platelet Concentrate Collection 
System) uses centrifuges that consist of two connected chambers or 
compartments. The citrated blood is transferred into the first chamber and 
centrifuged briefly to obtain three layers (RBC, buffy coat, platelet-poor plasma 
or PPP). Then, by using air pressure, the superficial layers (PPP and buffy coat) 
are transferred to the second chamber and centrifuged again for a longer 
period. Finally, most of the PPP layer is transferred back into the first chamber 
using the same air pressure system.  
Automatic devices allow around about 5mL to 10mL of PRP to be obtained from 
40- 60 mL of whole blood which is sufficient for most minor surgical procedures, 






surgeries (Gibble and Ness, 1990). Therefore, in maxillofacial reconstruction 
therapies, up to 500mL of blood should be drawn from the patient to obtain 
larger amount of PRP required for larger surgical defects.  
Several commercial systems are also available for preparing platelet 
concentrate, such as SmartPReP system (Harvest Autologous Hemobiologics, 
Norwell, MA), the Tisseel system (Baxter Health Corporation, Deerfield, IL) and 
the Curasan PRP kit (Curasan, Pharma Gmbh AG, Lindigstrab, Germa ny) 
(Nikolidakis and Jansen, 2008). However, not all the commercially available 
devices are able to produce adequate platelet concentration and this might 
explain some of the variation in clinical efficacy of PRP reported by different 
studies (Weibrich and Kleis, 2002). Some studies have compared these 
systems and found that the PCC System may produce the greatest platelet 
concentrations in a short time with great ease of handling (Appel et al., 2002; 
Marx, 2004).  
Although this sophisticated technology is the more accurate method from a 
technical point of view, it still can result in PRP containing residual RBCs and 
leucocytes. Moreover, the platelet collection efficiency is rather low and the 
platelets could be damaged during the process (Leitner et al., 2006). Platelet-
poor plasma (PPP) cannot be collected using automated PRP preparation 
techniques as it is re-infused in to the blood donor. In addition, the main 
drawback of all these automated techniques is that they are unwieldy and 
labour-intensive as they often require the help of a haematologist, thus, their 
use in daily practice remains rare. Therefore, developing alternative manual 
protocols was necessary to make it possible to use platelet concentrates in daily 
practice without the need for transfusion laboratory support.  
 
2) Manual protocols of PRP preparation 
The first platelet concentrate manual protocol was described by Anitua to 
prepare plasma rich in growth factors (PRGF) (Anitua, 1999; Anitua et al., 
2007). In this protocol, blood is collected and centrifuged to obtain the three 
typical layers: RBCs, buffy coat and platelet-poor plasma (PPP). The PPP is 
discarded from each tube by careful pipetting to avoid creating turbulences. The 






eyeballing as a measuring tool. The pipetting steps are associated with possible 
pipetting and handling errors. Therefore, this technique may be more prone to 
errors leading to a low platelet collection efficiency because platelets and 
leucocytes are found together in the intermediate layer (Weibrich et al., 2005). 
Anitua’s PRGF method is an inexpensive manual protocol for the preparation of 
leucocyte-poor PRP or pure PRP. However, the lack of reproducibility of the 
procedure is problematic.  
In another protocol uses also a two-step centrifugation procedure, the blood 
components are separated into three parts (RBCs, buffy coat and PPP) in the 
first centrifugation step. The PPP and the buffy coat are carefully collected in 
another tube, avoiding RBC contamination and are subjected to a second 
centrifugation step at high speed to separate the platelets from the platelet-poor 
plasma (PPP). Most of the PPP fraction, identified by simple visual inspection, 
is discarded and the platelet pellet is re-suspended in a low volume of plasma to 
obtain the PRP. The PRP obtained with this method is composed of a high 
quantity of platelets, leucocytes and circulating fibrinogen, but it also may 
contain residual RBCs. 
The manual PRP preparation process is time consuming and yields small 
volumes of PRP, but PPP fraction can be well preserved. PPP contains 
fibrinogen and can be used to increase the final volume of PRP (Pietrzak and 
Eppley, 2005). In general, it is necessary to point out that the success of the 
manual method depends on the operator and results are not always reliably 
reproduced. This is especially true considering that various authors use different 
centrifuges and different g forces to spin the blood samples. Consequently, 
PRP samples obtained by different labs differ in platelet concentrations which in 
turn leads to variability in the published results. Furthermore, platelet activation 
might be triggered inadvertently during PRP preparation and can result in the 
early release of GFs in the PPP and their subsequent loss (Marx, 2001). 
 
1.8.2.2 Components of PRP 
1) Platelets 
Platelets are small discoid blood cells (1–3 µm). The average platelet count in 






platelets /µL). The in vivo half-life time of platelets is about 7 days (5 to 9 days). 
Platelets are synthesized in bone marrow by the pinching off of pieces of 
megakaryocyte cytoplasm that are extruded into the blood circulation. Platelets 
have a cytoskeleton comprising a peripheral ring of microtubules containing 
actin and myosin. Platelets contains a number of intracellular molecules such as 
glycogen, lysosomes, and two types of granules; dense granules which contain 
ADP, ATP, serotonin and calcium, and ɑ-granules which contain clotting factors, 
growth factors and other proteins (Zucker-Franklin, 1988). Normally, in the 
resting state, platelets are non-thrombogenic and require a trigger before they 
become an active player in the wound healing process. On activation by contact 
with a foreign surface or by thrombin, they change shape and develop 
pseudopodia, which promote platelet aggregation and the subsequent release 
of the GFs from the granules through the open canalicular system (Figure 8). 
 
Figure 8: Schematic overview of a resting and activated platelet. Normally 
platelets are in a resting state. On activation with an activator, platelets change 
their shape with the development of pseudopods to promote platelet aggregation 





Liquid PRP formulations also contain soluble fibrinogen which is the precursor 
molecule to fibrin monomers. Thrombin cleaves soluble fibrinogen into fibrin 
monomers that assemble into networks of insoluble fibrin polymers at the site of 






specific functions (Laurens et al., 2006). The structure and function of fibrin 
matrices used as scaffolds for tissue regeneration therapies are determined by 
several conditions, including; clotting, fibrinogen concentration, fibrin density 
and polymerization rates (Brown et al., 1994; Laurens et al., 2006).  
Cellular responses to fibrinogen or fibrin matrices within PRP applications may 
be greatly individualised because of the differences in fibrinogen which is 
depending on posttranslational protein modifications and genetic variants (de 
Maat and Verschuur, 2005). Fibrinogen regulates the activity of monocytes and 
macrophages and therefore mediates the transition between inflammatory and 
regenerative stages of the response to injury response (Kells et al., 1995).  
Fibrin density is determined by the concentration of native fibrinogen during 
preparation (Clark, 2001). Fibrin polymerization is determined by the ratio of 
fibrinogen and thrombin where high thrombin concentrations trigger rapid 
polymerization, leading to the formation of a dense network that hampers 
cytokine signalling and cellular migration. In contrast, slow polymerization 
induced by low thrombin concentrations creates a more flexible scaffold that is 
more conducive to cellular migration and cytokine signalling (Hinsbergh et al., 
2001). 
 
3) Growth factors and cytokines 
As outlined in table 1, PRP contains numerous growth factors (GFs), whose 
properties vary significantly. Many of the GFs and cytokines that are believed to 
be responsible for the biological effects of PRP are released from the ɑ-
granules of the platelets. VEGF, PDGF, and TGF-β1 are the main growth 
factors derived from platelets. PRP typically contains 3 to 5 fold increase in 
growth factor concentrations over baseline blood levels (Doessing et al., 2010; 











Table 1: Some important biologically active molecule contained in PRP cited by 
Sell et al. (2012)  
 
General category Specific molecules Physiological role 
Adhesive proteins Fibrinogen, fibronectin, 
vitronectin, 
thrombospondin-1, von 
Willebrand factor, laminin-8 




Clotting factors and 
associated proteins 
Factor V, factor XI, protein S, 
antithrombin, tissue 
factor pathway inhibitor 
Thrombin activation and 
its regulation, eventual 
fibrin clot formation 








Tissue inhibitor of 
metalloproteases 1–4 (TIMP 
1–4), MMP-1, -2, -4, -9  
Regulation of matrix 
degradation, regulation of 




TGF-β, PDGF, insulin-like 
growth factor (IGF)-I and -II, 
FGF, EGF, VEGF, ECGF, 
KGF, GM-CSF, hepatocyte 
GF, TNFα, RANTES,IL-8,IL-




of ECM production, 
regulation of inflammation, 
angiogenesis. 




αIIbβ3, αvβ3, CD-40 ligand, P-
selectin, tissue factor, 
PECAM-1, CD63 






F2α, leukotriene B4  
Inflammation modulation, 
cell migration and 
proliferation, etc 
Basic proteins and 
others 
Platelet factor 4, β-
thromboglobulin, endostatins, 
albumin, immunoglobulins G 
and M 
Regulation of endothelial 








1.8.2.3 Mechanism of GF and cytokine action of PRP on bone healing 
process 
The application of PRP amplifies the surge of chemical mediators to the 
microenvironment of the injured area. Therefore, many studies have focused on 
the role of PRP on the molecular mechanisms of bone healing process through 
three aspects of bone repair; inflammatory cytokines, growth factors, and 
angiogenic factors. 
 
1. The role of inflammatory cytokines to promote bone healing process 
Inflammatory reactions involve a number of biochemical and cellular alterations 
depending on the initial trauma (Kamoda et al., 2012). Histamine and serotonin 
are released by dense granules of the platelets. They increase capillary 
permeability in the healing area, which allows inflammatory cells greater access 
to the wound site and activates macrophages (McManus and Pinckard, 2000). 
Adenosine, also released from the dense granules, is a potent endogenous 
physiological mediator that regulates a wide variety of physiological 
processes. In addition to its effects on angiogenesis, adenosine is a potent 
regulator of inflammation, the first stage of the wound-healing process 
(Montesinos et al., 2002).  
 
2. The Role of growth Factors to promote bone healing process 
The action of PRP on the natural healing pathway of bone is related to the 
increased concentration of growth factors and bioactive proteins released by 
activated platelets (Pietrzak and Eppley, 2005). The best known growth factors 
are PDGF, TGF-𝛽eta and IGF-1. 
 
 Platelet-derived growth factor (PDGF): it is mainly found and stored in the 
alpha granules of the platelets (Antoniades, 1981), and thus is directly 
proportional to the number of platelets in PRP. PDGF can also be found in other 
cells, such as macrophages (Rappolee et al., 1988), fibroblasts (Antoniades et 
al., 1991) and in bone matrix (Hauschka et al., 1986). Human PDGF was 
originally identified as a disulfide-linked dimer of two different polypeptide 






homodimers (AA and BB), one heterodimer (AB) (Miyazono and Takaku, 1989). 
The reason for three distinct forms remains unclear, but a differential binding 
between the three distinct forms and various target cells such as macrophages, 
fibroblasts, endothelium and marrow stem cells has been suggested (Ross et 
al., 1986). This view lasted for more than 15 years until combinations of 
genomic and biochemical efforts identified two additional PDGF genes and 
proteins, PDGF-C (Li et al., 2000) and PDGF-D (LaRochelle et al., 2001). 
PDGF isoforms signal through a homo- or heterodimeric receptor of PDGF 
receptor- α (PDGF-R α) or PDGF receptor- β (PDGF-R β) subunits (Andrae et 
al., 2008). One heterodimer (PDGF-AB) has been found in human platelets 
(Ekman et al. 1999). The biological activities of PDGF are mostly involved in the 
stimulation of mitogenesis, angiogenesis and macrophage activation (Raines et 
al., 1990), fibroblast chemotaxis and collagen synthesis (Matsuda et al., 1992) 
and proliferation of bone osteoblast cells (Yang et al., 2000). Cell migration is 
one of the well-documented effect of PDGF in vitro (Heldin and Westermark 
1999). It also promotes the deposition of fibronectin and glycosaminoglycan 
(Anitua et al., 2005). The effect of PDGF on mesenchymal stem cells (MSCs) 
has been intensively studied. PDGF signalling has been identified as the key 
pathways involved in MSCs differentiation into osteogenic lineage where genes 
of the PDGF pathway are expressed strongly in undifferentiated MSCs (Ng et 
al., 2008).  
 
 Transforming growth factor (TGF): TGF-𝛽1 and 𝛽2 are members of a 
super-family of growth and differentiation factors including the bone 
morphogenetic protein (BMP) which are involved in connective tissue healing 
and bone regeneration (Celeste et al., 1990). The most important function of 
TGF-𝛽1 and -𝛽2 is chemotaxis and mitogenesis of preosteoblasts during bone 
formation (Beck et al., 1993). TGF-β1 has been reported to promote the 
biosynthesis of type I collagen and fibronectin, to stimulate the deposition of 
bone matrix (Bonewald and Mundy, 1990), and to inhibit osteoclast formation 
and bone resorption (Mohan and Baylink, 1991). Accordingly, TGF-𝛽 not only 
initiates bone regeneration but also supports long term healing and remodelling 






 Insulin-like growth factor (IGF-1): it is produced by the liver and is primarily 
found in plasma, and is therefore found at fixed levels in most PRP preparations 
regardless of the platelet count (Doessing et al., 2010). IGF-1 is known to 
enhance bone formation when it binds to a specific receptor on the cell 
membrane of preosteoblasts and stimulates their proliferation and differentiation 
(Hock et al., 1988). The presence of IGF-1 could also inhibit apoptosis of bone 
cells (Joseph et al., 1996). It is known to be responsible for the bone formation-
bone resorption interaction (Mohan and Baylink, 2002).  
The biological effect of IGF-1 could be regulated by IGF binding proteins 
(IGFBPs) where IGFBPs could be involved in transporting IGF-1 and increasing 
its half-life (Govoni et al., 2005).  
 
3. The Role of angiogenesis factors to promote bone healing process 
Angiogenesis is essential in the bone healing process where osteogenesis 
needs a sufficient blood supply. It is, therefore, vital to promote angiogenesis 
rapidly in the bone healing area in the early healing stages and also during the 
long-term process of ossification. There are two independent pathways 
stimulating angiogenesis; one depends on vascular endothelial growth factors 
(VEGF) released from platelet granules, and the other depends on angiogenin. 
VEGF mainly stimulates the growth of new-born local blood vessels and specific 
mitogen of endothelial cell, whereas angiogenin mainly affects large vessels 
and collateral circulation formation (Behr et al., 2011).  
The vascularisation potential of PRP was found to be associated with some 
important factors such as; the concentration of plasma, activation of Ca2+, the 
release of VEGF and the formation of platelets (Karp et al., 2005).  
 
1.8.2.4 PRP activation 
PRP activation initiates 2 main processes within PRP preparations; 
degranulation of platelets to release ɑ-granules containing growth factors, and 
fibrinogen cleavage to initiate fibrin matrix formation (Wasterlain et al., 2012). 
Once the PRP is activated, the extracted PRP fraction is often called the PRP 






calcium chloride and thrombin, freeze/thaw cycles, and direct exposure to 
collagen in vivo.  
 
 Calcium chloride and thrombin activation 
At the time of clinical application, the PRP is combined with a certain amount of 
a sterile saline solution containing 10% calcium chloride and thrombin which 
causes the platelets to degranulate and release GFs and cytokines. Calcium 
chloride is a citrate inhibitor that allows the plasma to coagulate by replenishing 
the binding site that were previously bound by anticoagulant. Thrombin directly 
activates platelets through a proteolytic G-coupled protein receptor and also 
allows polymerization of the fibrinogen into an insoluble fibrin gel. Different 
protocols for PRP activation exist. However, the standard clinical approach uses 
a ratio of thrombin to CaCl2 of 142.8 U/mL thrombin to 14.3 mg/mL CaCl2.2H2O 
as suggested by Marx et al. (1998). A mixture of 1,000 UI of thrombin powder 
suspended in 10mL of sterile saline with 10% calcium chloride was also 
reported for the initiation of the coagulation process (Sánchez et al., 2003). 
While, Anitua (1999) suggested that 50 µL of 10% calcium chloride can be 
utilised to activate 1.2mL of PRP for 15 to 20 min, then a PRP gel can be 
formed without using thrombin.  
One of the disadvantages of using calcium chloride and thrombin as exogenous 
activators is the increased risk of infections and allergic or other reactions. This 
is especially true with the use of bovine thrombin, which is immunogenic. 
Therefore, calcium can be used independently as an alternative way to 
stimulate platelet activation (Anitua et al., 2012).  
 
 Freeze/thaw cycle activation 
PRP is stable for 5 days at room temperature (Cognasse et al., 2009) and for 
longer when frozen. However, freeze/thawing cycles are reported to physically 
damage and lyse the platelets, and hence initiate the de-granulation and 
release the contents of the ɑ-granules (Johnson et al., 2011). It seems that 
activation through freeze/thaw cycles initiates platelets degranulation only, 
whereas addition of thrombin and calcium chloride is effective in activating both 






cycles necessary for complete degranulation is not clear. Many protocols 
suggest 4 freeze/thaw cycles for in vitro studies. The freeze/thaw cycle 
activation method is useful for in vitro PRP applications and laboratory 
experiments because it does not use chemical substances to activate the 
platelets and therefore does not alter the composition of the sample. However, 
this method is time consuming and thus is impractical for clinical applications 
(Wasterlain et al., 2012). 
 
 In vivo collagen activation 
It was suggested that the liquid form of PRP (non-activated) can be injected 
directly into the injured tissue to be activated on contact with collagen. 
Thrombogenic fibrillar collagen types I and III (COL1 and COL3) are regarded 
as the most potent activators of platelet adhesion and aggregation because of 
their high content of von Willebrand factor, which is an important substrate that 
mediates the interaction between collagen and platelets (Farndale et al., 2003) 
Many clinical applications prefer the use of in vivo collagen activation for 
activating PRP, as it leads to a slower and more sustained release of growth 
factors, compared with thrombin. It was proved that collagen activation leads to 
a more sustained release and 80% greater cumulative release of TGF-β1 over a 
seven-day period, compared with thrombin activation (Fufa et al., 2008; 
Harrison et al., 2011). While, cumulative release of VEGF appears unaffected 
by the activation method used, and PDGF has shown mixed results.  
One of the main benefits of using in vivo collagen activation is that it enables 
the PRP to be injected through a smaller-gauge needle as the clotting as not 
occurred. Furthermore, its use eliminates the risk of immunologic reactions to 
exogenous activating substances such as calcium or thrombin (Wasterlain et 
al., 2012). 
 
1.8.2.5 The Application of PRP in bone tissue engineering  
The application of PRP in dentistry have been intensively published to clarify 
the clinical efficiency of PRP as a source of many growth factors on bone 
regeneration and healing process (Schliephake, 2002; Sánchez et al., 2003; 






Nikolidakis and Jansen, 2008; Plachokova et al., 2008; Anitua et al., 2012; 
Albanese et al., 2013). 
 
1) PRP in dental implant applications 
Many human and animal studies using PRP have yielded promising results in 
dental implant applications. PRP was used topically at the implant site to 
enhance bone regeneration (Zechner et al., 2002). In 2006, Anitua indicated 
that coating the dental implant with PRP prior to its insertion into the jaw bone 
might generate a new active surface which could potentially enhance the 
osseointegration process. Similarly, Gentile et al. (2010) reported the efficacy of 
PRP treatment in postoperative patients' satisfaction of 15 cases including 
maxillofacial surgery, post-extraction bone regeneration and dental 
implantation. Anitua et al. (2008) and Anand and Mehta (2012) have suggested 
the use of a PRP coated implant to improve the prognosis of immediate loading 
protocol with dental prosthesis. However, PRP efficiency in dental implant 
applications was controversial. Thor et al. (2005) in a conflicting study failed to 
show a positive effect for PRP gel in association with autogenous bone graft on 
the survival rates of the dental implants of severely resorbed maxilla. Likewise, 
Garcia et al. (2010) did not find a significant enhancement in bone formation 
around sandblasted acid etched dental implants placed in association with PRP 
gel. 
 
2) PRP and bone grafts in dental surgery  
Clinical studies have shown that the bone density and the maturation rate 
increased significantly after implanting bone grafts in combination with PRP into 
mandibular bone defects compared to using grafts alone (Marx et al., 1998). 
The combination of mesenchymal stem cells (MSCs) with PRP and autogenous 
bone grafts also showed a significantly higher maturation of bone in a canine 
model (Yamada et al., 2004). Moreover, it was demonstrated previously that 
PRP combined with autologous cancellous graft could significantly improve the 
bone regeneration compared to graft applied alone in a critical size defect of 
load-bearing long bones of minipigs (Hakimi et al., 2010). In another published 






with autograft was evaluated in bone defect model of 23 rabbits. They found 
that the use of PRP in this study enhanced type III to type I collagen ratio and 
the chemotaxis of CD34+ bone progenitor cells (Giovanini et al., 2010). The use 
of PRP with bone graft was also proved to significantly enhance the quality of 
bone healing in rabbit model (Kanthan et al., 2011).  
 
3) PRP and biomaterials in dental surgery 
Studies of tissue engineering have obtained more favourable clinical results in 
bone repair when PRP was used in association with biomaterials which resulted 
in better bone inductivity (improved the cells ability to induce bone formation) 
and conductivity (support the bone growth on the biomaterial).  
Some investigators reported that using PRP in combination with hydroxyapatite 
or tricalcium phosphate scaffolds and bone substitute materials may hold some 
promise for tissue engineering purposes by enhancing in vivo bone 
regeneration compared to the use of the scaffold alone (Okuda et al., 2005; 
Abhijit, 2006; Rai et al., 2007; Chevallier et al., 2010; Bi et al., 2010, Klein et al., 
2010; Qi et al., 2015).  
Kim et al. (2002) introduced a combination of particulate dentine, plaster of 
paris (calcium sulphate) and PRP around titanium dental implants in a canine 
model where they observed a better histological outcome of bone formation 
when PRP was added to the biomaterials. Bone density and the maturation rate 
was increased significantly after implanting calcium phosphate scaffolds in 
combination with PRP in mandibular bone defects compared to using scaffolds 
alone (Kovács et al., 2003). Yamada et al. (2004) in an animal study observed a 
well-formed mature bone in osseous defects when injected with PRP gel and 
MSCs compared to PRP alone or autogenous bone graft. They found a 
progressive and complete resorption of PRP gel and relatively mature bone. 
Another animal study showed that the bone regeneration around dental 
implants was promoted when the implants were placed simultaneously with a 
combination of MSCs, PRP and fibrin glue (a composite contains fibrinogen and 
thrombin) in areas with poor bone quality or low bone volume (Ito et al., 2006). 
The fibrin glue was used as an osteoconductive scaffold for the stem cells and 






and PRP combinations as a novel biomaterial that is able to induce bone 
formation in bone defects. They assumed that the exothermic reaction 
generated by the mixture of calcium sulphate with PRP activates the platelets 
contained within the PRP and that this combination behaves as time-controlled 
releasing matrix for all platelet GFs (Intini et al., 2007). The effect of PRP in the 
treatment of periodontal intrabony defects was also evaluated by Yamamiya et 
al. (2008) who observed a more favourable clinical improvement in the 
periodontal defects when treated with a combination of HA, PRP and human 
periosteum sheet (contain osteoprogenitor cells and extracellular matrix) 
compared to HA and PRP combination. They attributed this result to the 
additional benefit of the osteogenic cells found in the periosteum sheet. 
However, Sammartino et al. (2009) did not find a higher grade of bone 
regeneration in vivo when combined PRP with a resorbable collagen membrane 
compared to PRP alone (Sammartino et al., 2009). 
Studies on the effect of PRP on bone healing were not all positive. In previous 
animal studies, it was revealed that the use of PRP gel did not have any effect 
on the bone-implant contact of trabecular bone (Nikolidakis et al., 2006) and 
cortical bone (Nikolidakis et al., 2008) to calcium phosphate coated implants, 
while non-activated PRP in a liquid form induced an increase in bone apposition 
to roughened titanium implants. They related this difference to the mechanical 
trauma caused by the pressure of the PRP gel on the bone walls of the already 
tightly fitted implant leading consequently to bone resorption and necrosis of 
interfacial bone. They supported their hypothesis by indicating remnants of PRP 
gel around the implant surfaces which couldn’t be seen around calcium 
phosphate coated implants, suggesting that calcium phosphate coating may 
enhance macrophage activation (Silva et al., 2003) and play a role in the faster 
degradation of PRP gel. Kasten et al. (2008) investigated in vitro effect of PRP 
on MSCs seeded on calcium phosphate scaffold and found that PRP improved 
cell proliferation on the scaffold but reduced the osteogenic differentiation 
compared to calcium phosphate scaffold alone, relating the reason to inefficient 
PRP preparation and storage method. Another recent animal study also 






did not show a significant difference compared to PRP alone (Sebben et al., 
2012).  
Despite some benefits demonstrated to date, mixed results were reported about 
the potential establishment of platelet therapy as a reliable therapy in managing 
the bone, and therefore no definitive conclusions could be drawn. In addition, 
limited information is available regarding the biological effect of PRP alone or in 
combination with other biomaterials on osseointegration of dental implants 
which would require the completion of high quality clinical trials with long-term 
follow up.   
 
1.9 Stem cells used in bone tissue engineering  
For tissue engineering purposes, it has been proposed that a complex of 
interactions involving osteoprogenitor cells, osteoinductive mediators and 
osteoconductive matrices would be the ideal restoration of both soft and hard 
tissues (Giannoudis et al., 2007). 
Stem cells are one of the most obvious source of cells that are known for their 
unique ability to self-renew to be used for bone tissue engineering (Caplan, 
1991). Pluripotent Stem cells can give rise to different progenitors of all body 
tissues, whereas multipotent stem cells are cells that have the capacity to 
develop into multiple specialised cell types present in a specific tissue or organ. 
Most adult stem cells are multipotent stem cells. They usually remain inactive 
but in cases of disease and injury, they become activated to regenerate the 
damaged tissues (Castro-Malaspina et al., 1981, Caplan, 1991, Ying et al., 
2002).  
Osteoblasts were also used for tissue engineering purposes. Nevertheless, 
many limitations for using these cells were highlighted including; the osteoblast 
cells available for harvesting are usually low in number, and their expansion in 
vitro is limited, expensive and slow (Salgado et al., 2004). 
 
Stem cells are divided into different categories on the basis of origin: 
 Embryonic stem cells (ESCs): are pluripotent stem cells, isolated originally 
from the inner cell mass of mouse early pre-implantation blastocyst that can 






for drug discovery, immunotherapy and regenerative medicine. However, their 
use in humans has been restricted due to ethical issues.  
 
 Mesenchymal stem cells (MSCs): are self-renewable multipotent cells 
(differentiate into more than one cell type) that exist in adult tissues. They have 
the ability to differentiate in vitro into adipocytes, chondrocytes and osteoblasts 
(Dominici et al., 2006).They are easily obtainable and can be expanded in vitro. 
Their exceptional genomic stability and ethical acceptance made MSCs 
important tools in cell therapy and regenerative medicine (Horwitz et al., 2005). 
To identify MSCs in mixed population of cells, the cells should possess specific 
set of cell surface markers called cluster of differentiation (CD) including CD73, 
CD90, CD105, CD34, CD45 and human leucocyte antigen-DR (HLA-DR) 
(Dominici et al., 2006). 
MSCs isolated from bone marrow have been reported to be an efficient 
population of MSCs (Pittenger et al., 1999). Cells which exhibit characteristics 
of MSCs were also isolated from different tissues such as adipose tissue and 
umbilical cord (Wagner et al., 2005), amniotic fluid (Scherjon et al., 2003), 
placenta and fetal membrane (Raynaud et al., 2012), salivary gland (Rotter et 
al., 2008), synovial fluid (Morito et al., 2008) and dental tissues (Huang et al., 
2009). 
Recently, a distinct population of human postnatal dental pulp stem cells 
(hDPSCs) have been described and have offered promising prospects for tissue 
engineered constructs including dentin and bone (Miura et al., 2003; Shi et al., 
2005). Normally, dental pulp tissue comprises of condensed connective tissue 
that contains a mixture of fibroblasts, lymphocytes, macrophages, dendritic 
cells, nerve cells, pericytes, endothelial cells and undifferentiated mesenchymal 
cells, embedded in a fibrous vascular stroma (de Oliveira et al., 2003). This 
mixed population of cells originates mainly from the neural crest and first 
branchial arch mesoderm and later on from the dental follicle. Dental pulp cells 
retain a mitotic potential even in the adult tissue (Tecles, 2005), and hence they 
were expected to act as adult stem cells (Mrozik et al., 2010). hDPSCs were 
proved to be a generic source of mesenchymal stem cells. They retain the 






culture (Papaccio et al., 2006, Govindasamy et al., 2010). Moreover, hDPSCs 
were known to express various mesenchymal stem cell markers such as CD29, 
CD44, CD146, CD90, CD105, STRO-1, CD106, and OCT4 (embryonic stem 
cell marker) (Gronthos et al., 2002; Lindroos et al., 2008). hDPSCs were shown 
to undergo self-renewal and multi-lineage differentiation. They are able to 
differentiate into odontoblasts, adipocytes, chondrocytes, and osteoblasts in 
vitro (d’Aquino et al., 2008, Koyama et al., 2009). The ability of hDPSCs to 
differentiate into functional osteoblasts and produce a mineralised matrix have 
been reported in many in vitro studies (Pisciotta et al., 2012, Riccio et al., 2010). 
In addition, the ability of hDPSCs to reconstruct bony structures were confirmed 
in some in vivo studies (d’Aquino et al., 2009, Giuliani et al., 2013, Sheth et al., 
2017).  hDPSCs were shown to have comparable behaviour to human bone 
marrow stem cells (El-Gendy, 2010). hDPSCs are easily collected from third 
molars and premolars that were extracted for clinical reasons and are easily 
banked (Volponi et al., 2010). Wisdom teeth are the preferred source for 
hDPSCs as they are the last teeth to develop, thus their cells retain maximum 
pluripotency and proliferative potential (Couble et al., 2000). The cells are 
usually isolated from pulp tissues via two main methods; explant outgrowth 
cultures and enzyme digestion. The method of explant outgrowth simply 
involves excavating the pulp tissue from the extracted teeth under aseptic 
conditions and growing it in culture medium (Huang et al., 2006). The enzyme 
digestion method is achieved by mincing the pulp tissue and immersing it in a 
digestion cocktail of collagenase type I and dispase, then the digested cell 
solution is passed through a cell strainer to obtain a suspension of single cells 
(Gronthos et al., 2000, Huang et al., 2006). The enzyme digestion method 
results in a higher yield of cells that have faster proliferation compared to the 
former method. Further, it can give rise to a distinct variety of cells that were not 
reliably obtained using the outgrowth method (Tsukamoto et al., 1992, Couble 







Chapter 2: Aim of the study 
 
The purpose of the present study was to investigate in vitro, the synergistic 
effect of FA coatings and PRP on cell adhesion, growth, differentiation and 
mineralization, with the long term and ultimate goal of enhancing bone 
formation and hence osseointegration of dental implants. 
 
Objectives: 
1. To investigate the growth of FA crystals grown by a hydrothermal method on 
stainless steel discs. 
2. To characterise PRP fraction extracted from total human blood. 
3. To evaluate the biocompatibility of the FA coatings and PRP. 
4. To investigate the effect of the FA coatings on the release of osteogenic 
growth factors from PRP. 
5. To assess the adsorbed proteins of PRP on FA coatings. 
6. To investigate the attachment and growth of osteoblast cell line on FA 
coatings and PRP combinations. 
7. To evaluate the synergistic effect of FA coating and PRP on the osteogenic 










Chapter 3: Materials and Methods 
 
3.1 Fluorapatite coatings (FA) 
3.1.1 Synthesis of the FA coatings on metal substrates 
3.1.1.1 Principle 
The methodology of FA coating synthesis on metal substrates used herein has 
been previously described by Chen et al. (2006b) and modified by Czajka-
Jakubowska et al. (2009a). In this method, EDTA was used in the precipitation 
solution to stabilize the release of Ca2+ ions under a specific pH and under mild 
hydrothermal conditions (121°C, 2 atm for 10 hours). The morphology of 
synthetic FA crystals changes during this time from amorphous deposits to 
hollow balls and finally ends with well-defined, long nanorods crystals.  
 
3.1.1.2 Materials  
The details of the materials and chemicals that were used in FA coating 
procedure are recorded in table 2, unless otherwise stated.  
 




A bar of SS was purchased and cut into discs of 12 mm diameter and 1mm 
thickness. Their flat surfaces were ground smoothed using an aluminium oxide 
60,000 grit grinding wheel (Mester Tooling, UK). The discs were treated with 
Material/ Chemical Company Cat no. 
Stainless steel (SS grade 316) bar Metals 4U LTD NA 
Sulphuric acid 98% Analar -Analytical Grade VWR Chemicals 102765G 
Hydrogen peroxide 35% wt.  in H2O  Sigma 349887 
Etheylenedeiaminetetraacetic acid calcium 




Sodium phosphate monobasic monohydrate 
98.0-102.0% (NaH2PO4.H2O)  
Sigma-Aldrich S3522 






piranha solution comprising of equal volumes of sulphuric acid 98% and 
hydrogen peroxide 35% for 24 hours. The discs were then rinsed generously 
under tap water, sonicated in distilled water for 1 hour with changing of the 
water every 15 min and left to dry. Etched SS discs were then hydrothermally 
coated with FA as shown in figure (9). In brief, 9.36g of EDTA.Ca.Na2 (0.25 M) 
and 2.07g of NaH2PO4.H2O (0.15 M) were mixed with 80mL distilled water. The 
suspension was stirred continuously and the pH was adjusted to 6.0 using 
NaOH. The suspension was then made up to 90 mL with distilled water. 
Meanwhile, 0.21g NaF (0.05 M) was dissolved in 10 mL distilled water (pH 7.0) 
and added to the mixture to produce 100mL of coating (mineralising) solution.  
FA crystal growth on the SS discs was achieved by immersing the discs, 
positioned vertically or tilted at 45° as illustrated in figure 1, in the freshly 
prepared FA coating solution. The coated discs were then autoclaved (Rodwell, 
UK) at 121°C, at a pressure of approximately 2 atmospheres for 10 hours.    
 
 
Figure 9: Diagram showing the mild hydrothermal method used to synthesise FA 
coatings on SS discs (dH2O, distilled water). 
 
  
3.1.2 Optimisation of post synthesis treatment of the FA coatings 
After the autoclaving cycle of 10 hours was completed, the coated discs were 






clear. The discs were then left to dry overnight in a dryer. The effect of the 
subsequent washing and drying process on the FA coatings was observed. The 
following groups were set up with using three samples in each group:  
Group I:  Discs tilted at 45°, dried in vacuum desiccator for 24 hours without 
washing (no washing but dried i.e. unwashed group). 
Group II: Discs tilted at 45°, dried in vacuum desiccator for 24 hours then 
rinsed several times with distilled water (dried- washed group) and dried again. 
Group III: Discs tilted at 45°, rinsed several times with distilled water (pH7.0), 
then dried in vacuum desiccator for 24 hours (washed- dried group). 
Group IV: Discs positioned vertically (unwashed but dried group). 
Group V: Discs positioned vertically (dried- washed group). 
Group VI: Discs positioned vertically (washed- dried group).  
 
3.1.3 Characterisation of FA-coated substrates 
3.1.3.1 Scanning Electron Microscopy (SEM)  
3.1.3.1.1 Principle 
Scanning electron microscopy (SEM) is used to investigate the microstructure 
and topography of a surface. Under the SEM, the specimen surface is scanned 
with a finely focused electron beam emitted from an electron gun fitted with a 
tungsten filament cathode toward the conductive sample. The electrons are 
detected by detectors to obtain images for the surface with different signal 
characteristics. Two types of electrons can be detected; secondary electrons 
(SE) and back scattered electrons (BSE). SE are low energy electrons. They 
are generated very closely to the surface within a few nanometers allowing for 
high resolution images to be produced. The electron beam hits the sample 
leading to interaction between the sample surface and the electron. As a result 
of this interaction, the electrons are displaced from within the sample resulting 
in energy converted into image for the surface of the sample. Backscattered 
electrons mode (BSE) consists of high energy electrons that are back scattered 
out of the specimen interaction. It is used to detect the contrast between areas 
with different atomic numbers and chemical compositions. Since heavy 










Back scattered SEM (Hitachi S-3400N) was used to characterise the 
synthesised FA coatings by looking at the microstructure, topography, 
morphology and orientation of the crystals of upper and under surfaces of FA 
coated discs. Prepared FA coated specimens were mounted on aluminum stubs 
at a 5 mm distance and scanned under low vacuum with an accelerating 
voltage of 20kV and a beam current of 50 µA using different magnifications. 
SEM images showed disorganised FA coatings on upper disc surfaces and 
organised FA coatings on the under surfaces.  
 
3.1.3.2 Energy dispersive x-ray spectroscopy (EDS) 
3.1.3.2.1 Principle 
The elemental composition of a specimen surface can be determined using 
energy dispersive x-ray spectroscopy (EDS). EDS is based on generating 
secondary X-rays in a specimen through electron bombardment. Subsequently, 
the elements of the specimen and their relative percentages are identified using 
the wavelengths and intensities of the produced X-rays (Gruia, 2017). EDS is 
regarded as a semi-quantitative analysis which can provide a comparative 
information about the relative proportions of the elements within a sampling 
depth of 1-2 microns (Goldstein et al., 2017). 
 
3.1.3.2.2 Method 
The EDS apparatus used to analyse the chemical composition of the FA 
coatings (Bruker 4030 Quantax SDD-EDS system, Germany) was attached to 
the SEM (operated at 20kV with a beam current of 50 µA). Analysis was carried 








3.1.4 Biocompatibility assessment of FA coatings 
According to the results of FA coating characterisation conducted previously, it 
was decided to use group III FA-coated discs (i.e. discs tilted at 45°/ washed 
then dried) for the subsequent cell culture experiments. The biocompatibility of 
FA coatings was assessed under the microscope on the basis of cell adherence 
and colonisation of osteoblast-like cells (human osteosarcoma G292 cell line) 
on the FA coated surfaces. All cell culture experiments were carried out 
aseptically in a class II biological safety laminar flow hood. G292 cells were 
purchased from the European Collection of Cell Cultures (ECCAC) and 
received as frozen cells. The cells were revived, expanded and seeded on FA 
coated discs for the biocompatibility test.  
 
3.1.4.1 Materials  
All reagents and materials used in cell culturing and biocompatibility testing 
were listed in table 3, unless otherwise stated. 
 
Table 3: List and details of the materials that were used for cell culturing 
 
Materials/ chemicals Company Catalogue no. 
Alpha minimum essential medium without 
L-Glutamine (α-MEM)   
Lonza, BioWhittaker BE12-169F 
Fetal bovine serum (FBS)  Sigma - Aldrich  F9665 
Penicillin (10,000 units/mL) – Streptomycin 
(10 mg/mL) (P/S)   
Sigma- Aldrich,  Life 
science 
P4333 
L-glutamine (200 mM) (L-G) Sigma - Aldrich  G7513 
Phosphate buffered saline 1x, pH 7.4 
without Ca or Mg (PBS) 
Lonza, BioWhittaker BE17-516F 
Trypsin-EDTA (Ethylenediaminetetra- 
acetic acid ) 0.25 % (w/v) solution (T/E) 
Sigma- Aldrich, Life 
science 
T4049 
Trypan blue 0.4% Sigma- Aldrich T8154 
Agarose low gelling temperature  Sigma- Aldrich A9045 
Neutral buffered formalin (10%) (NBF) Cellpath BAF-0010-01A 






3.1.4.2 Recovery of Cryopreserved Cells 
3.1.4.2.1 Principle 
The cells are commonly cryopreserved (frozen) at −80°C or in liquid nitrogen for 
long-term storage. Cell freezing allows secure preservation of the cells without 
contamination, senescence and genetic drift. The cells should be cryopreserved 
in culture medium supplemented with 10% to 20% (v/v) serum and 10% (v/v) 
preservative like dimethylsulfoxide (DMSO). The DMSO allows gradual freezing 
of the cells with a slow cooling rate of 1°C/ minute. This minimises the risk of ice 
crystal formation and consequent cell damage. To recover the cells with a high 
survival rate, they need to be thawed as quickly as possible to prevent 
formation of ice crystals that can cause cell lysis. The cell freezing medium 
should be diluted for about 10-20 fold in order to reduce the potential 
cytotoxicity of DMSO on the cells. During cell recovery, DMSO should be 
completely removed from the cell culture by centrifuging and re-suspending the 
cells in fresh medium or alternatively changing the medium once the cells are 
attached (Freshney, 2006).     
 
3.1.4.2.2 Method 
Frozen cells were thawed by agitating the cell vial in a water bath (37°C) for 
about 1 minute and pipetting the content into falcon tube containing 10 mL of α-
MEM supplemented with 10% FBS, 1% P/S and 1% L- G. Then the resulting 
cell suspension was centrifuged at 200 g for 5 minutes. The supernatant was 
discarded and the cell pellet was re-suspended in 15 mL cell medium and 
plated in 75cm2 cell culture flask at 37°C in 5% (v/v) carbon dioxide (CO2) in air 
and 98% relative humidity. The cells were cultured for 2-3 days until they 
became 80-90% confluent and were then passaged (expanded).  
 
3.1.4.3 Cell expansion 
3.1.4.3.1 Principle 
Cells in monolayer culture are usually subcultured when becomes 80-90% 
confluent so as to expand the cell population. The first step in subculturing 
monolayers is to detach cells from the surface of the culture vessel by 






facilitate cell adhesion to the culture vessel and to other cells. Trypsin is 
inhibited by serum and calcium (Ca2+) and magnesium (Mg2+) ions. Therefore, 
EDTA (disodium ethylenediamine tetraacetic acid) is added to trypsin solution 
as a chelating agent to bind to Ca2+ and Mg2+ ions found in the culture. The 
resultant cell suspension is then subdivided and reseeded into new cultures. 
Secondary cultures are monitored for growth and nourished with fresh medium 
every 3-5 days. Cells are once again passaged when they become 80-90% 
confluent (Phelan and May, 2007). 
 
3.1.4.3.2 Method 
Cell culture medium was aspirated from the cell culture flasks (75cm2) and the 
cell surface monolayer was washed twice with PBS (without Ca or Mg). The 
PBS was then thoroughly aspirated and the cells were detached using Trypsin / 
EDTA. Five mL of 0.25 % (w/v) Trypsin / EDTA solution was added to the cell 
culture flask and incubated with the cells for no longer than 2 minutes at 37°C.  
Following incubation, the culture was checked for cell detachment with an 
inverted microscope to be sure that the cells are rounded and detached from 
the surface. On successful detachment, 5 mL of complete cell medium (α-MEM 
and 10% FBS) was added to each flask to deactivate and stop further action of 
trypsin that might be harmful to the cells. Flask contents were then transferred 
into a universal tube and centrifuged at 200 g for five minutes.  Following 
centrifugation, the supernatant was discarded and the cell pellet was 
resuspended and homogenised in complete culture medium.  A viable cell count 
was performed before being seeded at a specific cell density according to the 
design of the experiment. 
 
3.1.4.4 Viable cell counting 
3.1.4.4.1 Principle 
Seeding the cells in culture with a specific cell density is important in performing 
accurate quantitation experiments for standard culture conditions. Cell number 
is determined by a hemocytometer. It is a thick glass slide with a counting 
chamber of a specific volume. The chamber has 9 major squares with a volume 






so the final volume of each square is 0.1 mm3 (0.0001 mL). The cells are 
stained with Trypan blue dye to distinguish between live and dead cells. 
Nonviable cells which take up the dye through the damaged cell membrane are 
not counted. While live cells with intact cell membrane are impermeable to the 
dye (Phelan and May, 2007). 
 
3.1.4.4.2 Method 
To count the cells, a mixture of a 20 µL cell suspension and 20 µL trypan blue 
was loaded into the hemocytometer chamber. Under a light microscope (x10 
objective lens), the cell number was manually counted in 4 corner squares. The 
total viable cells were counted and the average cell number was calculated. The 
total number of the cells per mL was calculated by multiplying the average cell 
count by the dilution factor of trypan blue (2), then by 10,000: 
Cell number (cells/mL) = average of cell number of 4 squares x 2 x 10,000 
 
3.1.4.5 Agarose wells preparation 
3.1.4.5.1 Principle  
Agarose wells (12 mm in diameter) were used to accommodate and restrict cell 
attachment and growth on FA coated discs 
 
3.1.4.5.2 Method  
Agarose solution was prepared by mixing 3% (w/v) agarose of low gelling and 
melting points (congealing temperature 26-30°C and melting point ≤ 65°C) in 
PBS. The agarose solution was then autoclaved at 121°C. Subsequently, the 
agarose solution was left to cool down for 5 minutes before being poured into a 
12-well plate containing 12 mm diameter moulds suspended in the wells. Once 
the agarose had gelled, the moulds were gently removed leaving agarose wells 











Figure 10: Schematic diagram (A) and photograph (B) for agarose wells 
preparation. SS moulds of 12mm diameter are suspended inside the wells of 12-
well plate with agarose poured around them. 
 
3.1.4.6 Cell seeding procedure on FA coatings 
FA coated discs and uncoated etched SS discs were autoclaved at 121°C for at 








atmospheric pressure. Sterile FA-coated discs (three with ordered and three 
with disordered FA crystals) and three control uncoated discs were placed in 
the agarose wells and equilibrated with 10% FBS culture medium for 2 hours. 
Subsequently, G292 cells were seeded on each disc of the three groups at a 
density of 1x104 cells/cm2 in 500 µL media. After 3 - 4 hours, 500 µL 10% FBS 
media was equally added into each well and cultured for 2 days (Figure 11).  
 
 
Figure 11: G292 cells seeded on uncoated and FA coated discs placed inside 
agarose wells.  
 
 
3.1.4.7 SEM observation for the cells 
3.1.4.7.1 Principle 
SEM (BSE) could be used to detect contrast between areas with different 
chemical compositions. The high beam energy of BSE penetrates deeply into 
the cells, producing an image with Z contrast and allowing the identification of 
major cellular compartments such as cellular cytoskeleton. If the scanned 
sample is not conductive as is the case of cells and tissues, a discharge of the 
electrons will happened when they hit the sample surface resulting in unclear 
image with low resolution. Therefore, it is preferable to sputter- coat the sample 
with a thin gold or copper layer to conduct the incident electrons (Khursheed, 






transmitted light microscopy. Thus, cell morphology and the distribution of G292 
grown on FA coated discs were observed under the SEM using BSE. 
 
3.1.4.7.2 Method  
After 2 days of cell culturing, the discs were removed from the agarose wells 
and gently washed with PBS. The cells on the discs were fixed with 10% neutral 
buffered formalin (NBF) overnight at 4ºC. To minimise tissue shrinkage, a 
graded series of ethanol was used for tissue dehydration instead of absolute 
ethanol. Thus, after fixation, the specimens were thoroughly washed with PBS 
and serially dehydrated in ethanol for 30 minutes in each concentration (30%, 
50%, 70%, 90% and 100%). After that, the discs were left to dry in a vacuum 
desiccator overnight before being sputter-coated with about 5 nm gold film to 
prevent specimen charging and image artefacts using an argon sputter coating 
unit (Agar Scientific, Stanstead, UK). The samples were then mounted on 
aluminium stubs at a 5 mm distance and scanned under low vacuum with an 
accelerating voltage of 20Kv using BSE.  
 
3.1.4.8 Confocal laser scanning microscopy (CLSM) 
3.1.4.8.1 Principle 
Alexa Fluor 488 Phalloidin and TO-PRO-3 nucleic acid stain are used to label 
the cells’ cytoskeleton and nucleus respectively. Phalloidin conjugated to bright, 
photo stable, green fluorescent Alexa Fluor 488 dye is a bicyclic peptide 
commonly used to selectively label F-actin. TO-PRO-3 is a dye composed of 
carbocyanine monomers that have very strong binding affinity for dsDNA giving 
a strong and selective staining of the nucleus in cultured cells. In this study, the 
cells that were grown on FA coated discs were stained with Alexa Fluor 488 
Phalloidin (Life Technologies, A12379) and TO-PRO-3 (Life Technologies, 
T3605) according to manufacturer’s instructions. The cells were then analysed 
under a laser scanning confocal microscopy (LSCM). LSCM uses Argon laser 
as a light source at visible wave lengths giving five different excitation lines in 
the blue/blue-green range. The light beam becomes a parallel beam of 
expanded diameter when it passes through a pinhole aperture, encounters a 






90° when it hits the dichromatic mirror and is focused onto the desired focal 
plane on the sample when it passes through the objective lens (Paddock, 
2000). When the light is absorbed by the fluorophore molecules of Alexa (i.e 
becomes excited) at a particular wave length (488nm), the fluorophore emits 
light at longer wave lengths (emission at 580nm). The emitted light is collected 
by the objectives and sensitive photomultiplier tube (PMTs) detectors. The 
microscope use TIFF images which are acquired with software for subsequent 
measurement and analysis. TO-PRO-3 dye exhibits fluorescence with excitation 
at 590 nm and emission at 700 nm. 
 
3.1.4.8.2 Method 
Briefly, the FA-coated samples were rinsed with PBS and fixed in 10% NBF for 
15min. After rinsing with PBS for 3 x 5 mins, 0.1% Triton X-100 in PBS was 
used to permeabilise the lightly fixed cell membrane for 15 min at room 
temperature. The samples were then rinsed with PBS (3 x 5 mins) before being 
stained with Alexa Fluor with a dilution of 1/10 in PBS for 2 hours in the dark 
and at room temperature. The samples were subsequently washed with PBS (3 
x 5 mins) and incubated in TO-PRO-3 nucleic acid stain (1/100 in PBS) for 20 
mins in the dark and at room temperature. Later, the staining solution was 
aspirated and replaced with fresh PBS. The cells were then analysed under a 
Spectral Confocal Leica TCS SPE microscope (Leica, GmbH) in conjunction 
with x10 and x40 dipping lenses to obtain three-dimensional images for the 
cells. 
 
3.1.5 Cytotoxicity of FA coatings 
3.1.5.1 Direct contact cytotoxicity test 
3.1.5.1.1 Principle 
 The direct contact cytotoxicity test allows both qualitative and quantitative 
assessment of cytotoxicity after direct exposure to the test sample. 
Qualitatively, the cells are checked under the microscope for any changes in 
morphology and growth rate compared to the control. In the quantitative 
assessment, the cells could be counted manually and checked for release of 






LDH release is an important and frequently applied test to measure cell death 
and inhibition of cell growth. LDH is a stable cytosolic enzyme that is released 
upon cell lysis, cellular membrane permeabilisation and severe irreversible cell 
damage. According to the International Standard Organisation’s ISO 10993-
5:2009E (DIN) standard, a decrease in cell viability by more than 30 % is 
regarded as a cytotoxic effect. LDH release is measured by recording the 
conversion of a tetrazolium salt (INT) into a red formazan product. The amount 
of formazan red colour is proportional to the number of dead cells. In this 
colorimetric reaction, LDH strips an electron from lactate and this electron is 
transferred to NAD to yield NADH. The NADH subsequently reduces the INT 




Test sample and control preparation 
Sterile FA coated and uncoated discs were placed in 6-well plate in triplicate. 
The discs were attached to the underlying culture plate surface by a 
biocompatible collagen gel. One drop of collagen gel (15 µL collagen gel and 
7.5 µL of sterile 0.1% NaOH to neutralise the gel) was loaded into the centre of 
each well. The discs were placed immediately over the drops and left to set for 
15 min. Subsequently, G292 cells were seeded in the wells at a cell density of 
(104/cm2) and cultured in 10% FBS supplemented Α-MEM (3mL/well) for 2 
days. Cells cultured on collagen gel drop with no discs in 10% FBS MEM were 
used as a negative control (nontoxic group). The positive control (100% toxic) 
was performed by placing a drop of cyanoacrylate contact adhesive into the 
centre of a one well. Blanks (culture medium background control) were 
prepared for LDH assay using the same conditions described above but without 
 
Lactate + NAD+                                    pyruvate + NADH 
 









cells. The absorbance value determined from the blank is used to normalize 
absorbance values obtained from the other samples.  
 
Qualitative evaluation of direct contact FA cytotoxicity  
After 2 days of incubation, the growing cells alongside the discs were examined 
microscopically to record any changes in the cell morphology and cell 
detachment and membrane integrity. Images were taken by digital camera 
attached to the inverted microscope (Olympus, CKX41).  
 
Quantitative evaluation of direct FA cytotoxicity  
The media was collected in eppendorf tubes and stored at -80°C to be 
investigated later for the release of LDH. The cells were detached by trypsin 
(0.25%) and counted using Trypan blue and hemocytometer as described in 
section 3.1.4.4.2. To measure LDH release, a 30-minute coupled enzymatic 
assay (CytoTox 96 colorimetric assay, Promega, Cat. no: G1780) was carried 
out according to the manufacturer’s instructions. Briefly, the collected media 
was thawed on ice and centrifuged at high speed (10000 g) for 10 min. Then, 
50 µL of the supernatant of each experimental sample, control and blanks were 
transferred into 96-well plate (flat bottom enzymatic assay plate) in triplicate. To 
each well, 50µL of reconstituted substrate mix was added and incubated at 
room temperature in the dark. After 30 minutes, the reaction was stopped by 
adding 50µL of stop solution into each well. The absorbance (optical density) 
was measured using VARIOSKAN FLASH spectrophotometer (Thermo 
scientific, UK) at 490nm. To calculate the results, the average of absorbance 
values of the culture medium background was subtracted from all absorbance 
values of experimental. The corrected values obtained were used in the 
following formula to compute percent cytotoxicity for each experimental group:  











3.1.5.2 Indirect contact cytotoxicity test 
3.1.5.2.1 Principle 
Indirect cytotoxicity tests are used to determine cell lysis and growth inhibition 
caused by a sample extract according to International Standard Organisation 
(ISO/EN 10993). The result of this indirect test depends on the concentration of 
the test material, the extraction volume, pH, chemical solubility, diffusion rate of 
molecules out of the test sample, temperature and time. Culture medium with 
serum is the preferred extraction vehicle because of its ability to support the 
cellular growth and to extract the polar substances (ionic compounds) and non-
polar substances (organic compounds). However, the use of culture medium 
without serum should be considered in order to specifically extract the polar 
substances as serum proteins are known to bind to some extractable ions and 
therefore mask and prevent the release of these ions (ISO 10993‐5, 2009).  
 
3.1.5.2.2 Method 
Preparation of liquid extracts of FA crystals 
A schematic diagram showing the steps of the indirect cytotoxicity test is shown 
in figure 12. FA crystals were prepared using the same mild hydrothermal 
method mentioned previously (section 3.1.1.3) but without adding SS discs to 
the mineralising solution. The synthesized crystals were rinsed several times 
with distilled water and dried in a dryer for 24 hours. The crystals were weighted 
and autoclaved at 121°C for at least 30 minutes by using saturated steam under 
at least 15 psi above atmospheric pressure. Subsequently, FA crystals were 
incubated in serum free α-MEM at a ratio of 200mg/mL at 37°C in 5% (v/v) 
carbon dioxide (CO2) in air and 98% relative humidity for 24 hours (Wei et al.,  
2011; Forghani et al., 2013). The mixture was then centrifuged at high speed 
(5000 g) and the supernatant was filtered (0.2 µm) to get rid of any FA crystal or 
debris. In the same time, a 50 mL of serum free unconditioned medium was 
exposed to the same incubation conditions of the FA extract and used to 










Figure 12: Schematic diagram for indirect cytotoxicity test of FA crystals. Sterile 
FA crystals were incubated in serum free α-MEM at a ratio of 200mg/mL and 
incubated at 37°C for 1 day. The mixture was then centrifuged and the 
supernatant was filtered and added to the cell culture. After 3 days, the 
cytotoxicity of FA- conditioned medium was analysed quantitatively using LDH 
assay. 
 
Test sample and control preparation 
G292 cells were plated in a 24-well plate at a density of 104/cm2, and cultured in 
10% FBS culture medium. After 24 hours, the culture medium was removed and 
replaced by 1 mL FA extract medium supplemented with 10% FBS (test group) 
or 1 mL unconditioned medium with 10% FBS (negative control). All the groups 
were prepared in triplicate. Corresponding blanks (10% FBS unconditioned 
medium) were prepared by omitting the cells.  
 
Quantitative evaluation of FA indirect contact cytotoxicity (FA extract) 
After 1, 4 and 7 days of incubation, the media were collected and assayed for 
lactate dehydrogenase enzyme (LDH) released from dead cells using the same 
spectroscopic assay according to the manufacturer’s instructions previously 
described (section 3.1.5.1.2). Triton X-100 was used to provide the positive 
control by adding Triton (1% in PBS) for about 30 min to cells grown in 







3.2 Platelet-rich plasma (PRP) 
3.2.1 Preparation of PRP 
3.2.1.1 Principle 
The principle of PRP preparation is to generate plasma that contains a higher 
concentration of platelets than baseline blood. PRP used herein was prepared 




Venous blood samples were donated by healthy volunteers who were not taking 
any medication. Consents were obtained from the donors and ethical approval 
was issued by University of Leeds research ethics committee on 20th May 
2015. 
The blood was withdrawn from antecubital region of the participants into sterile 
4.5 mL vacutainer tubes containing sodium citrate anti-coagulant (0.105M) 
(Greiner Bio-one, Cat. no: 12306949). The blood was first centrifuged without 
brake (centrifuge 5810R; Eppendorf, Darmstadt, Germany) at low speed with 
centrifugal force (RCF) of 200 g for 10 minutes at room temperature resulting in 
separation of the whole blood into plasma and erythrocytes sediment. To obtain 
concentrated platelets, the plasma was collected into sterile falcon tubes under 
the hood (class II laminar flow hood) and centrifuged for 10 minutes at high 
speed (1000 g). Subsequently, 80% of the supernatant comprising platelet-poor 
plasma (PPP) was decanted and the platelet pellet was then re-suspended in 







Figure 13: Preparation steps of platelet-rich plasma (PRP) fraction by two-step 
centrifugation cycle process. In the first cycle, the blood is separated into 
plasma and erythrocytes sediment and in the second one, the platelets are 
pelleted down and separated from the plasma. Platelets re-suspended in low 
amount of plasma is collected as PRP (Adapted from https://www.researchgate. 
net/publication/273952492_ Principles _and_Methods_of_ Preparation_ of_ 
Platelet-Rich_Plasma_ A_Review_ and_ Author's_Perspective). 
 
To obtain liquid serum from the PRP samples (PRP releasate), PRP samples 
were activated in a sterile centrifuge tube under the cell culture hood (class II 
safety cabinet) using a final concentration of either 23 mM CaCl2 for 1/2 hour or 
20 U/mL thrombin from bovine plasma reconstituted in 0.1% (w/v) BSA solution 
(Sigma- Aldrich, T4648) for 1/2 hour. After PRP activation and formation of fibrin 
gel, PRP releasate was separated from the cellular debris and fibrin gel by 
centrifugation at high speed (15000 g) for 10 min and the supernatants were 






Both of PRP and PRP releasate samples were either prepared fresh before the 
experiment or stored at -80°C for use within a maximum of 2 weeks. PRP 
samples were usually collected in cryogenic vials and frozen at -80°C using Mr 
Frosty freezing containers (Nalgene, Sigma, Cat. no: C1562) overnight before 
being transferred to a normal freezing box. This was to achieve the optimal 
platelets preservation by providing a rate of cooling very close to -1°C/minute 
using Mr Frosty.  
 
3.2.2 Determining of platelets concentration in the PRP samples 
3.2.2.1 Principle 
Platelet concentration in PRP samples is analysed manually using a 
haemocytometer and phase-contrast microscopy. In order to facilitate the 
recognition of the small sized platelets, the PRP samples are diluted 1:100 in 
PBS (standard dilution). The isotonic balance of the diluent (PBS) results in 
erythrocytes lysis while the platelets and leukocytes remain intact (Brecher and 
Cronkite, 1950). Recently, automated counting techniques have become more 
commonly used to count platelets and they are regarded as a more rapid and 
precise technique compared with manual counting (Harrison and Briggs, 2013).  




In the manual counting procedure, 20 µl of diluted PRP (1:100 in PBS) was 
placed onto the counting chamber of the haemocytometer. The platelets were 
allowed to settle and then were counted under the microscope. The counting 
chamber has 9 major squares with a volume of 0.1 mm3 per square. Each 
square has 20 small squares except the middle one which has 25 square. The 
platelets in the middle major square were counted under the light microscope 
using a high magnification (x20 objective lens). The platelets were counted in 9 
small squares out of the 25. Then, the average platelets number was 
calculated. The total number of the platelets was calculated by multiplying the 
average platelets number by number of the small squares (25) then by the 






Platelets number (platelets/mL) = average of cell number of 4 squares x 25 x 
100 x 10,000 
To further confirm the counting procedure, platelet counts from same PRP 
samples were obtained using automated platelets counting machine (XP-300 
automated CBC analyser, Sysmex). Upon switching on the device, three 
automatic rinse cycles were performed followed by a background check. Each 
sample of about 100 µL was mixed by pipette then was held up to the aspiration 
probe of the machine. The probe aspirated 50 µL to count the platelets in about 
50 second. This machine was used to measure and record concentrations of 
white blood cells (WBCs) and red blood cells (RBCs) in addition to platelets 
counts for PRP and corresponding PPP samples. 
 
3.2.3 PRP cytotoxicity  
3.2.3.1 Principle 
It is assumed that PRP preparations containing maximal concentrations of 
growth factors are ideal for promoting cell proliferation. Therefore, the aim of 
this study was to assess the effect of different configurations and concentrations 
of PRP on cell viability using the LDH assay in two experimental set-ups: 
 
3.2.3.2 Method 
First cytotoxicity experiment 
This test compared activated and non-activated PRP when added to the cell 
culture after 30 minutes of activation. G292 cells were seeded in 24-well plates 
at a density of 1x104/cm2 in 10%FBS media for 24 hour adhesion period then 
the media was replaced with α-MEM supplemented with:   
1. Non-activated PRP added to the culture medium to a final concentration 
of 5%. This media was aseptically prepared and left for 30 minutes at 
room temperature before being added to the adherent cells.   
2. Activated PRP with 23 mM CaCl2 added to the culture medium to a final 
concentration of 5%. This media was also aseptically prepared for 30 







3. FBS added to the culture medium to a final concentration of 5% forming 
the control group.   
 
Second cytotoxicity experiment 
The principle of the second test was to compare between the effect of two PRP 
gel forms and PRP releasate used at two concentrations on the viability of 
seeded G292 cells. PRP was added to the cell culture in 96-well plate using the 
following schemes: 
1. PRP gel under the cells (cells seeded on top of a layer of gelled PRP): A 
volume of 5 µL or 10 µL PRP was pipetted in the wells of the culture 
plate forming 5% or 10% of the total culture medium (100 µL) 
respectively. PRP was activated with 23 mM CaCl2 (final concentration). 
After 1/2 hour, G292 cell suspension was added (1x104/cm2) to each well 
on top of the already established PRP gel.  
2. PRP gel encapsulated the cells: The cells were seeded at a density of 
1x104/cm2 in culture medium in the wells followed by adding PRP and its 
activator (23 mM CaCl2 as a final concentration) to the culture medium to 
a final concentration of 5% or 10% (vol/vol) of the total culture medium 
(100 µL). The PRP was homogenised immediately and thoroughly with 
the cell suspension to embed the cells within the gel. 
3. PRP releasate (soluble components extracted from activated PRP): The 
cells were seeded in the wells of the culture plate at a density of 
1x104/cm2 in culture medium. PRP releasate was added to the wells to a 
final concentration of 5% or 10% (vol/vol) of the total culture medium 
(100 µL). 
 
Quantitative evaluation of PRP cytotoxicity 
In both experimental set-ups described above, all the groups were prepared in 
triplicate included corresponding blanks without cells. Cells seeded in 10% FBS 
culture medium was used as the controls. After 3 days of incubation at 37°C 
and 5% (v/v) carbon dioxide (CO2) in air and 98% relative humidity, cell viability 
was investigated via LDH assay. Triton X-100 was used to provide the positive 






FBS medium (assumed to kill 100% of the cells present).The samples’ media 
were collected and assayed for LDH release using the same spectroscopic 
assay previously described (section 3.1.5.1.2). 
 
3.2.4 Effect of PRP on cell proliferation (DNA quantification assay) 
3.2.4.1 Principle 
PicoGreen reagent is an ultrasensitive fluorescent nucleic acid stain, which can 
detect double stranded DNA in solution at concentration as low as 25 pg/mL in 
the presence of single stranded DNA, RNA and free nucleotides. Since nucleic 
acid content can be directly related to cell number, the PicoGreen assay was 
used to assess the effect of PRP gel and releasate on cell proliferation.  
 
3.2.4.2 Optimisation of cell digestion used for PicoGreen DNA assay 
3.2.4.2.1 Principle 
It is standard practice to lyse the cells in 0.1% triton to quantify the DNA content 
of monolayer culture but not of 3-D culture as in the case of PRP gel which 
might need different lysing solutions such as papain. Papain is a cysteine 
protease of the peptidase C1 family. Cysteine peptidases of papain catalyse the 
hydrolysis of peptide, amide, ester, thiol ester and thiono bonds, thereby 
digesting most cellular and extracellular proteins and liberating DNA from cells 
and tissues (Dubey et al., 2007). Papain has proven more efficient and less 
destructive than other proteases on certain tissues. In order to assess the 
efficacy of Triton and papain in releasing DNA from cells in the presence of 
PRP gel, a comparative study was undertaken to determine the most effective 
digestion method.  
 
3.2.4.2.2 Method 
Test and control sample preparation 
G292 cells were cultured (104/cm2) for 3 days in 2 x 24-well plates in culture 
medium supplemented with 10% PRP gel or releasate (100 µL) in triplicate. 
Each plate contained 3 experimental groups; PRP gel under the cells, PRP gel 
encapsulated the cells and PRP releasate (see the second cytotoxicity test in 






control group. Corresponding sample blanks were also prepared. One plate will 
be treated with triton and the other papain. After 3 days in culture at 37°C and 
5% (v/v) carbon dioxide (CO2) in air and 98% relative humidity, the 24 well 
plates were centrifuged at 300 g for 5 min to pellet down the gels and their 
embedded cells. The culture media was gently discarded and the cells and PRP 
gels were carefully washed twice with PBS before being digested.  
 
Triton digestion 
The cells of the first culture plate were lysed in 0.1 % triton followed by three 
freeze/thaw cycles. The cells and PRP gels were scraped off the wells and 
mixed using a pipette to assist cell break-up. The complete lysis of the cells was 
confirmed under the light microscope. 
 
Papain digestion 
PRP gels and cells of the second culture plate were digested with papain 
(Sigma, Cat. no: P4762) using 0.25 mg/mL papain in 5 mM L-cysteine, 100 mM 
sodium phosphate dodecahydrate and 5mM Ethylenedinitrilo-tetraacetic acid 
disodium salt dihydrate (pH= 6.5) at 65°C overnight (Kim et al., 1988; Hoemann 
et al., 2002).  
 
Picogreen DNA assay  
PicoGreen DNA quantification assay (Invitrogen, Life Technologies, Cat. no: 
P7589) was used to measure the DNA content of the cell digests. The lysates of 
the two digestion methods were centrifuged at 10000 g for 10 minutes and the 
supernatants were diluted (1:20) in Tris-EDTA buffer (TE ,10 mM Tris-HCl, 1 
mM EDTA, pH 7.4, Sigma-Aldrich, Cat. no: 93283). Lambda DNA standard 
(100µg/mL in TE) was supplied with the kit and the sample fluorescence was 
measured against 7 standards made up at 2000, 1000, 500, 250, 125, 62.5, 
31.3 ng/mL and standard blanks (TE buffer alone). Aliquots of 100 μL of each 
standard, diluted test samples and diluted sample blanks were added to 96 well 
plates in triplicates. An aliquot of 100 μL PicoGreen (1:200 in TE buffer) was 
then added to each well and the plates were incubated in the dark at room 






scientific (ELISA) microplate reader (VARIOSKAN FLASH spectrophoto-meter) 
with an excitation wavelength of 480 nm and an emission (detection) 
wavelength of 520 nm. The unknown values of DNA concentrations (ng/mL) 
were then calculated using the standard curve generated. The total amount of 
DNA (ng) per well was generated from the calculated DNA concentrations 
multiplied by cell lysis harvest volume from each well. Graphs of the mean ± SD 
was plotted using GrapPad Prism 7. The results showed a higher amount of 
DNA content detected in papain lysis compared to triton lysis indicating the 
suitability of using papain for digestion (results are shown in results section). 
 
3.2.4.3 Effect of PRP on cell proliferation  
Cell culture of G292 cells for test samples, control and corresponding sample 
blanks were prepared. The cells were seeded at a density of 104/cm2 in 24-well 
plates in 10% PRP supplemented culture medium using the same four culture 
conditions described above (PRP gel under the cells, PRP gel encapsulated the 
cells, PRP releasate and FBS as a control). All the groups were prepared in 
triplicate and the experiment was repeated twice using PRP samples derived 
from 2 different blood donors. The DNA content was assessed after 5 hours 
(day 0), 1 day, 4 and 7 days. At each time point, the 24 well plates were 
centrifuged at 300 g for 5 min, the culture medium was discarded. The cells and 
the gels were washed twice with PBS and digested with papain as described 
above. The DNA content was measured using PicoGreen DNA assay as 
described in the previous section. 
 
3.3 FA coatings and PRP combinations 
3.3.1 Evaluation of growth factor release from PRP/FA combinations 
3.3.1.1 Principle 
This experiment was aimed at studying the effect of FA coatings on the release 
of growth factors (GFs) from PRP using sandwich enzyme linked immune-
sorbent assays (ELISA). ELISAs were designed to detect and quantify 
substances such as peptides, proteins, antibodies and hormones in aqueous 
samples. In the simplest form of the sandwich technique, the antigen must be 






linked to an enzyme capable of catalysing a colour generating reaction (Figure 
14). The amount of colour, determined by spectroscopy, is proportional to the 
concentration of antigen bound to the well, and can be quantified if standard 
concentrations of the antigen in question are assayed at the same time. A most 
commonly used enzyme label is horseradish peroxidase (HRP). The ability to 
wash away non-specifically bound proteins makes the ELISA a powerful tool for 
measuring specific antigens. ELISA has several formats but the most powerful, 
specific and sensitive one is the sandwich assay. In the sandwich assay, the 
targeted antigen is specifically selected out from a sample of mixed antigens via 
a capture antibody and sandwiched between two primary antibodies (capture 
antibody and detection antibody). This eliminates the need to purify the antigen 
from a mixture of other antigens and simplifies the assay (Gan and Patel, 2013). 
  
 
Figure 14: Diagram of Sandwich ELISA. The antigen of interest is immobilized by 
a capture antibody previously attached to the microplate surface and 
sandwiched between the capture antibody and a primary detection antibody. The 






A list of the materials that were used in sandwich ELISA technique is shown 







Table 4: List of the materials and chemicals that were used in ELISA 
Materials/ Chemicals Company Catalogue no. 
Human IGF-1 DuoSet R&D Systems DY291 
Human PDGF-AB DuoSet R&D Systems DY222 
ELISA Plate-coating Buffer (PBS, 137 
mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 
1.5 mM KH2PO4, pH 7.2-7.4) 
R&D Systems DY006 
Reagent Diluent Concentrate 2 (1% BSA 
in PBS) 
R&D Systems DY995 
Reagent Diluent Concentrate 3 (5% 
Tween 20 in PBS, pH 7.2-7.4) 
R&D Systems DY004 
Quantikine Wash Buffer ( 0.05% Tween® 
20 in PBS, pH 7.2-7.4) 
R&D Systems WA126 
Substrate Reagent (1:1 mixture of Color 
Reagent A (H2O2) and Color 
Reagent B (Tetramethylbenzidine)  
R&D Systems DY999 
Stop Solution 2N Sulfuric Acid (H2SO4) R&D Systems DY994 
96 well microplate, polystyrene, sterile Greiner Bio-One  655161 




Test sample and control preparation 
In this experiment, a loading volume of PRP activating solution comprising 
thrombin from bovine plasma (20 IU/mL as a final concentration) or calcium 
chloride CaCl2 (23 mM as a final concentration) and 40 µL of PRP were 
sequentially pipetted onto uncoated etched SS discs, disorganised FA coated 
discs (DS FA) and organised FA coated discs (OR FA) placed in 24-well plates 
at 37°C. Similarly, 40 µl of non-activated PRP was loaded onto uncoated 
(control) and FA coated discs. The loading volume was determined based on 
the surface area of the discs. SS and FA coated discs treated with thrombin, 
CaCl2 or left untreated served as blanks. Figure 15 shows an illustration of 
sample preparation. Three samples were adopted for each experimental group 








One hour after the initiation of PRP clotting, 1 ml of PBS was added into each 
well and incubated at 37°C. After 2 hours, 1 day, 3 and 7 days, the PBS was 
collected and stored at -80°C for analysis. At each time point, the PBS was 
completely removed and replaced with fresh PBS. The sandwich ELISA 
technique was used to determine the temporal (not cumulative) release of IGF1 
and PDGF-AB growth factors from PRP gels into the PBS following the 
manufacturer’s instructions of the relevant Duo Set kit. 
 
Figure 15: Diagram for samples prepared for ELISA used to measure the release 
of GFs from PRP gel inducted by FA coatings into PBS (SS, stainless steel; DS, 
disorganised FA; OR, organised FA; PRP, platelets rich plasma; Thr, thrombin; 
Ca, calcium). 
 
Assay procedure (Measurement of IGF-1 concentrations) 
IGF-1 concentrations was assessed according to IGF-1 DuoSet protocol. First 
of all, diluted capture antibody (mouse anti-human IGF-1) at 4 μg/mL in PBS 
was used to coat 96 well microplate (100μL/well) and the plate was incubated 
overnight at room temperature. On the following day, the plate was washed with 
400μL of diluted washing buffer (1:25 v/v) in deionized water (0.05% Tween 20 
in PBS) for a total of three washes. Plates were blocked using 300μL of diluted 
reagent diluent concentrate 3 (1:5 v/v) in PBS (5% Tween 20 in PBS) and 
incubated for 1 hour at room temperature. Then, the aspiration/wash step was 






being centrifuged at 10000 g and 4°C for 10 min. Recombinant Human IGF-1 
standard (STD) was reconstituted with 0.5 mL of distilled water (110ng/mL) and 
seven standards using 2-fold serial dilutions in reagent diluent were prepared in 
a range between 2000 pg/mL and 31.3 pg/mL. Subsequently, 100μL of the 
sample supernatants, blanks supernatants and standards were loaded in 
duplicates (n=3 for each blood donor for 2 donors) into the 96 well plate and 
incubated for 2 hours at room temperature. The plates were washed again as 
above and 100μL of detection antibody (Biotinylated Goat Anti-Human IGF-1 
Detection Antibody) reconstituted with 1.0 mL of reagent diluent were added at 
a working concentration of 150 ng/mL in reagent diluent for 2 hours at room 
temperature. After 3 aspirations/ washings, 100μL of working dilution of 
Streptavidin conjugated to horseradish-peroxidase (HRP) (1:40, v/v) in reagent 
diluent was added and the plates were incubated for 20 minutes in the dark at 
room temperature followed by similar washing steps. A 100μL of substrate 
solution (colour reagent A: H2O2 and colour reagent B: Tetramethyl-benzidine, 
1:1 v/v) were added per well and the plate was incubated for 20 minutes at 
room temperature in the dark. Finally, 50μL of stop solution (2 N H2SO4) was 
added to the substrate solution and the absorbance was immediately measured 
at 450 and 570 nm to eliminate background signal using a VARIOSKAN FLASH 
plate reader (Thermo scientific, UK). The unknown values of IGF-1 
concentrations (pg/mL) were then calculated using the standard curve 
generated. 
 
Assay procedure (Measurement of PDGF-AB concentrations) 
For PDGF-AB growth factor, the assay was performed following the Duo Set kit 
instructions. It was the same protocol and assay procedure of IGF1 with the 
exception that, for PDGF-AB, reagent diluent concentrate 2 was used for 
blocking of the plate. It was diluted 1:10 (v/v) in deionized water (1% BSA in 
PBS). The standard used was recombinant human PDGF-AB reconstituted with 
0.5 mL of reagent diluent. The prepared standards (STDs) ranged from 1000 
pg/mL to 15.6 pg/mL. The sample supernatants were diluted 1:2 in 
corresponding reagent diluent and the dilution factor (2) was put into 






AB detection antibody was reconstituted with 1.0 mL of reagent diluent and 
diluted to a working concentration of 50 ng/mL in reagent diluent. Streptavidin-
HRP was dilute to a working concentration of 1:200 (v/v) using reagent diluent. 
 
3.3.2 Evaluation growth factor release from PRP gel and PRP releasate  
3.3.2.1 Principle 
The release of the GFs present in PBS supernatants of PRP gel and releasate 
loaded onto FA and uncoated discs was compared. Based on the previous 
findings of this study, it was decided to use organised (OR) FA coating only in 
this experiment because the organised coatings showed better potential to 
induce cell proliferation and to stimulate sustained release of GFs from PRP 
compared to the disorganised coating.  
 
3.3.2.2 Method 
Test and control preparation 
Uncoated SS and organised FA coated discs were placed in 24-well plates and 
loaded with 10 µL thrombin (20 IU/mL as a final concentration) and 40 µL of 
PRP. Likewise, 40 µl of PRP releasate were loaded onto SS (control) and OR 
FA coated discs. All the experimental samples were in triplicates. Relative 
blanks were prepared by omitting PRP. The discs were incubated at 37°C for 30 
minutes allowing the formation of PRP gels. Then, 1 ml of PBS was added into 
each well and incubated at 37°C for 3 days.  
 
Assay procedure 
After 3 days, the PBS was collected and stored at -80°C to quantify, at a later 
day, the concentrations of IGF1 and PDGF-AB growth factors cumulatively 
released from the PRP gels or releasate into the PBS were measured using 
sandwich ELISA according to the manufacturer’s instructions of the Duo Set kits 
and as described in the previous section (3.3.1.3). No dilution was used for the 
samples of IGF1 assay but a dilution of 1:2 in the corresponding reagent diluent 
was used for all samples of PDGF-AB assay. The samples, standards and 
blanks were loaded in triplicate in the 96-well plate. The experiment was 






3.3.3 Calcium ion release from FA coatings in presence of PRP 
3.3.3.1 Principle 
In order to observe the dissolution behaviour of FA coatings in presence of PRP 
gel, the concentration of calcium ions (Ca2+) dissolved from the coatings into the 
PBS was measured using inductively coupled plasma-optical emission 
spectroscopy (ICP-OES). The principle of ICP is based on generating plasma 
by argon gas. The component elements (atoms) of the sample are excited and 
emission rays (spectrum or photon rays) are emitted and measured. The 
spectrum obtained is characteristic of the elements present and the intensity of 
the spectral lines is proportional to the amount of each element present. 
 
3.3.3.2 Method 
Disorganised (DS) and organised (OR) FA coated discs, either bare or loaded 
with 10 µL thrombin (20 IU/mL) and 40 µL PRP, were placed in 12-well plate in 
triplicate. PRP gellification was allowed for 30 min, then PBS was added into 
the wells (2mL/well) and incubated at 37°C. Corresponding PBS and PRP 
blanks were prepared without FA coatings. After 2 hours, 1 day, 3 days, 7 days, 
10 days and 14 days, the PBS was collected and stored at 4°C for analysis. At 
the end of each incubation period, the PBS was completely removed and 
replaced with fresh buffer. Prior to the test, all collected PBS and blank samples 
were diluted 1:10 in distilled water and the concentrations of Ca2+ ions dissolved 
from FA and FA/PRP coatings into the PBS were kindly measured by the 
School of Geography/ University of Leeds using inductively coupled plasma-
optical emission spectroscopy (Thermo Scientific iCAP 7000 Series ICP-OES).   
 
3.3.4 Indirect contact cytotoxicity of FA/PRP combinations (LDH assay) 
3.3.4.1 Principle 
In this study, cytotoxicity of FA in presence of PRP was investigated using the 
LDH assay. LDH release as explained previously (section 3.1.5.1.1) is 
measured by recording the conversion of a tetrazolium salt (INT) into a red 
formazan product and the amount of formazan red colour is proportional to the 








Preparation of liquid extracts of FA crystals 
FA crystals extract was prepared as described previously in section 3.1.5.2.2. 
At the same time, serum free unconditioned medium exposed to the same 
incubation conditions of the FA extract was used to prepare the controls and 
blanks.  
 
Test and control sample preparation  
The filtered FA extract was added to the cell pellet of human osteosarcoma cell 
line (G292) to be seeded in 24-well plate at a cell density of 1 x 104 cells/cm2. 
The cell culture was supplemented with either 10% FBS or 10% activated PRP 
using CaCl2 (23 mM as a final concentration). The cells were also cultured in 
unconditioned α-MEM medium with 10% activated PRP or 10%FBS (negative 
control). Triton X-100 (1% in PBS) was used to provide a positive control (100% 
cell death). Corresponding blanks were prepared by omitting cells. All PRP 
groups were prepared in triplicate for 2 blood donors. All the groups were 
incubated at 37°C in 5% (v/v) CO2 in air and 98% relative humidity for 3 days. 
Then, the media were collected and assayed for LDH released from dead cells 
using spectrophotometer as described previously (section 3.1.5.1.2). 
 
3.3.5 PRP protein adsorption on the FA coatings 
3.3.5.1 Principle 
The effect of the FA surface characteristics on adsorption of PRP proteins is 
important for cell adhesion and attachment. PRP proteins adsorbed to the FA 
coatings were extracted and subjected to Sodium Dodecyl Sulfate (SDS)-
polyacrylamide gel electrophoresis (SDS-PAGE) analysis. SDS-PAGE is 
commonly used for the separation of proteins based on their molecular weight 
and on their differential rates of migration through a polyacrylamide gel under 
the influence of an applied electrical field. SDS is an anionic detergent that has 
a negative charge. It denatures the proteins and gives them a uniform net 
negative charge making them move in a single direction through the porous gel 
toward the positively charged electrode. The denatured protein molecules are 






TEMED, ammonium persulfate and Tris-HCl buffer. The gel has two phases, a 
stacking gel and a separating (running) gel. Under an applied electric field, the 
stacking gel concentrates the denatured linear protein molecules while the 
separating gel separates the proteins according to their molecular weight 
(Saraswathy and Ramalingam, 2011). 
 
3.3.5.2 Method 
Test sample preparation 
Uncoated (etched) and FA coated discs (disorganised and organised coatings) 
were placed in 24- well plate in triplicates and loaded with either PRP gel (10µL 
thrombin + 40µL PRP), 40 µL PRP releasate or 40 µL FBS and were incubated 
at 37°C and 5% (v/v) CO2 and 98% relative humidity overnight. The experiment 
was done using PRP from 2 blood donors.  
 
Protein extraction 
To solubilise and extract PRP proteins adsorbed to the surfaces of SS, 
disorganised FA and organised FA, the discs were first washed gently 3 times 
on a shaker with Tris buffer (50 mM, pH 7.4) (5 minutes each wash). After the 
last wash, the discs were placed on a clean filter paper to absorb the extra 
buffer from the discs. Phosphate buffer (0.1 M, pH 7.4) was prepared containing 
equal amounts of Na2HPO4 2H2O (0.5M) and NaHPO4 (0.5M) to desorb the 
proteins from the discs. Phosphate buffer desorbs proteins from apatite by 
competitive binding to the apatite surface. The surface of each disc was loaded 
with 40µl of the phosphate buffer at room temperature and in a humid 
environment. After 30 min, the phosphate buffer was collected slowly and gently 
from each disc and kept at -20°C until analysis.  
 
SDS-PAGE analysis 
The desorbed protein samples were denatured (3:1) with 4x Laemmli sample 
buffer (BIO-RAD, Cat. no: 161-0747) at 100°C for 2 minutes. Equal amounts of 
the protein extract samples were separated by SDS-polyacrylamide gel 
electrophoresis using mini-protean TGX stain-free™ precast gels (8-16%) (BIO-






Hamilton syringe (20μL/well). In addition, 3μL of a suitable molecular weight 
markers (precision plus protein molecular weight blue marker, 10 -250 kD) was 
loaded in a lane next to the samples. The molecular mass (kDa) markers were 
used to assess the relative molecular weight of the target proteins. The marker 
was diluted 1/20 in 1x Laemmli sample buffer. Gels were run with 1 X 
TRIS/glycine/SDS running buffer at 200V for 1/2 hour. Afterward, the gels were 
transferred to polystyrene boats filled with distilled water. 
 
Silver staining of SDS gels 
The protein bands were visualized with silver stain using the Pierce® silver stain 
kit (ThermoFisher Scientific, Cat. no: 24612) according to the manufacturer’s 
instructions. Briefly, each gel was washed 2 × 5 minutes in ultrapure water and 
fixed in 30% ethanol: 10% acetic acid solution (2 × 15 minutes). The gel was 
then washed in 10% ethanol (2 × 5 minutes) and 2 × 5 minutes in ultrapure 
water. The gel was sensitized for 1 minute with a prepared sensitizer working 
solution (50μL sensitizer with 25mL water). The gel was washed 2 × 1 minute 
with water before being stained for 30 minutes in a prepared silver stain working 
solution (0.5mL Enhancer with 25mL Stain). Later, the gel was washed 2 × 20 
seconds with ultrapure water and developed for 2-3 minutes in a prepared 
developer working solution (0.5mL Enhancer with 25mL developer). When the 
protein bands became visible, the developing was stopped with 5% acetic acid 
for 10 minutes. The intensity of the protein bands was determined and recorded 
using a ChemiDoc imager (BIO-RAD). 
 
3.3.6 Effect of FA/PRP combinations on cell proliferation 
3.3.6.1 Principle 
This study aimed at investigating the growth pattern of G292 cells on FA/PRP 
coated disc surfaces using PicoGreen DNA quantification assay. PicoGreen 
reagent as mentioned before (section 3.2.4.1) is an ultrasensitive fluorescent 
nucleic acid stain used to detect double stranded DNA in solution at a 
concentration as low as 25 pg/mL in the presence of single stranded DNA, RNA 








Test and control preparation 
Agarose wells were prepared in 12-well plates as described previously (section 
3.1.4.5). Sterile FA coated discs with disorganised and organised coating 
surfaces and uncoated etched SS discs (control group) were placed in the 
agarose wells. The discs were loaded with either PRP gel (12.5 µL thrombin 
and 50 µL PRP), 50 µL PRP releasate or 50 µL FBS forming 10% of cell culture 
medium. The samples were incubated for two hours at 37°C in 5% (v/v) CO2 in 
air and 98% relative humidity. Subsequently, G292 cells were seeded on the 
substrates at a density of 1 x104 cells/cm2 in 450 µL of a serum-free medium. 
Blanks were also cultured under the same conditions of the samples with no 
cells. The schematic diagram shown in figure 16 summarises the experimental 
set-up of the test samples.  
 
 
Figure 16: Schematic diagram of sample preparation for DNA content assay of 
cells cultured on FA/PRP combination. SS, stainless steel; DS, disorganised FA; 
OR, organised FA; FBS, fetal bovine serum; PRP, platelet-rich plasma.  
 
Papain digestion   
After 5 hours and 1, 3 and 7 days in culture, the discs were carefully transferred 
using a clean tweezer from the agarose wells into a dish filled with PBS. The 






paper to absorb and remove any residual PBS. Subsequently, the discs were 
placed in 24-well plates containing 500 µL papain buffer (0.25 mg/mL) to digest 
the attached cells as described in section 3.2.4.2. The cell lysates were 
homogenised by micropipette and transferred to eppendorf tubes and left on 
heat block at 65°C overnight.  
 
PicoGreen DNA assay 
Next day, the lysates and blanks were centrifuged at 10000 g for 10 min. The 
supernatants were diluted in Tris-EDTA buffer (1:20) and loaded into ELISA flat 
bottom 96-well plates (100 μL/well) in triplicates, DNA standards were also 
prepared at concentrations between 2000 ng/mL and 31.3 ng/mL and loaded 
(100 μL/well). Then, diluted PicoGreen (1:200 in TE buffer) reagent was added 
to each well (100 μL/well) and the plates were incubated in the dark at room 
temperature for 5 min. Sample fluorescence was measured using microplate 
reader with an excitation wavelength of 480 nm and an emission (detection) 
wavelength of 520 nm. DNA concentrations (ng/mL) were then calculated using 
the DNA standard curve generated and the total amount of DNA (ng) per well 
was also calculated from the cell lysis volume harvested from each well 
multiplied by corresponding DNA concentrations. 
 
3.3.7 Microscopic evaluation of cell attachment and growth on FA/PRP  
3.3.7.1 Principle  
Morphology and distribution of G292 cells on FA/PRP coated discs were 
observed under SEM and confocal microscopy. Principles of SEM and confocal 
microscopy were earlier explained in sections 3.1.4.7 and 3.1.4.8 respectively. 
 
3.3.7.2 Method  
G292 cells were seeded and cultured on FA/PRP coatings for 2 days under the 
same conditions described in section 3.3.6. The discs were then removed from 
the wells and gently washed with PBS. Subsequently, the cells attached to the 
coated discs were fixed with 10% neutral buffered formalin (NBF) for 24 hours 
at 4ºC. Then the specimens were thoroughly washed with PBS, serially 






The discs were sputter-coated with gold film and examined under the SEM. At 
the same time, the cells grown on FA coated discs were labelled using Alexa 
Fluor 488 Phalloidin cytoskeleton stain and TO-PRO-3 nucleic acid stain 
according to manufacturer’s instructions described previously in section 
3.1.4.8.2 and were analysed under confocal laser scanning microscopy. 
 
3.3.8 Osteogenic differentiation of hDPSCs 
3.3.8.1 Quantitative real time polymerase chain reaction (qRT-PCR) 
3.3.8.1.1 Principle  
FA/PRP combinations were investigated for their ability to support the 
differentiation of hDPSCs towards an osteoblastic phenotype using qRT-PCR 
technique. qRT-PCR assay is the most powerful and sensitive technique used 
for the expression analysis of single or multiple genes. This technique involves 
a series of procedures including; detection of RNA expression levels, 
quantification of mRNA transcription levels, producing multiple copies of the 
DNA isolates through amplification and finally measuring the amplification of 
DNA using fluorescent dyes. In RNA extraction, QIAshredder might be used as 
a homogenizer for simple and rapid homogenization of the cell lysates. 
QIAshredder consists of a unique biopolymer-shredding system in a 
microcentrifuge spin-column format placed in a collection tube. It reduces loss 
of sample material and filters out insoluble debris like agarose, FA crystals and 
PRP gel. In a real time PCR assay, a positive reaction is detected by 
accumulation of a fluorescent signal. The cycle threshold (Ct) determined by the 
PCR is the number of cycles required for the fluorescent signal to cross the 
threshold (exceeds background level) (Radonić et al., 2004). In the current 
study, expression levels of 4 genes (ALP, RUNX2, OCN and OPN) in addition 
to the house keeping gene or control gene (GAPDH) by hDPSCs were 
determined by qRT-PCR using TaqMan gene expression assays. 
 
3.3.8.1.2 Materials 








Table 5: List of the materials and chemicals that were used in PCR assays 
Materials/ Chemicals  Company Catalogue 
no. 
RNase, DNase free-Culture plate 24-well plates  Clearline 131020C 
RNeasy mini kit  Qiagen 74104 
QIAshredder Qiagen 79654 
β-mercaptoethanol  PanReac 
AppliChem 
A4338,0100 
Ethy alcohol, pure, for molecular biology Sigma- Aldrich E7023 
Ultrapure DNAse/RNase-free distilled water Thermo Fisher 
Scientific 
10977035 
RNase- Free DNase set   Qiagen 79254 
High Capacity RNA to cDNA kit  Applied 
Biosystems  
4387406 
TaqMan gene expression master mix   Applied 
Biosystems  
4369016 
TaqMan gene expression assay  
(Glyceraldehyde-3-phosphate dehydrogenase, 







TaqMan gene expression assay (Alkaline 






TaqMan gene expression assay (Runt-related 








TaqMan gene expression assay (Bone gamma-
carboxyglutamic acid-containing protein, Select 









TaqMan gene expression assay (secreted 





(Assay ID:  
Hs00959010-
m1)   
96-Well Semi-Skirted PCR Plate for Roche 







3.3.8.1.3 Validation of using GAPDH as a house keeping gene 
It is standard practice to use an endogenous control housekeeping gene in 
qRT-PCR analysis to normalise the expression of target genes. This 
housekeeping gene should be expressed at a constant level in all samples and 
to act essentially as a reference by reducing error in cDNA concentrations or 
reaction volumes (Ragni et al., 2013). In order to validate that the housekeeping 
gene of choice (in this case GAPDH) shows constant expression irrespective of 
scaffold used in cell culture, a validation experiment was carried out. GAPDH 
expression levels were measured for hDPSCs/P5 cultured under osteogenic 
condition for 3 days on uncoated and organised FA coated discs combined with 
either PRP gel, PRP releasate or FBS using qRT-PCR (the procedure of cell 
seeding will be described in detail in the next section). The results of this 
experiment (results are shown in results section) showed no change in the 
GAPDH levels and displayed no statistical differences between levels in all 
experimental groups indicating the suitability of using GAPDH as a 
housekeeping gene.  
 
3.3.8.1.4 Method  
Test and control preparation 
As organised (OR) FA coating showed better induction of cell proliferation and 
sustained release of GFs from PRP compared to the disorganised coating, the 
osteogenic differentiation of hDPSCs was studied on organised FA crystals 
only. The hDPSCs (P1) were kindly donated by Dr Fahad Al-Dabbagh (Division 
of Oral Biology, University of Leeds). The cells were expanded in α-MEM 
supplemented with 10% FBS, 1% L-G and 1% P/S. At passage 5, when 
reached 80% confluence, the cells were used for the differentiation 
experiments. By continuous monitoring of cell morphology and rate of 
proliferation with each passage under the light microscope, the cells showed a 
good and fast rate of proliferation. 
Agarose wells were prepared aseptically in 12-well plates as explained 
previously (section 3.1.4.5.2) using 4% agarose (w/v) in PBS. Uncoated etched 
SS and organised (OR) FA coated discs were placed inside the agarose wells 






1. SS/ FBS (50 μL) 
2. SS/PRP gel (12.5 μl thrombin + 50 μL PRP)  
3. SS/ PRP releasate (50 μL) 
4. OR FA/ FBS(50 μL) 
5. OR FA/PRP gel (12.5 μl thrombin + 50 μL PRP)  
6. OR FA/ PRP releasate (50 μL) 
 
 All the groups were incubated at 37°C in 5% (v/v) CO2 in air and 98% relative 
humidity overnight. Subsequently, hDPSCs (P 5) were seeded on the discs at a 
cell density of 2 x 105/cm2 in 450 μL of serum-free α-MEM osteogenic medium 
containing 1 μL/mL dexamethasone (10nM) and 2μL/mL of L-ascorbic acid 
(100μM) in addition to 1%P/S and 1%L-G. Four hours later, the media and the 
discs were carefully transferred from the agarose wells into new 24-well plates 
containing 450 μL osteogenic medium supplied with 50 μL PRP gel, releasate 
or FBS according to the relative group. After 3 days, the cells were examined 
for mRNA expression of 4 osteogenic bone markers using qRT-PCR. The 
experiment was performed twice testing PRP extracted from 2 donors. 
 
Extraction of mRNA from hDPSCs cultured on FA/PRP under osteogenic 
conditions 
Cell seeded-discs were collected, dipped once in PBS and placed on a clean 
filter paper to absorb any residual buffer from the discs. The discs were then 
transferred into RNase free 24-well plate for mRNA extraction that was 
performed according to manufacturer’s instructions of Qiagen’s RNeasy minikit. 
To perform the experiment, 500 μL of Buffer RLT containing β-mercaptoethanol 
(10μL/mL) were added to each disc and the cells were disrupted by pipetting. 
Then, the cell lysates were transferred into QIAshredder tubes and centrifuged 
for 2 min at 10000 g. The homogenized lysates were then collected in RNase 
free centrifuge tubes and 500 μL of 70% ethanol were added to each lysate and 
mixed well by pipetting. Subsequently, the samples were transferred to RNeasy 
Mini spin columns placed in 2 mL collection tubes and centrifuged for 15 sec at 
10000 g. The silica gel membrane spin columns were utilised to bind RNA in the 






went through multiple wash steps. To ensure that the mRNA was pure and clear 
of any genomic DNA, RNase- Free DNase set was used to digest any genomic 
DNA contaminate. The flow-through of the RNeasy columns was discarded and 
350 μL of buffer RW1 were added to the RNeasy columns and centrifuged for 
15 sec at 10000 g. The flow-through was discarded then 80 μL of DNase I 
incubation mix (10 μL of DNase I stock solution and 70 μL Buffer RDD) was 
added directly to RNeasy column membrane and left at room temperature for 
15 min. Later, 350 μL Buffer RW1 was added to the columns and centrifuged for 
15 sec at 10000 g. The flow-through was discarded and 500 μL of Buffer RPE 
was added to the spin columns and centrifuged for 15 sec at 10000 g. The flow-
through was discarded and another 500 μL of Buffer RPE were added to the 
columns and centrifuged for 2 min at 10000 g. Finally, after discarding the flow-
through, the RNeasy columns were placed in new 1.5 mL collection tubes and 
30 μl of RNase-free water were added directly to the spin column membranes 
and centrifuged for 1 min at 10000 g to elute the RNA. The RNA samples were 
stored at - 80 until required. 
 
Quantification of mRNA 
The extracted mRNA samples were checked for concentration and quality using 
a NanoDrop spectrophotometer (ND1000). Simply, 2μL of the samples were 
pipetted onto the lower pedestal of the NanoDrop and the quantities of mRNA 
were systematically recorded as ng/μL in addition to the ratio of sample 
absorbance at 260 and 280 nm to assess the mRNA purity. All ratios were 
found to be between 1.8 and 2, indicating acceptable purity. A dry clean lens 
cleaning tissue was used to wipe the pedestals of the instrument upon 
completion of each measurement to prevent sample carryover and residue build 
up. Before making the sample measurements, a blank of RNase-free water was 
measured to ensure that the instrument is working properly and the pedestal is 
clean.   
 
Reverse Transcription (RT) of mRNA 
High capacity RNA to cDNA kit was used to produce single stranded cDNA 






mix was aliquoted in 0.2 mL RNase-free centrifuge tubes comprising 9 μL of 
dilute mRNA sample in nuclease-free water (300 ng of mRNA), 1 μL of RT 
enzyme and 10 μL of RT buffer. The tubes were centrifuged briefly and placed 
in the PTC-100 Thermal Cycler to perform the RT at 37°C for 1 hour, followed 
by an enzyme denaturing step at 95 °C for 5 minutes. Tubes of cDNA samples 
were then stored at - 20°C until used for the next step within maximum 2 weeks. 
It was assumed that the reverse transcription reaction was 100 % efficient, so 
cDNA synthesised was the same amount as the RNA used. 
 
Performing qRT-PCR 
The reactions were carried out in 96- well PCR plates in duplicate using 20μL 
reaction volume contained 10 μL gene expression master mix, 1 μL of Taqman 
assay probe (gene of interest) and 9 μL diluted cDNA template (1 μL cDNA and 
8 μL water). The plates were sealed securely and centrifuged briefly for 10 sec 
using spinner, then placed in the Roche LC480 light cycler machine to start the 
amplification procedure. Amplification curves were obtained using a LightCycler 
480 real time QPCR system. All samples underwent a 10 minute 95°C pre-
incubation step, followed by 45 cycles of 10 seconds at 95 °C, 30 seconds at 60 
°C and 1 second at 72 °C. Samples were cooled to 40 °C at the end of the 45 
cycles for 30 seconds. The cycle threshold (Ct) values were generated for each 
gene of interest and for the house keeping gene or the control gene (GAPDH) in 
all the samples by LightCycler 480 software.  
 
Calculation of gene expression levels 
First of all, ΔCt was calculated by normalising Ct value of each gene of interest 
to that of GAPDH determined for the same sample. Then, the relative change in 
gene expression was calculated using the 2-Δct. Finally, in order to determine the 
effect of FA/PRP scaffolds on gene expression compared to the control, the 2-Δct 
value for each sample was normalised to the mean of the control sample 
(uncoated SS/FBS). The log10 of 2-Δct (fold change) ± SD and were plotted for 







3.3.8.2 Alkaline phosphatase (ALP) activity quantitative assay 
3.3.8.2.1 Principle 
Cultures of hDPSCs seeded on FA/PRP coatings were terminated at 2 weeks 
for further investigation of the cells osteogenic differentiation by analysing 
alkaline Phosphatase (ALP) quantity. ALP is a cell membrane-bound 
glycoprotein. It is the most widely recognized biochemical marker for osteogenic 
activity and hard tissue cell differentiation (Sharma et al., 2014). ALP is involved 
in skeletal mineralisation by acting both to increase the local concentration of 
inorganic phosphate (a mineralisation promoter) and to decrease the 
concentration of extracellular pyrophosphate (an inhibitor of mineral formation) 
(Golub and Boesze-Battaglia, 2007). 
ALP activity was measured by the ability of ALP enzyme released from 
osteogenic differentiated cells to convert the colourless substrate 
paranitrophenylphosphate (pNPP) into yellow paranitrophenyl (pNP).  
 
3.3.8.2.2 Method 
Test and control preparation 
hDPSCs/P5 were cultured at a cell density of 2 x 105 cells/cm2 on FA/PRP, 
FA/FBS, SS/PRP and SS/FBS for 2 weeks under osteogenic conditions as 
described above (section 3.3.8.1.4). Blanks were also prepared for background 
readings using the same culture conditions but without cells. The experiment 
was repeated twice using PRP samples of 2 blood donors (the same donors of 
qRT-PCR assay). The media was changed every 3 days by transferring the 
discs into new 24-well plate by sterile tweezers. The new wells contained 1mL 
osteogenic α-MEM supplied with either 10% PRP gel, PRP releasate or FBS.  
 
Evaluation of ALP activity 
At day 14, the cell culture was terminated. The discs were washed once in PBS 
and dried on clean filter paper. To lyse the attached cells, the discs were added 
to new 24-well plates containing 500 µL/well of 2 % triton X100 with three 
freeze/thaw cycles. To assist cells break up, the cell lysates were homogenised 
thoroughly by pipetting up and down several times after each thawing. Cell 






speed (10000 g) for 10 min. The lysates’ supernatants were used to quantify 
alkaline phosphatase activity using the 4-nitrophenyl colorimetric phosphate 
liquid assay. Briefly, standards for the ALP activity assay were prepared at 
concentrations of 5 μM to 300 μM by a serial dilution of 4-nitrophenyl (10 mM 
solution, Sigma-Aldrich, Cat. no: N7660) in an assay buffer solution [60 μL of 
2 % aq. solution of Tergitol type NP-40 (Sigma-Aldrich, Cat. no: NP40S) in 10 
mL of 1.5 M alkaline buffer solution (Sigma-Aldrich, Cat. no: A9226) and 20 mL 
dH2O]. In triplicate, a 100 μL of each standard was added to wells of an ELISA 
96-well plate. A 10 μL of each cell lysate solution and blank was loaded into the 
plate along with 90 μL of p-nitrophenyl phosphate liquid substrate system 
(pNPP, Sigma-Aldrich, Cat. no: N7653) and incubated at 37°C for 30 minutes in 
the dark. The reaction was stopped by addition of 100 μL of 1 M NaOH to all of 
the standards, samples and blanks. The absorbance was then read at 405 nm 
using a spectrophotometer. ALP concentrations were calculated using the 
generated standard curve. DNA concentrations of the lysates were also 
measured using PicoGreen assay (explained in section 3.2.4.2.2). ALP data 
were normalised to total DNA concentrations obtained from the same cell 
lysates. 
 
3.3.8.3 Alkaline phosphatase staining 
hDPSCs were seeded on the discs (12 x 104 cells/cm2) as described above 
(section 3.3.8.1.4) and cultured for 2 weeks using PRP sample of donor 1 of the 
previous differentiation assays. The discs were then washed once in PBS and 
fixed in 98 % ethanol for 15 min in 24-well plate. The ethanol was then fully 
aspirated and the discs were washed once in distilled water. ALP stain solution 
was prepared by adding 4.2 mg Fast violet B salt (Sigma-Aldrich, Cat. no: 
F1631) and 0.4 mL Naphthol AS-MX (0.25% (w/v), buffered at pH 8.6, Sigma-
Aldrich, Cat. no: 855) to 9.6 mL dH2O. The cells were then stained by adding 
500 µL of the ALP stain solution to each well and the plates were incubated at 
37°C for 60 minutes in the dark. Subsequently, the stain solution was aspirated 
and the discs were washed one time with dH2O and analysed under stereo-






hDPSCs/P5 were also tested for ALP deposition on monolayer, therefore, the 
cells were cultured in 24-well plates under basal and osteogenic conditions in 
triplicates, at cell density of 1 x 105 cells/cm2. After 2 weeks, the cells were 
stained for ALP using the same instructions mentioned above and observed 
under a Leica DMI6000 B inverted microscope. 
 
3.3.8.4 Alizarin red staining for calcium accumulation 
3.3.8.4.1 Principle 
Alizarin red stain (ARS) was used to evaluate calcium deposits in cell culture 
inducted by FA/PRP combinations.   
 
3.3.8.4.2 Method 
hDPSCs/P5 were seeded on SS/PRP and organised FA/PRP coated discs (2 x 
105 cells/cm2) and cultured for 2 weeks using PRP of donor 1 (Section 
3.3.8.1.4). Subsequently, the cell seeded-discs were gently washed 3 times with 
PBS, fixed in 10 % NBF for 15 minutes at room temperature and then washed 
three times with dH2O. The samples were then incubated with Alizarin Red 
solution (40 mM, Caltag Medsystems Ltd, Cat. no: SC-8678) for 20 - 30 min at 
room temperature with gentle shaking, followed by 5 washes of dH2O. Cells 
were then observed under a stereo-microscope. A red coloured stain indicates 
calcium deposition.  
 
3.4 Statistical analysis 
All experiments were carried out in triplicate and repeated twice using PRP of 
two different blood donors. hDPSCs used in the differentiation experiments 
were from one donor. The quantitative data of LDH assay, DNA content assay, 
ELISA and qRT- PCR results were expressed as mean ± standard deviation 
(SD). Due to small sample size, statistical analysis cannot be reliable. The data 








Chapter 4: Results and discussion (Flourapatite coating)  
 
4.1 Introduction 
The use of dental implants for correction of tooth and tissue loss has increased 
exponentially around the world. Dental implant surfaces are often modified by 
coating with hydroxyapatite and fluorapatite (FA) to improve the 
osseointegration process and promote faster bone healing. Fluorapatite 
[Ca10(PO4)6F2,]  exhibits a hexagonal unit cell, composed of Ca2+ and PO4-3 
arranged around a central column of F- which extends along the c-axis of the 
crystal (Brown and Constantz, 1994). The release of Ca2+ and PO4-3 ions from 
the coating could control bone cell proliferation, differentiation, modulation of 
expression of osteogenic genes and synthesis of osteogenic growth factors 
(Stvrtecky et al., 2003). Fluoride is the most electronegative element and its 
small ionic diameter and high charge density enable the fluoride to have a great 
capacity to form strong ionic and hydrogen bonds and to have a high potential 
for interacting with mineral phases and organic macromolecules (Robinson et 
al., 2004). It is believed that, fluoride replaces and occupies a column hydroxyl 
place in the hydroxyapatite crystals leading to reduction in (a) and (b) lattice 
parameters of the crystal lattice and a consequent reduction in the crystal 
energy. This, in turn dramatically decreases the acid solubility of the crystals 
and generates a more stable crystal structure (Robinson et al., 2017). This 
could also improve the mechanical strength, decrease the dissolution rate of HA 
and enhance bone tissue growth (Fathi and Zahrani, 2009). Some in vivo 
studies have proved the increased stability and the lower degradation of FA 
over hydroxyapatite as an implant coating (Dhert et al., 1991; Dhert et al., 1993; 
Overgaard et al., 1997; Bhadang and Gross, 2004). Therefore, FA coatings 
have been selected for investigation in this study to explore their potential to 
enhance implant osseointegration. 
The excellent properties and biocompatibility of FA nanostructures have 
resulted in many studies focusing on their synthesis. The development of 
nanotechnology has created many ways to grow 1D nanostructures (Xia et al., 
2003) such as the hydrothermal method that was widely used as an effective 






et al. (2006b) demonstrate a hydrothermal technique to grow a film of 
compacted well-aligned FA crystals on metal plates at 121°C and 2 atm for 10 
hours. The FA crystals were very similar in their chemical composition to natural 
tooth enamel. Czajka-Jakubowska et al., (2009a) adopted the hydrothermal 
method of Chen et al. (2006b) but successfully changed the surface 
morphology of the FA crystals from organised to disorganised depending 
whether they were deposited on the under surfaces or upper surfaces of the 
substrate respectively. The same group also attempted to grow FA on different 
substrates and found that only etched stainless steel and titanium substrates 
could produce surfaces entirely covered with FA crystals of uniform 
composition, alignment, size, shape and structure (Czajka-Jakubowska et al., 
2009b).  
The purpose of the present study was to investigate the topography of the FA 
coatings including crystal alignment, composition and the effects of post-
synthesis treatments such as washing the hydrothermal reaction mixture off the 
samples. The biological activity of the coatings was also examined to develop a 
better understanding of their biocompatibility.  
 
4.2 Results 
4.2.1 Characterisation of the FA coatings 
FA coatings were prepared on SS substrates using a mild hydrothermal method 
as described in the methods chapter (section 3.1.1.3). The discs were either 
tilted at 45° or positioned vertically during the coating process. 
 
4.2.1.1 Macroscopic examination 
The upper and under surfaces of the discs, tilted at 45° appeared to be 
completely covered with FA crystals. However, the coating on the upper 
surfaces looked whiter, denser and thicker than that of under surfaces. 
Conversely, the discs that were positioned vertically showed a similar thin layer 
of coating covering both surfaces of each sample. Figure (17) shows etched 
uncoated SS disc, SS disc with thick coating on the upper surface and SS disc 







Figure 17: A photograph of etched SS discs that were either left uncoated or had 
FA coatings deposited on their upper or under surfaces while held at 45° during 
coating. Note that the coating deposited on the upper surface was visually 
thicker. 
 
4.2.1.2 Microscopic analysis of FA crystal growth (SEM) 
SEM was used to look at the surface topography of the FA coated discs and to 
make a more detailed comparison between the coatings. After coating, all discs 
immediately underwent 3 different treatments: dried, dried - washed- dried or 
washed- dried as described in section 3.1.2. All the SEM images are presented 
at standard magnifications of x100 and x1000. 
 
Discs tilted at 45°  
In the case of the  discs tilted at 45°, upper surfaces of the unwashed discs 
(group I) that were simply dried following coating showed FA crystals embedded 
in a magma-like mass of residual material (Figures 18A, 18B). This material 
was less evident on the under surfaces of the discs (Figures 18C, 18D). The 
washed discs (groups II and III) were free of magma-like or any residual 
material and the FA crystals were clearly visible (Figures 19 and 20 
respectively). Moreover, no difference was found between groups II (dried-
washed-dried coatings) and group III (washed-dried coatings) in terms of 
crystals morphology and orientation.  
In comparing the growth of the FA crystals on upper and under sides of the 






The upper surfaces displayed randomly arranged hexagonal crystals grown in a 
disordered manner (disorganised FA coating) with complete coverage of the 
upper surfaces (Figures 18A, 18B, 19A, 19B, 20A and 20B). In contrast, the 
under surfaces were completely covered with well aligned and organised 
hexagonal crystals (organised FA coating). The crystals were compact and 
deposited parallel to each other in an ordered manner and perpendicular to the 
substrate surface (Figures 18C, 18D, 19C, 19D, 20C and 20D). Occasionally, 
some of the organised crystals were aggregated into bundles (Figure 18D). 
Although it is difficult to measure the dimensions of the crystals accurately due 
to perspective effects, SEM showed that the crystals were 10-30µm in length 




















Figure 18: SEM images of group I (unwashed FA coatings of discs tilted at 
45°). The crystals of upper surfaces (A, B) were embedded in a magma like 
mass of material which was seen to a less extent on under surfaces (C, D). 
D) Organised coating 
A) Disorganised coating B) Disorganised coating 
C) Organised coating 





























Figure 19: SEM images of group II (Dried-Washed-Dried FA coatings of discs 
tilted at 45°). The upper surfaces displayed randomly arranged hexagonal 
crystals or disorganised coatings (A, B). The under surfaces showed well aligned 
hexagonal crystals or organised coatings (C, D). 
D) Organised coating 
B) Disorganised coating A) Disorganised coating 



























Figure 20: SEM images of group III (Washed-Dried FA coatings of discs tilted at 
45°). They displayed the same topography of group II where the upper surfaces 
exhibited a disorganised FA coating (A, B) and the under surfaces showed an 









A) Disorganised coating 
D) Organised coating C) Organised coating 



















Figure 21: Micrograph showing the dimensions of the synthesised FA crystals 




Vertically positioned discs 
In the case of the vertically positioned discs, unwashed FA coated samples 
(group IV) also exhibited a magma-like residual material that covered the 
crystals and accumulated between them (Figure 22). Images of the washed 
groups (group V and VI) showed clearly visible FA crystals with no residual 
material (Figures 23 and 24 respectively). SEM analysis for these three groups 
exhibited complete coverage of both disc surfaces with ordered films of well 
aligned hexagonal crystals. The crystals were compacted and deposited parallel 
to each other and perpendicular to the substrate surface. However, many 
patches of disordered crystals were grown randomly over these organised 
crystal surfaces (Figures 22C, 23A, 24C), because of that, only the 45° tilted 

































Figure 22: SEM images of group IV (unwashed FA coatings of vertically 
positioned discs). Residual material covered the crystals on both surfaces of 








B) 1st surface  A) 1st surface 





























Figure 23: SEM images of group V (Dried-Washed-Dried FA coatings of vertically 
positioned discs). FA crystals were clearly visible completely covering both 
surfaces of vertically orientated discs; (A, B) 1st surface and (C, D) 2nd surface 
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Figure 24: SEM images of group VI (Washed-Dried FA coatings of vertically 
positioned discs). The FA crystals were not covered with residual material. Both 
surfaces of vertically orientated discs (A, B) 1st surface and (C, D) 2nd surface 
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4.2.1.3 Elemental analysis of the FA coatings (EDS) 
EDS was conducted for further characterisation of the synthesised coatings by 
identifying the chemical composition of the FA coatings and measuring the 
abundance of elements in the sample. Mean values for the atomic percentage 
of FA coatings elements for both of the 45° tilted discs and vertically positioned 
discs are illustrated in figures 25 and 27 respectively showing results for 
unwashed, dried-washed-dried and washed-dried groups. In general, EDS 
spectra of all groups showed that the elemental composition of the synthesised 
FA coatings was as expected; comprised of the main elements of FA (calcium, 
phosphorus and fluorine) in addition to carbon, oxygen, sodium elements.  
In both of the 45° tilted discs (Figure 25) and vertically positioned discs (Figure 
27), the atomic percentage of all elements in the unwashed upper and under 
coated surfaces exhibited differences to the corresponding washed surfaces. It 
was clear that washing the discs considerably reduced the proportion of carbon 
and sodium detected on the surfaces. Whereas oxygen (the most abundant 
element), fluorine, phosphorus and calcium were present in proportionally 
greater amounts after washing the coatings. The elemental composition of the 
washed coatings was not affected by the order of the washing steps as no 
difference in the elements level of the coatings was seen between groups II 
(dried-washed-dried) and group III (washed-dried) of 45° tilted discs (Figure 25) 
and between group V (dried-washed-dried) and VI (washed-dried) of vertically 
positioned discs (Figure 27). Further, no difference was noticed between the 
composition of the disorganised coatings (upper surfaces) and organised 
coatings (under surfaces) of the 45° tilted discs (Figure 26) or between the 
compositions of the coatings on either side of the discs of the vertically 



































Figure 25: Mean values ±SD for the atomic percentage of the FA coating 
elements for the discs tilted at 45° (n=3) including disorganised coatings (A) and 
organised coatings (B). Ca, P and F comprised a larger proportion of the 
elements present after washing the coatings. No difference was found between 






















U n w a s h e d -D r ie d
D r ie d -W a s h e d -D r ie d
W a s h e d -D r ie d
A ) 4 5   t i lte d  d is c s  (D is o rg a n is e d  F A  c o a tin g s )















U n w a s h e d -D r ie d
D r ie d -W a s h e d -D r ie d
W a s h e d -D r ie d




































Figure 26: Mean values ±SD for the atomic percentage of the FA coating 
elements for the discs tilted at 45° (n=3). No difference was found between 
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Figure 27: Mean values ±SD for the atomic percentage of the FA coating 
elements for the vertically positioned discs (n=3). Ca, P and F comprised a larger 
proportion of the elements present after washing of the coatings of both disc 
surfaces (A, B). No difference was found in the elements atomic % between both 
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Figure 28: Mean values ±SD for the atomic percentage of the FA coating 
elements for the vertically positioned discs (n=3). No difference was found 
between first and second coating surfaces in all coating groups.   
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The chemical analysis of the coatings also confirmed that the ratio of Ca/P and 
Ca/F were close to the theoretical values of Ca5(PO4)3F (Ca/P= 1.67 and Ca/F= 
5) as shown in table 6 for the 45˚ tilted discs and the vertically positioned discs.  
 
 
Table 6:  Mean atomic ratios ± SD of calcium to phosphorus elements (A) and 
calcium to fluorine elements (B) in FA coatings of the 45° tilted discs and 
calcium to phosphorus elements (C) and calcium to fluorine elements (D) in FA 
coatings of the vertically positioned discs (n=3). The ratios of all the groups were 
close to the theoretical values (Ca/P=1.67, Ca/F=5). DS, disorganised FA; OR, 
organised FA; Ca, calcium; P, phosphate; F, fluorine.    
 
 
In summary, washing the newly synthesised FA coating either before or after 
drying proved crucial to get rid of residual magma-like deposits. Therefore, it 
was decided to use group III discs (45˚ tilted, washed then dried) in the 







4.2.2 Biocompatibility assessment of FA coatings 
4.2.2.1 SEM analysis for cell attachment to SS and FA coatings 
G292 osteoblast-like cells were seeded on SS uncoated and coated discs as 
described previously (Methods chapter, section 3.1.4), and after 2 days, cell 
attachment was investigated under the SEM. G292 cells grown on uncoated 
etched SS were well attached, spindle-like in shape and displayed a 
characteristic fibroblast-like morphology in monolayer cell culture, indicative of 
cell spreading. Interestingly, the cells were confluent in the centre of the disc 
surface and were migrating from the centre toward the edges of the disc surface 












Figure 29: SEM micrograph for G292 confluent cells grown on etched SS surface 
for 2 days. The cells were spindle-like and well attached on the surface of the 
discs. The cells were confluent in the centre of the disc surface (A) and migrating 
from the centre to the edges of the disc surface (B).     
 
 
The cells that were grown on disorganised and organised FA coatings adopted 
different configurations. On the disorganised coatings, the cells were seen to 
adhere very well to the underlying FA crystals by the cytoplasmic extensions. 
The cells formed small and big clusters that colonised patches of the coating 
material (Figures 30A, 30B). In the case of the organised coatings, a viable cell 







were spread evenly on the coating surface either as single spindle cells or small 
























Figure 30: SEM micrograph for G292 cells grown for 2 days on disorganised and 
organised FA coatings. They show clusters of adhering cells colonising patches 
of the disorganised coating crystals (A,B) while the organised coatings showed 
more spindle-shaped cells that were well spread on the organised FA coatings 











4.2.2.2 Confocal laser scanning microscopy (CLSM) 
Cell attachment and growth were also investigated using Alexafluor 488 
phalloidin cytoskeleton stain and TO-PRO-3 nucleic acid stain under the 
confocal microscope. The morphology of the cells that were spread over both 
disorganised and organised coating surfaces is shown in figure 31. The cells of 
the disorganised coatings looked relatively spindle-like in shape with a degree 
of polygonal appearance (Figure 31A). Most of the cells tended to adhere to 
each other forming isolated clusters of cells attached to the crystals. However, 
cells cultured with organised coatings appeared more spindle-like in shape with 
more pronounced and long cytoplasmic extensions adhering to the underlying 













Figure 31: Confocal images showing green stained cytoskeleton and blue 
stained nuclei of cells attached to disorganised and organised FA coatings. The 
cells were well attached to disorganised FA coated surfaces (A), where they 
tended to attach to each other forming clusters. The organised FA surfaces (B) 
showed well spread and more spindle-like cells with more pronounced 










4.2.2.3 Cytotoxicity of FA coatings 
4.2.2.3.1 Direct contact cytotoxicity test 
 Cell morphology 
The cells grown on the plastic wells surfaces alongside the discs were 
examined under the light microscope and imaged using a digital camera as 
shown in figure 32. The images of cells cultured on the negative control, 
uncoated SS and FA coated discs showed a high number of confluent spindle 
cells adopting the morphology of live and growing cells with no signs of lysis or 
cell death (detached cells). Whereas the positive control (comprising cells 
treated with the toxic agent cyanoacrylate) exhibited only dead, round shape 



















Figure 32: Images taken by a digital camera for osteoblast cells. The cells were 
cultured for 2 days with uncoated SS discs (A) and FA coated discs (B) revealing 
a good biocompatibility of the discs compared to the negative control (C) and the 
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 Cell counting 
The direct contact cytotoxicity of FA coatings on osteoblast cells (G292) was 
determined quantitatively by counting the number of the cells cultured with 
uncoated and FA coated discs after 2 days using a haemocytometer. The 
media was collected and the cells were harvested by trypsin and counted 
manually (in duplicate for each group). Mean values of the number of cells of 
three samples per group are presented in figure 33. The data revealed a higher 
number of cells in all the tested groups, ranged between 90 x104  cells/mL and 
120 x104 cells/mL compared to the positive control (100% toxic) (19 ±1.2 
x104/mL). The uncoated SS discs showed a high number of cells (119± 24.8 
x104/mL) comparable to that of the negative control (nontoxic group) (106±6.4 
x104/mL). However, there appears to be less number of cells on FA coated 
discs (90±12.3 x104/mL) compared to the the negative control. The number of 













Figure 33: Number of osteoblast cells ±SD cultured directly for 2 days with FA 
coated and uncoated SS discs and counted manually using a haemocytometer 
(n=3). The positive control (Ctr+) or the toxic group showed extremely low 
number of cells compared to the other groups. There appears to be fewer 
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 LDH assay 
The media collected was subjected to LDH assays. Lactate dehydrogenase 
(LDH) is an easily measured glycolytic enzyme and is commonly used to 
measure cell lysis. The degree of cytotoxicity (LDH release) for each 
experimental group was determined as the ratio of released LDH amount and 
total LDH amount released from the positive control (toxic group) expressed as 
a percentage (Figure 34). In relation to the positive control (100% cell death), 
none of the experimental groups were cytotoxic, all of them showed % 
cytotoxicity less than 30%. The negative control showed the lowest release of 
LDH (1.4% ±8.2) compared to the positive control. However, LDH release 
measured in both of uncoated SS (13.3%±24.6) and FA coated (8.1%±19.2) 












Figure 34: Cytotoxicity (% LDH release) ±SD of uncoated and FA coated SS discs 
in relation to the positive control (100% toxic) (n=3). Both showed no cytotoxicity 
compared to the positive control (Ctr+). LDH release measured in both 
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4.2.2.3.2 Indirect contact cytotoxicity test 
The toxic potential of any material leaching out of the FA coating was tested by 
growing G292 cells in preconditoned medium (10% FBS that had been 
previously exposed to FA as described in section 3.1.5.2 ) for 1, 4 and 7 days. 
Cells cultured in unconditioned medium acted as negative control. At each time 
point, the media were collected and assayed for LDH release. The percentage 
of LDH release for each experimental group relative to the positive control (cells 
grown in media containing the cytotoxic chemical Triton 1% in PBS) was 
determined and plotted as illustrated in figure 35. FA-treated and non-treated 
groups were not toxic compared to the positive control at all time points. The FA 
treated groups exhibited less than 30% cell death compared to the control after 
one day (9.6% ± 1.7) and four days (16% ± 4) of cell culture. However, after 7 
days, a slight increase of cell cytotoxicity above 30% was seen in the FA-
treated group (30.9% ±11). It is noteworthy that the FA treated cells showed a 
similar level of LDH release to the untreated cells at any time point indicating 
that there was no evidence of any potential cytotoxic material leaching out of 




Figure 35: Percentage of LDH release ±SD of FA extract and negative control 
(Ctr-) cultures in relation to the positive control (100% toxic) (Ctr+) after 1, 4 and 7 
days of cell culturing (n=3). FA showed no cytotoxicity and showed no difference 
to the untreated cell culture in LDH release compared to the positive control. 





























 (T o x ic )
F A  e x tra c t
C t r
-






4.3 Discussion:  
In this study, FA coatings were synthesised on grade 316 stainless steel (SS) 
discs using a hydrothermal synthesis as described by Chen et al (2006b) and 
Czajka-Jakubowska et al. (2009a). The synthesis procedure was carried out by 
controlling the pH of the reaction solution and by using EDTA to stabilise the 
calcium ions in the precipitation solution allowing their slow release under the 
mild hydrothermal conditions (121°C, 2 atm for 10 hours).  
Stainless steel (medical grade 316) discs were used in the present study as 
coating substrates instead of titanium for various reasons. Firstly, Czajka-
Jakubowska et al. (2009b) compared FA coatings grown on titanium and SS 
surfaces, and found that the FA crystal composition, alignment, size, shape and 
structure were identical for both surfaces. SS metal bars are cheaper and 
available in more varied sizes when purchased and relatively easy to cut and 
polish compared to titanium. Finally and most importantly, the present study 
focuses on investigating the FA coating as an osteoconductive biomaterial or 
scaffold interfacing between the implant surface and the surrounding bone 
rather than the underlying substrate surface itself.    
Before being coated with FA crystals, the SS discs were etched with a mixture 
of sulphuric acid and hydrogen peroxide (piranha solution) as recommended by 
Czajka-Jakubowska et al., 2009a. This solution is an extremely powerful 
oxidising agent as well as strongly acidic and  treatment of the metal substrates 
is believed to etch the surface material to provide surface roughness, reduce 
surface energy and decrease the possibility of contamination as any organic 
contaminates are oxidised (Braceras et al., 2009).  
The current study investigated how the orientation of the discs during the 
coating process would affect the subsequent growth of the FA crystals. The SS 
discs were coated while tilted at 45° or positioned vertically. The tilted discs 
showed microscopically two different growth patterns for the FA crystals; 
disorganised on upper surfaces and organised on under surfaces. This finding 
was consistent with the research performed by Chen et al. (2006b), Czajka-
Jakubowska et al. (2009a and b) who reported that as the crystals grow on the 
under surface, the densely packed growth mode along the c-axis forced them to 






films with a similar growth rate. Moreover, crystals growing on the under 
surfaces were self-assembled or packed together in cohorts. This was most 
likely due to the strong attraction among adjacent crystals which causes the 
spontaneous aggregation of these rods into bundles reportedly similar to those 
seen in human enamel (Chen et al., 2006b; Czajka-Jakubowska et al., 2009b). 
The comparison of these bundles to human enamel prisms should be regarded 
with caution. The width of a single FA crystal is approaching the width of a real 
enamel prism which is composed of thousands of crystals and the aspect ratio 
(length/width) of a real enamel prism may be as much as 400:1 (assuming 
prisms transverse the full enamel thickness). Whereas the FA crystals here 
have a ratio of about 5:1 or less.  
In contrast to the under surfaces, FA crystals on the upper surfaces were 
randomly arranged which may be related to precipitation of several crystal 
layers over the already established crystal film resulting in the disorganised 
orientation of the crystals, according to Czajka-Jakubowska et al. (2009a). 
However, the role of gravity cannot be ignored as any mineral particles 
nucleating in free solution may have a high propensity to settle on the upper 
surface in a random orientation, and as they elongate, give rise to the random 
crystal orientation. In contrast, the underside are more likely to be populated by 
crystals that nucleated on the steel surface (which acts as a nucleating 
template), rather than settling there randomly under the influence of gravity. 
Subsequent elongation of these crystals gives rise to a more organised crystal 
coating. However, the chemical composition of both types of coatings 
(disorganised and organised) was the same as they were grown from the same 
mineralising solution under the same conditions. This similarity in the chemical 
composition of the coatings is in agreement with Czajka-Jakubowska et al. 
(2009a).  
Analysis of the crystal size distribution showed that FA crystals’ average 
diameter ranged between 1-3 μm and length 10-30 μm, similar to the 
dimensions reported by Chen et al (2006b). However, disorganised and 
organised FA coatings might have different thickness. Alhilou et al. (2016) 






(7.28 ± 0.46 µm compared to 49.07 ± 6.58 μm), depending on SEM, 3D optical 
profilometer and diffraction peaks associated with the underlying SS substrate. 
The chemical compositions and morphological features of the FA coatings 
produced in this study were similar to that produced by Chen et al. (2006b) who 
further investigated and identified the phase composition and crystallinity of the 
synthetic crystals using X-ray diffraction (XRD). They found that all the 
diffraction peaks can be readily indexed to a pure hexagonal phase with lattice 
constants a = 9.331 Å and c = 6.840 Å that are characteristic of FA. The same 
synthesis method of FA was adopted in previous studies (Alhilou et al., 2016; 
Al-Taie, 2017) in which the apatitic structure and the high crystallinity of FA 
coatings were confirmed. It is believed that fluoride may aid the stability of the 
coatings which could be clinically advantageous (Okazaki et al., 1981). Alhilou 
et al. (2016) also indicated that the diffraction pattern of the organised coatings 
showed the same peak positions as that of the disorganised coatings, but with 
different peak heights, confirming the similarity of the material but with 
preferential orientation of the crystals.  
In the current study, vertically positioned FA coated discs were also prepared 
and investigated. In contrast to the tilted discs, vertical discs generally exhibited 
an organised crystal alignment on both surfaces. This supports the contention 
described above that the upper surface of a tilted disc is subject to crystals 
growing from nucleating centres that settled on the surface randomly. These 
crystals then grew in addition to nuclei forming directly on the surface to 
generate the disorganised layer observed. With vertical discs both sides would 
be subject to nuclei forming directly on the surface as opposed to nucleating 
centres settling on the surfaces randomly. However, small patches of 
disorganised crystals were observed on each surface of the coated discs 
preventing its usage as a typical organised coating.  
The impact of washing and drying on the elemental composition, attachment 
and orientation of FA crystals was investigated and compared between three 
groups; the first group was only subjected to a drying step following the 
hydrothermal coating process with no washing, a second group was dried 
following the hydrothermal coating process then washed then dried again while 






dried. Washing is a chemistry term used for removing any excess reactants 
after a chemical reaction is completed (Nordquist, 2011). In this study, the 
upper surfaces of unwashed 45° tilted discs showed disorganised crystals 
embedded in magma of a residual material. The magma was probably the result 
of the precipitation of excess mineral ions and residues of EDTA hydrolysis. 
This hypothesis was supported by EDS results which showed a higher 
percentage of carbon on the upper surfaces of unwashed discs compared to 
washed upper surfaces, resulting more likely from the precipitation of a mixed 
salt comprised of EDTA (a carbon rich organic compound) and other reactants 
as the surfaces dried in air. The magma was also seen on unwashed under 
surfaces but to a lesser extent. Washing the discs before or after drying 
eliminated the magma presumably because the salts comprising the magma 
are relatively soluble. The coatings on washed discs were predominantly 
composed of calcium, phosphate and fluorine, presumably due to removal of 
the more soluble salts containing residual EDTA and other salts.  
Fluoride is cytotoxic, and as reported by Nordquist (2011), excess fluoride from 
FA coatings might interfere with the clotting of blood in an implantation site. 
Therefore, washing of the coatings to remove readily soluble fluoride salts 
present as contaminats is an essential consideration for future work especially 
when thinking about how FA coatings might be translated into the clinical 
setting. Leaching of fluoride may be deleterious biologically and in terms of 
public acceptance given the passions that surround the debate on fluoridated 
water. From the results of this study, it can be concluded that the drying process 
pre or post washing had no effect on crystal alignment, attachment or elemental 
composition. Therefore, for all the subsequent cell experiments, following 
hydrothermal synthesis, the coated discs were washed, dried and sterilised 
autoclaving at 121°C for 1 hour. 
PBS has been used previously for washing FA coated discs under sterilized 
conditions (Liu et al. 2010, 2011 and 2012). How washing with PBS compared 
to using distilled water at pH 7 (as used in this study) affects the chemistry of 
the coating and henceforth cell attachment and growth is unclear. However, 
since discs should be placed in culture medium prior to cell seeding, the nature 






distilled water is preferable since it would be expected to be more effective than 
PBS in washing away soluble salts. This is due to the common ion effect where 
the ions in PBS; phosphate, sodium, potassium and chloride, will inhibit the 
solubilisation of contaminating salts containing phosphate and sodium from the 
hydrothermal reaction. 
Ca/P and Ca/F ratios in the current study were close to the theoretical values of 
FA. The ratios were similar in both of the disorganised and organised FA 
coatings. Unwashed and washed groups had the same ratios as well.   
In this study, biocompatibility of uncoated and FA coated SS discs was studied 
using SEM and confocal microscopy. A high number of evenly spread cells 
were seen on the etched uncoated SS discs adopting a fibroblastic 
configuration typical of that observed in traditional 2D monolayer culture. 
However, the cells grown on disorganised and organised FA coatings exhibited 
different configurations. On the disorganised FA surfaces, the cells formed 
isolated clusters. They created a 3D cellular network between the crystals 
through establishing filopodia and intercellular connections. Filopodia are one-
dimensional structures filled with cores of long, bundled actin filaments (Alberts, 
2002). The cells of the organised FA surfaces were more spindle-like in shape 
compared to the cells of the disorganised coatings. They attached to the 
underlying crystals and exhibited prominent cytoplasmic extensions indicative of 
cell adhesion, migration and proliferation. The cells seemed to maintain physical 
contact with each other and migrate using long, thin and dynamic filopodia 
confirming the potential support of the coatings to the cellular growth. This was 
in accordance with studies of Liu et al. (2010, 2011 and 2012) and Czajka-
Jakubowska et al. (2011) who investigated the cell response to FA coatings. 
They revealed that both organised and disorganised FA coatings appeared to 
induce cell adherence, growth, differentiation and mineralization, but to a 
greater extent for the organised coatings. It is believed that adsorbed proteins 
may act as mediators for cell adhesion if they have the correct geometry (Roach 
et al., 2005). The different topographical and physical properties of the two 
coating surfaces (e.g. van der Waals forces and hydrophobic) have probably led 
to difference in proteins adsorbed to both surfaces and the subsequent 






capabilities of the cells in sensing the substrate geometry, rigidity and 
microstructure was reported previously (Vogel and Sheetz, 2006). They stated 
that the cells transfer these geometrical and physical signals into cellular 
biochemical signals that regulate various cellular events. Liu et al. (2010) 
observed enhanced mineralized tissue formation integrated within organised FA 
coatings where over 80% of the organised FA coating was integrated with the 
mineralized tissue layer covering the substrate surface after 5 weeks, in 
comparison to 40% integration in the case of the disorganised FA coating.  
The preliminary observation of this study identified a relatively high number of 
G292 cells under the microscope grown on the disorganised surfaces compared 
to the organised surfaces after 2 days in culture. This was probably due to the 
higher roughness and increased surface area of the disorganised surfaces as 
indicated by Alhilou (2016) compared to uncoated SS and organised FA 
surfaces. Osteoblastic adhesion and proliferation and collagen synthesis were 
reported to increase on the rough surfaces (Wennerberg and Albrektsson, 
1999; Boyan et al., 2001). However, it is important to appreciate that the current 
data are only derived qualitatively from a limited number of samples. Thus, 
further quantitative studies are needed to generate data and conduct a 
meaningful statistical analysis in order to compare cell attachment, proliferation 
and differentiation over both types of FA topographies.  
Finally, in the current study, both of the direct contact and indirect contact (FA 
extract) cytotoxicity tests showed clearly that FA was not cytotoxic compared to 
the positive and negative controls. In addition, FA and uncoated SS showed no 
difference in LDH release. Under phase-contrast microscopy, a high number of 
spindle and confluent cells were seen to grown beside the FA coated discs. 
However, the number of cells cultured with etched SS surfaces were slightly 
higher than that of the FA surfaces after 2 days of cell culture. This finding was 
in agreement with earlier studies which investigated the growth of MG-63 
osteoblast-like cells and adipose -derived stem cells on SS and FA discs for 3 
days (Liu et al. 2010 and 2012). However, the potential release of Ca2+ from FA 
samples may inhibit trypsin enzyme activity used for detachment of the cells 
prior to cell counting. In addition, the 3D structure of the FA coating could 






cells could be mechanically trapped in the forest of crystals that could 
compromise the collection of the cells compared to the flat surfaces of SS discs 
(negative control) and lead to artefactual low cell counts for the FA surfaces. 
This result was in contrast to a previous study, in which no significant difference 
was found between the number of dermal-derived human microvascular 
endothelial cells grown on SS and organised FA surfaces for 1, 7 and 14 day 
when trypsinised and counted manually (Wang et al., 2013).  
In summary, the present work showed that disorganised and organised FA 
coatings were synthesised successfully on etched SS discs. They have different 
topography but were very similar in chemical composition. This study indicated 







Chapter 5: Results and Discussion (Platelet-Rich Plasma) 
 
5.1 Introduction 
PRP is a concentrated derivative of blood plasma that has a platelet 
concentration 3-8 times above that of blood. It is potentially a rich source of 
growth factors (GFs) as these bioactive molecules, sequestered in platelets, 
can be released after platelet activatation (Marx, 2004). PRP was introduced in 
1998 by Marx et al. as a successful, novel approach to tissue engineering in 
oral surgery. When applied locally in a bone healing site, GFs released from 
PRP can potentially enhance the recruitment, proliferation and differentiation of 
stem cells and subsequently promote the initial bone healing response (Garg, 
2000; Mehta and Watson, 2008). When the initial, direct influence of PRP fades 
away with time, the physiological mechanisms of bone repair continue to 
proceed at a faster rate (Jakse et al., 2003). Currently, there is limited scientific 
evidence in the dental literature in favour of the clinical use of PRP for bone 
regeneration. PRP is used clinically in an inactivated liquid form that can be 
easily injected in the defect area or as a coating on the implant surface so that 
the platelets can be activated later by contact with the surrounding collagen 
tissue (Roberts et al., 2004). PRP was also used in the surgical sites in a 
hydrogel formulation by activating the PRP with an exogenous activator such as 
batroxobin, chitosan, calcium chloride, thrombin or a combination of the last two 
activators (Betoni-Junior et al., 2013). The high concentration of platelets and 
the native amount of fibrinogen have encouraged the use of PRP gel as 
osteoinductive, osteoconductive scaffold for bone defect bridging (Kawase et 
al., 2003; Malhotra et al., 2014; Jalowiec et al., 2015). Another form of PRP that 
was used successfully to enhance cell viability in vitro and to induce the tissue 
healing process in vivo is PRP lysate or releasate (the active soluble releasate 
isolated following platelet activation of PRP). It is derived from the PRP gel by 
centrifuging the gel at high speed and extracting a liquid form of plasma rich in 
GFs (Aiba‐Kojima et al., 2007; Schallmoser et al., 2007; Fallouh et al., 2010). 
The clinical efficiency of PRP remains controversial as evidenced by 
contradictory in vivo studies (Thor et al., 2005; Anitua, 2006; Gentile et al., 






when investigated the effect of PRP on cell function (Liu et al. 2002; Lucarelli et 
al. 2003; Gruber et al. 2004; Kilian et al. 2004; Soffer et al. 2004; Kanno et al. 
2005; Koellensperger et al., 2006; Kocaoemer et al., 2007). It is still uncertain 
which concentrations of PRP are optimal in promoting cell viability. Also, little 
has been reported comparing the influence of PRP gel to PRP releasate on cell 
proliferation. Therefore, the aim of this study was to determine and to analyse in 




5.2.1 Characterisation of the prepared PRP (platelet concentration) 
PRP samples were extracted from three blood donors according to the protocol 
mentioned previously in section 3.2.1. The platelet (Plt) count analysis was 
performed manually on PRP samples for each study participant using a 
haemocytometer and by using automated cell counting machine. For each 
donor, the counting was repeated twice, and the data were represented as a 
mean ± standard deviation as shown in table 7.  
 
Table 7: Platelet concentration (mean ± SD x103/ µL) counted manually and 
automatically in PRP samples from 3 blood donors. PRP concentration resulted 
in around an 8 fold and 5 fold increase in platelet concentration over reference 









Platelet counts performed manually yielded a mean platelet value of 1637 x 103 
± 324 x103 Plt/µL (ranged from 1355 x103 ± 78 x103 Plt/µL to 1992 x103 ± 260 
x103 Plt/µL). Whereas the automated cell counter yielded a lower mean platelet 
value of 1073 x103 ± 559 x103 Plt /µL (ranged from 469 x103 ± 139 x103 Plt/µL to 
Platelet concentration (x103 /µL) 
 
Manual counting Automated counting 
Donor 1 1355 ± 78 469 ± 139 
Donor 2 1564 ± 5 1177 ± 239 
Donor 3 1992 ± 260 1572 ± 212 






1572 x103 ± 212 x103 Plt/µL). It was well known that the average platelet count 
in healthy human adults is about 200 x103/µL. Therefore, manual counting 
indicated that the platelets had been concentrated by a factor of about 8 
compared to whole blood while the results obtained using automatic counting 
indicated that the platelets had been concentrated by a factor of about 5. The 3 
donors showed different levels of platelet numbers in the same way when using 
manual or automated counting. 
In addition to the platelets, concentrations of white blood cells (WBCs) and red 
blood cells (RBCs) in PRP and corresponding PPP samples were also been 
measured using automated cell counting. The results presented for each donor 
as mean ± SD in table 8, showed that the PRP samples contained a very low 
number of WBCs and RBCs. Whereas PPP samples had very low number of 
platelets (4.2 x 103 ± 5 Plt/ µL) and had no WBCs and RBCs.  
 
Table 8: Platelets concentration (mean ± SD x103/ µL), white blood cells (WBCs) 
(mean ± SD x103/ µL) and red blood cells (RBCs) (mean ± SD x106/ µL) counted 




5.2.2 Cytotoxicity of PRP (LDH assay) 
Two experimental set-ups were used to assess the cytotoxicity of PRP on G292 
osteoblast-like cells after 3 days of cell culture. In the first experiment, the 
cytotoxicity effect of non-activated and activated forms of PRP was assessed on 
monolayer culture of G292 cells. In the second experiment, cytotoxicity was 
assessed when G292 cells were seeded on, or encapsulated in PRP gel (cells-
PRP construct) (Methods chapter, section 3.2.3). The cytotoxicity was 
evaluated by assaying the media for LDH. This is a convenient method to 
evaluate the cell damage, since LDH is released from lysed cells. All the tested 
 
Plt x103 WBC x103 RBC x106 
  PRP PPP PRP PPP PRP PPP 
Donor 1  469.0 ± 139 10.0 ±1 0.3 ±0 0.0 ±0 0.0 ±0 0.0 ±0 
Donor 2  1177.0 ± 239 2.0 ±3 0.7 ±0 0.0 ±0 0.1 ±0 0.0 ±0 






groups were analysed for LDH release and normalised to the positive control 
(100% cell death). According to ISO 10993-5:2009E (DIN), a decrease in cell 
viability by more than 30 % is regarded as evidence of cytotoxicity. 
 
5.2.2.1 Cytotoxicity of non-activated and activated PRP  
G292 cells were cultured under standard culture condition for 24 hours then 
treated with medium supplemented with 5% of either non-activated PRP or PRP 
activated with CaCl2. Both culture media (non-activated and activated PRP 
media) were allowed to stand for 30 min at room temperature before being 
added to the cells and incubated for 3 days. It was revealed that the 
absorbance values of the negative control, non-activated PRP and activated 
PRP were much lower than the positive control (Figure 36). As non-activated 
PRP and activated PRP induced less than 30% LDH release, they are therefore 
considered not cytotoxic. Interestingly, activated PRP showed lower LDH 
release (8%) relative to the positive control than non-activated PRP (15%). This 
result means that activated PRP induced less damage on cell membrane and 
maintained the cell viability compared to non-activated PRP. Compared to the 
negative control, non-activated PRP displayed a higher amount of LDH release 
while activated PRP showed a similar amount of LDH to that of the negative 










Figure 36: Cytotoxicity (% LDH release ± SD) of 5% PRP added to 24 attached 
G292 cells as non-activated or activated form in the culture medium. All the 
groups showed no cytotoxicity. However, activated PRP showed greater 
influence on cell viability compared to non-activated PRP. 
























5.2.2.2 Cytotoxicity of cell-PRP constructs  
Three approaches were used to incorporate cells to PRP (PRP added to a final 
concentration of 5% or 10% (vol/vol) of the culture medium). In the first 
approach, cells were seeded on pre-established PRP gels and overlaid with 
serum- free media (PRP gel under cells). In the second approach, the cells 
were mixed with serum-free media containing PRP prior to coagulation with 
CaCl2 (i.e. cells were grown encapsulated in PRP gel).  In third approach, cells 
were cultured with serum- free media containing PRP releasate. The control 
comprised cells grown in media supplemented with 10% FBS alone.  
As shown in figure 37, all the experimental conditions induced less than 30% of 
the total LDH release seen in the positive control, and therefore these 
conditions were considered non-cytotoxic. However, 10% PRP promoted cell 
viability when compared with 5% PRP in all 3 groups. Furthermore, the groups 
containing 10% PRP induced LDH release (4- 5%) at comparable levels to that 
of the negative control (4%). While 5% PRP groups induced an increase in LDH 









Figure 37: Cytotoxicity (% LDH release ± SD) of two PRP concentrations (5% and 
10%) used in 3 different cell culture scenarios. None of the groups showed 
cytotoxicity but 10%PRP enhanced the cell viability compared to 5%PRP. All 
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5.2.3 Effect of PRP on G292 osteoblast-like cell attachment and 
proliferation 
The attachment and proliferation of G292 cells cultured with 10% PRP under 
the conditions described above in section 5.2.2.2 was investigated by 
measuring DNA content. This required efficient digestion of the construct and 
cells in order to release the cellular DNA. The digestion was optimised using 
two procedures (see section 5.2.3.1). 
 
5.2.3.1 Optimisation of cell and PRP gel digestion procedure 
This optimisation experiment was done to determine the most effective 
digestion method. This was done by comparing the DNA yield obtained to the 
theoretical amount of DNA present in the seeded cells (assuming 0.0066ng 
DNA/cell). The doubling time of the cells was obtained in this study following a 
simple protocol (Korzyńska and Zychowicz, 2008) (data not shown) and it was 
27 hours. In this experiment, the cells were seeded in 24-well plates (2 cm2 
surface area) at a density of 104/cm2 (2 x 104 cell/well) for 3 days. Thus, the 
expected DNA content after 3 days should be around 8 fold (23 fold) the initial 
number of cells (~1000 ng)  
Theoretical DNA content = 8 x 2 x 104 x 0.0066 = 1056 ng 
 
Optimisation for DNA quantification of G292 cells cultured for 3 days in 10% 
PRP and 10% FBS supplemented media was carried out using 2 common 
methods for cell digestion; 0.1% Triton and papain (described in Methods 
chapter, section 3.2.4.2). DNA content (ng) was obtained and mean data (mean 
±SD) were plotted (Figure 38). DNA content of the control (FBS) extracted by 
Triton was 290ng ± 81, whereas papain extraction of FBS had DNA content of 
700ng ± 31 which was closer to the expected values (~ 1000ng) than Triton 
values. In PRP samples, the result showed a higher amount of DNA extracted 
by papain ranged from 412 ng ± 18 to 748 ng ± 81 compared to Triton (149 
ng±5 - 220ng± 11). Based on the finding of this experiment that papain was 
more efficient than Triton in digesting the cells, it was decided to use papain for 












Figure 38: A comparative study for cell digestion using 0.1% Triton and papain. 
G292 cells were seeded either: on control medium, on pre-established PRP gel, 
encapsulated in PRP gel or on medium containing PRP releasate for 3 days. DNA 
content (mean ±SD) for each group was determined using the picogreen assay. 
The results showed a higher amount of DNA closer to the expected values was 
extracted by papain compared to Triton in all groups. 
 
 
5.2.3.2 Effect of PRP on G292 cell attachment and proliferation  
G292 cells were cultured under the 3 conditions described above (cells seeded 
on PRP gel, cells grown encapsulated in PRP gel and cells cultured in PRP 
releasate supplemented medium) and compared with cells cultured in media 
supplemented with 10% FBS which acted as control. Cell attachment and 
proliferation were monitored and assessed by measuring the amount DNA 
content (ng) after 5 hours of cell seeding (day 0) and after 1, 4 and 7 days. The 
experiment was repeated twice separately using 2 PRP samples extracted from 
2 blood donors. Complete individual data sets for donor 1 and donor 2 are 
presented in appendix 1. Cell-population density tended to increase in all four 
groups over the 7 days in cultures associated with both donors. However, PRP 
releasate greatly enhanced the cell proliferation over time as compared with the 
others. DNA content of all the groups was normalised to the control (10% FBS) 
and mean data (mean ±SD) of the 2 PRP donors plotted for each time point 
(Figure 43 and 44).  
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After five hours of seeding the cells on the different constructs described above 
(Figure 39), the number of cells grown in PRP gel groups and in media 
containing PRP releasate (ranged between 90% and 123%) were not different 
to that grown in FBS control (100%). In contrast, after one day of cell culture 
(Figure 39), the cell releasate group exhibited a DNA content of about 96% 
similar to that of the control (FBS), while both PRP gel groups showed low DNA 
content (30%- 38%) compared to FBS and to PRP releasate.  
Interestingly, PRP releasate increased the proliferation rate of the cells 
compared to the control to 144% by day 4 and 139% by day 7 as shown in 
figure 40. PRP releasate induced cell proliferation at higher levels compared to 
PRP gel groups at both time points. PRP gel under cells group showed lower 
DNA content compared to the control by 29% at day 7. 
 
 
Figure 39: Cell attachment of G292 cells seeded on PRP gel, incorporated with 
PRP gel and in PRP releasate supplemented medium for 5 hours and 1 day. DNA 
content of the groups was normalised to the control (10% FBS) and mean data 
±SD of 2 PRP donors plotted for each time point. All PRP groups promoted cell 
attachment for 5 hours at a comparable level to the control. However, PRP gel 
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Figure 40: Proliferation of G292 cells seeded on PRP gel, incorporated with PRP 
gel and in PRP releasate supplemented medium after 3 and 7 days. DNA content 
of the groups was normalised to the control (10% FBS) and mean data ±SD of 2 
PRP donors plotted for each time point. PRP releasate induced the highest rates 






In the current study, blood samples were collected from healthy young donors 
aged 25-35 years of both genders. No influence of gender or age on platelet 
count and growth factor concentrations was detected by Weibrich et al. (2002). 
PRP was prepared manually from whole blood using a two-step centrifugation 
procedure. In the first step, the blood was subjected to a soft spin (200 g for 10 
minutes) and in the second step, the blood plasma obtained was subjected to 
hard spin (1000 g for 10 minutes). Several automated systems and manual 
protocols for PRP preparation are available. However, each method generates 
a different PRP product with different biological properties and uses. It is 
reported that up to 50% of the variation in GFs concentrations present in PRP 






2001). Ehrenfest et al. (2009) stated that elimination of WBCs is more difficult 
using manual PRP preparation protocols compared to automated systems. 
However, the PRP samples produced manually in this study were WBCs-free 
samples as evidenced by the results shown in section 5.2.1.  
PRP is consistently defined by the absolute quantity of platelets. Thus, in the 
present study, the total number of platelets (per microliter) was determined for 
aliquots of PRP samples from 3 blood donors. The platelet counting was 
performed manually using a haemocytometer and automatically using a cell 
counting machine. There has been some debate over which method 
counts more accurately. Previous comparative studies reported acceptable 
agreement between machine counting and the counting using phase contrast 
microscopy (manual counting) (Rowan et al., 1972; Woodell-May et al., 2005). 
In contrast to the above studies, Hänseler et al. (1996) reported that automated 
counting is more precise than the manual counting. In the current study, the 
quantification of platelets showed lower number of platelets when quantified in 
the automatic cell counter compared to the manual counting. It may be 
happened due to platelets clump formation resulting in a miscounting. In order 
to prevent platelets clumping, the PRP samples have to be adequately mixed 
for 5 min before automatic counting (Woodell-May et al., 2005). 
The average platelet count of the 3 donors performed manually was 1637 x103 
± 324 x103 Plt/µL and automatically was 1073 x103 ± 559 x103 Plt /µL. Thus, the 
platelet count obtained in this study was about 5- 8 times greater than the 
physiological average count in healthy human adult plasma (200 x103 Plt/µL). 
The concentration of 1000 x103 Plt /µL was suggested previously to be the 
working definition of what constitutes reliable therapeutic PRP levels (Marx, 
2001). Lower or higher concentrations might not enhance wound healing (Marx, 
2004). In early in vitro studies, platelet concentrations 2- 4 times above the 
baseline blood levels were suggested to promote the proliferation and 
differentiation of primary osteoblasts and fibroblasts (Graziani et al., 2006; 
Anitua et al., 2009a). Interestingly, it was proved earlier that excessively high 
concentrations of platelets (>2000 x 103 Plt/µL) in PRP might have deleterious 
effects on healing process (Foster et al., 2009; Yamaguchi et al., 2012). 






PRP gel containing 1000 x 103 Plt/µL to promote MSCs’ proliferation compared 
to PRP gels of 2000 x 103 and 10000 x 103 Plt/µL. In the light of the above 
studies, the PRP concentration obtained herein was regarded to be within the 
recommended range required to enhance a cellular response.  
The efficacy of PRP is based on the release of multiple GFs when platelets are 
activated. Hence, the biocompatibility of PRP samples was examined in the 
current study by examining the viability of pre-attached G292 cells incubated 
with activated and non-activated PRP supplemented culture medium. The high 
dose of GFs contained in the activated PRP medium reduced cell death 
compared to non-activated PRP. By activating the PRP with an exogenous 
activator such calcium chloride, two key processes may be initiated; activation 
of platelets to release GFs from their α-granules and the cleavage of fibrinogen 
into insoluble fibrin (Wasterlain et al., 2012). It was previously demonstrated 
that the minimal PRP concentration required to obtain the gel formation is as 
low as 0.5% in the culture medium and gelation occurred as rapidly as 30 
minutes post activation (Kawase et al., 2003). Platelets begin actively secreting 
GFs and clotting within 10 minutes after activation, with more than 95% of the 
pre-synthesised growth factors secreted within 1 hour. Then, the platelets 
synthesise and secrete further GFs for the remainder of their life span (5-9 
days) (Marx, 2004). The proportional relationship between high GFs 
concentrations and cell proliferation was evaluated in many studies (Eppley et 
al., 2004; Cho et al., 2011). The result of this study could be correlated with the 
findings of Kakudo et al. (2008), who detected a higher proliferative effect of 
activated PRP and higher levels of PDGF and TGF growth factors compared to 
the non-activated PRP group. PDGF and TGF are believed to trigger the 
preosteoblasts to undergo mitosis and differentiation into mature osteoblasts 
which eventually leads to bone remodeling and mineralization (Marx et al., 
1998; Carlson, 2000). In contrast, Han et al. (2009) reported that non-activated 
PRP has greater positive impact on proliferation of osteosarcoma and stromal 
cells in vitro and on the osteoinductivity of demineralised bone matrix in vivo 
compared to thrombin- activated PRP.  
In the literature, many studies have investigated the effect of PRP on cell 






gel and its effect on cell viability. The cytotoxicity of two PRP concentrations 
(5% and 10%) under three PRP configurations was investigated. There were: (i) 
cells grown on PRP gel and overlaid with serum free media, (ii) cells 
encapsulated in PRP gel and overlaid with serum free media and (iii) growing 
cells in serum free media supplemented with PRP relesate. PRP at 
concentrations of 5% or 10% showed no cytotoxic effects. Previous studies 
confirmed the positive effect of 5% PRP supplemented medium on proliferation 
of osteoblast cells (Okuda et al., 2003) and viability of periodontal fibroblast 
cells in which PRP was activated woth calcium chloride (Tavassoli-Hojjati et al., 
2016). In the present study, the viability of the cells was enhanced in 10% PRP 
samples compared with the 5% PRP. This finding was similar to the report of 
Kanno el al. (2005) who found that 10% PRP enhanced osteoblast-like cell 
viability, proliferation and diffrentiation compared to 5% PRP and related this 
effect to the greater amount of GFs released from the more concentrated 
preparation. Fallouh et al. (2010) also found in vitro a greater cell viability of 
anterior cruciate ligament cells in 10% PRP releasate compared to 5% PRP 
releasate supplemented media. Different GFs concentrations might result in 
different effects on cell viability. A linear increase of some GFs with increased 
platelet numbers has been observed and reported earlier (Zimmermann et al., 
2001; Eppley et al., 2004; Cho et al., 2011). However, no correlation was 
detected by Weibrich et al. (2002) between GFs contents and PRP 
concentration which might be attributed to the fact that they induced the release 
of the growth factors from PRP by freeze/thaw cycles without any exterior 
activator. In vitro, certain studies found that 10% PRP releasate caused a 
marked increase in cell proliferation of mesenchymal stem cells compared to 
lower or higher concentrations (Gruber et al., 2004; Mishra et al., 2009; Cho et 
al., 2011). Li et al. (2013) reported that 20% PRP releasate caused a significant 
increase in human muscle derived progenitor cells proliferation compared to 
10% PRP releasate. In contrast, Choi et al. (2005) showed that the viability and 
proliferation of alveolar bone cells were suppressed by high PRP concentrations 
compared to low concentrations (1% and 5% in media). Kakudo et al. (2008) as 
well could not find any significant differences between the effects for 10% and 






dermal fibroblast cells compared to lower doses (1% and 5%). Hsu et al. (2009) 
attributed the reason of the cellular anti-proliferative effect of high 
concentrations PRP to the presence of negative regulators in PRP (e.g. 
thrombospondin). While, Liu et al. (2002) related this negative effect to the pH 
changes associated with high PRP concentrations that adversely affect cell 
proliferation. In addition, these contrasting data may be related to the possibility 
that different cell types respond differently to PRP (i.e. the specific cell context 
may determine cellular response to PRP) and the different methodologies used 
in these studies (Graziani et al., 2006).  
In addition to cytotoxicity, the present study examined G292 cell proliferation 
when cultured with PRP obtained from 2 blood donors over 7 days compared to 
the standard culture condition (FBS). The cells were grown in 10%PRP 
supplemented medium under 3 configurations: (i) cells grown on PRP gel and 
overlaid with serum free media, (ii) cells growing encapsulated in PRP gel and 
overlaid with serum free media and (iii) growing cells in serum free media 
supplemented with PRP releasate. As platelets have no nucleus they cannot 
replicate and have a finite lifespan of 5 to 9 days (Marx et al., 1998) which 
raised two questions: (i) during this lifespan of 5 to 9 days, can the platelets 
provide the cells with sufficient growth supplements to ensure their growth? (ii) 
which of the 3 PRP configurations described above can provide the best cell 
microenvironment to ensure their growth? The results showed an increasing 
trend of the cell-population density over the period of 7 days culture in the three 
above PRP configuration (Appendix 1). As for the second question, which of the 
three PRP/cell configurations offered the best micro environment for cell growth, 
all PRP groups showed the same capabilities to promote cell attachment after 5 
hours of cell seeding. However, the trend has been changed after 24 hours and 
persisted over the 7 days during the cell growth where PRP releasate enhanced 
the cell proliferation compared to PRP gel groups. A possible explanation for 
this trend is the weak attachment of PRP gels to the surface of the culture 
plates leading to sample loss while recovering the gels for DNA quantification. 
This also might be the cause of the inconsistent results of PRP gel 
encapsulated cells group which showed reduced cell numbers after one day but 






of cell culture. Results of cells grown on PRP gel were also inconsistent where 
the gel seems to show a comparable results to that of the control after 5 hours 
and 3 days but didnot promot cell attachment and proliferation after 1 and 7 
days compared to the control. Therefore, a conclusive explanation cannot be 
made as the data of PRP gel groups were not fully reliable and cannot be used 
to compare between both PRP gel configurations and PRP releasate.  
Previous studies have reported a successful culture of cells incorporated into 
PRP gels, suggesting that the gel environment enhances viability and 
proliferation of encapsulated cells (Ho et al., 2006; Kawasumi et al., 2008; Xie 
et al., 2012; Jalowiec et al., 2015). However, the composition of PRP gels used 
in different studies has a wide variability, mainly because of differences in PRP 
preparation and activation methods, which in turn leads to remarkable 
differences in platelet concentration, leukocyte content and GFs release 
(Mazzucco et al., 2009). In addition, the stiffness of hydrogels may influence the 
behaviour and differentiation potential of incorporated cells (Brandl et al., 2007; 
Duarte Campos et al., 2014). The viscoelastic properties of PRP gels were 
investigated by Jalowiec et al. (2015) through oscillatory rheology and found 
that the highest storage modulus was achieved by PRP gels with 1000 x 103 
and 2000 x 103 platelets/µL making them slightly stiffer than those with 10,000 x 
103 platelets/µL. This means that the material tends to maintain its shape rather 
than creeping and spreading like a viscous fluid. This property, added to the 
presence of more than 95% culture medium, allows nutrition and waste 
transport, making the hydrogels as effective cell carriers.  
Cell proliferation tests carried out in the present study, indicate that proliferation 
rates with PRP releasate was consistently high from 1 to 7 days compared to 
the two other PRP gel configuration’s and to the FBS control at 3 and 7 days. 
The proliferation- promoting effect is likely due to the high concentration of 
natural growth factors that PRP releasate contain. The biological actions of GFs 
in cell proliferation and bone regeneration have been documented in many 
studies (Sporn and Roberts, 1993; Greenhalgh, 1996; Eppley et al., 2004; Cho 
et al., 2011). It has been reported in previous studies that PRP releasate 
significantly increased mesenchymal stem cells (MSC) expansion and 






FBS or FCS substitute (Doucet et al., 2005; Kocaoemer et al., 2007; Chevallier 
et al., 2010). Cho et al. (2011) indicated that the addition of 10% PRP releasate 
to the culture medium of MSCs induced marked cell proliferation compared to 
10% FBS. They also demonstrated the proportional relationship between TGF-
β1, PDGF and FGF-b concentrations and cell proliferation. Another in vitro 
studies confirmed that PRP releasate significantly increased cell proliferation 
compared to FBS supplemented media in culture of anterior cruciate ligament 
cells (Fallouh et al., 2010) and human muscle derived progenitor cells (Li el at., 
2013).    
Many human and animal studies have yielded promising results when PRP has 
been applied topically at the implant site to enhance bone regeneration 
(Zechner et al., 2002), or as an implant coating to improve the osseointegration 
process (Anitua, 2006; Anitua et al., 2008; Anand et al., 2012). Moreover, some 
investigators have obtained more favourable clinical results in bone repair after 
implantation when PRP has been used in association with other biomaterials 
like HA or tricalcium phosphate (TCP) (Okuda et al., 2005; Abhijit, 2006; 
Yamamiya et al., 2008; Bi et al., 2010). There is very little published information 
relating to the potential of using PRP synergistically with other biomaterials to 
promote osteoblastic differentiation. Therefore, in chapter 6, the effect of PRP 
as an autologous source of GFs on osteogenesis will be compared when used 
separately or in combination with FA coatings.  
In summary, the results showed that the PRP prepared during this study 
contained platelets at a concentration within the accepted range considered to 
provide therapeutic value. None of PRP concentrations and configurations used 
herein were cytotoxic. However, 10% PRP had the greatest effect on cell viability 
and proliferation. No meaningful data were derived from cell proliferation 
experiment because of PRP gel detachment from the culture plate prior to the 
digestion. Thus, it was decided in the future work to test the cell response to both 






Chapter 6: Results and discussion (FA/PRP combinations) 
 
6.1 Introduction 
Replacement of lost natural teeth with dental implants is regarded as a major 
advance in dentistry. The use of calcium phosphate implant coatings such as 
FA has been shown to enhance the bone response during the initial healing 
period after implant insertion (Vercaigne et al., 2000; Hayakawa et al., 2000). In 
the present study, disorganised and organised FA coatings were synthesised 
on SS metal surfaces using a hydrothermal technique (Chapter 4). Neither FA 
surface was cytotoxic and both supported initial cellular growth. The new 
generation of bone scaffolds and implant coatings should not only provide the 
mechanical architecture to support cell attachment but should also promote cell 
growth by acting as delivery vehicles for desirable factors such as growth 
factors  (Babensee et al., 2000). PRP was shown to promote the bone healing 
around the dental implants under the influence of IGF, TGF and PDGF growth 
factors which are present in PRP in high concentrations (Marx et al., 1998; 
Vehof et al., 2001; Vehof et al., 2002). With this in mind, to enhance the 
osseointegration of dental implants, PRP was selected for this study and 
prepared from whole blood using a manual protocol (Chapter 5). The prepared 
PRP had platelet concentrations of 5 - 8 times higher than that of the normal 
blood. A tremendous proliferative effect was detected for PRP releasate on 
G292 cells in monolayer culture. However, PRP gel showed a comparable 
influence on cell viability and proliferation to that of the standard cell culture 
conditions (10% FBS). According to the literature, combined application of PRP 
with calcium phosphate could facilitate the osteoinductive properties of PRP 
GFs and might be a promising strategy for stimulating osteogenesis (Vehof et 
al. 2001). However, the additional use of PRP did not show any significant 
effect on the early bone response to calcium phosphate coated implants 
(Nikolidakis et al., 2006; Nikolidakis et al., 2008). Therefore, more research has 
to be carried out to elucidate this issue. In the present study, the aim was to 
investigate in vitro, the synergistic effect of FA coatings and PRP on osteoblast-
like cell (G292) viability, attachment and proliferation. Furthermore, the release 






and the proteins adsorbed from PRP on to surfaces of FA coatings were also 
analysed. Human postnatal dental pulp stem cells (hDPSCs) were used to 
investigate whether combinations of FA/PRP can induce cell differentiation and 
mineralisation, as a result, can provide a scaffold for bone regeneration around 
the dental implant surface. hDPSCs are easily collected from healthy third 
molars and are easily banked (Volponi et al., 2010). The ability of hDPSCs to 
differentiate into functional osteoblasts and produce mineralised matrix have 




6.2.1 Temporal release of growth factors from PRP when used in 
combination with disorganised and organised FA coatings 
PRP was applied to SS surfaces coated with either disorganised FA, organised 
FA or plain uncoated SS surfaces (control). The loaded PRP samples are either 
activated with thrombin or calcium chloride or left non-activated. This 
concomitant activation allowed the release of growth factors and PRP 
gelification on the surfaces. Non-activated PRP applied to uncoated SS served 
as the control. The samples were overlaid with PBS and after 2 hours, the PBS 
was collected and fresh PBS was added and after 1 day collected and again 
fresh PBS was added and the process was repeated after 3 and 7 days. 
Collected PBS samples were assayed for IGF-1 and PDGF-AB growth factors 
using ELISAs. The whole experiment was conducted twice using PRP derived 
from two separate blood donors. The results for IGF-1 and PDGF-AB are 













Determination of IGF-1 released from PRP when used in combination with 
disorganised and organised FA coatings   
The overall release of IGF-1 from PRP derived from donor 1 and donor 2 into 
PBS is illustrated in Figure 41. The data revealed that PRP derived from donor 
1 released greater amounts of IGF-1 than PRP derived from donor 2. The 
maximum mean concentrations of IGF-1 occurred within 1 day after PRP 
gelification reaching around 620 pg/mL in blood donor 1 and 266 pg/mL in 
donor 2. The lowest concentrations for both growth factors were measured at 
day 7 post PRP gelification reaching about 25 pg/mL in both blood donors. 
There was also variation in the kinetics of IGF-1 diffusion out of the PRP gels. 
For example, in the case of the FA coated samples, PRP from donor 1 tended 
to release the bulk of the IGF-1 present between 2 hours and 1 day while PRP 
from donor 2 released the bulk of the IGF-1 present within the first 2 hours. 
However, a comparative lower sustained release at the later times was detected 
















































Figure 41: Concentrations of IGF1 (mean ±SD pg/mL) in PBS supernatants 
released from PRP gel of 2 blood donors combined with FA coatings. PRP 
samples were activated with either thrombin (Thr) or CaCl2 (Ca) or left non 
activated (control). Donor 1 showed higher levels of IGF1 compared to donor 2. 
There was variation in the kinetics of IGF-1 diffusion out of the PRP gels. FA 
coated samples showed that PRP from donor 1 tended to release the bulk of the 
IGF-1 between 2 hours and 1 day while PRP from donor 2 released the bulk of the 
IGF-1 within the first 2 hours with a comparative lower sustained release at the 
later times. DS, Disorganised FA; OR, organised FA; SS, stainless steel; PRP, 
platelet-rich plasma. 
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For further discussion here and to determine the effect of FA coatings and type 
of PRP activator on IGF-1 release, the quantitative data of IGF-1 release at 
each time point were expressed below as mean ± SD. 
 
Time point 1: IGF-1 released between PRP gelification and 2 hours post 
gelification  
As seen in figure 42A, after 2 hours of PRP gelification from donor 1, treatment 
of PRP with calcium chloride (Ca) appears to induce a higher IGF-1 release 
compared to non-activated PRP when combined with SS substrate. 
Interestingly, disorganised FA coatings enhanced the release of IGF-1 from 
non-activated PRP (443.5 ± 85 pg/mL) compared to thrombin- activated PRP 
(305.9±28 pg/mL). Similarly, IGF-1 was detected in higher amounts in non-
activated PRP samples combined with organised FA (365.8 ± 53 pg/mL) 
compared to thrombin-activated PRP (203±8 pg/mL).  
The same release pattern was detected in the case of donor 2 (Figure 42B). 
Calcium induced higher release of IGF-1 (239±16 pg/mL) compared to the 
control (non-activated PRP) (164.9±15 pg/mL) and to thrombin (130.6±38 
pg/mL) from PRP samples combined with uncoated SS. The disorganised 
coatings triggered a greater release of IGF-1 from non-activated PRP compared 
to thrombin- activated PRP and to calcium- activated PRP by about 30% and 
15% respectively. Similarly, organised FA coatings triggered a greater release 
of IGF-1 from non-activated PRP compared to thrombin- activated PRP and 
calcium-activated PRP by around 50% and 15% respectively. The release 
appears to be greater in non-activated PRP samples combined with 
disorganised FA coatings (266.4 ±35.6 pg/mL) compared to non-activated PRP 
samples combined with organised FA (236.6± 10 pg/mL). In both PRP donors, it 
seems that both FA coatings stimulated the release of IGF-1 from non-activated 

































Figure 42: IGF-1 (mean ±SD) released between PRP gelification and 2 hours post 
gelification. PRP samples of 2 blood donors were loaded on uncoated stainless 
steel (SS), disorganised FA (DS) and organised FA (OR) coated discs. The loaded 
PRP samples were either left non-activated (PRP) or activated using thrombin 
(Thr) or calcium chloride (Ca) and the discs were overlaid with PBS. IGF-1 
concentrations diffusing into the PBS were measured using ELISA and plotted. 
In SS samples, calcium induced the highest release of IGF-1. While both coatings 
showed higher release of IGF-1 from non-activated PRP compared to thrombin 
and calcium-activated PRP with a higher release shown in disorganised FA 
compared to organised FA coating. Both FA coatings stimulated the release of 
IGF-1 from non-activated PRP in high amounts compared to uncoated SS. 
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Time point 2: IGF-1 released between 2 hours post gelification and 1 day 
post gelification 
In the period between 2 hours and 1 day post PRP gelification, both thrombin 
and calcium induced a greater release of IGF-1 from PRP of donor 1 over that 
of the control (non-activated PRP) in uncoated SS and disorganised FA 
substrate groups by around 50%- 200% (Figure 43A). However, in SS groups, 
the PRP activated with calcium showed a higher IGF-1 content (320.6 ± 57 
pg/mL) compared to PRP activated with thrombin (190.3±20 pg/mL). Similarly, 
in the disorganised coatings, high levels of IGF-1 were detected in calcium-
activated PRP (579.3±128 pg/mL) compared to thrombin - activated PRP 
(370.4±49 pg/mL). Organised FA coatings stimulated a higher amount of IGF-1 
release from non-activated PRP (619± 174 pg/mL) and from calcium-activated 
PRP (563.6±62 pg/mL) compared to thrombin-activated PRP (394±74 pg/mL). 
The non- activated PRP combined with organised FA showed the highest IGF-1 
release (619±175 pg/mL) compared to that of disorganised and SS sample 
groups. 
PRP samples of donor 2 (Figure 43B) showed that calcium was the most potent 
activator for PRP as it induced the highest release of IGF-1 compared to non-
activated PRP and thrombin in uncoated SS and disorganised FA substrate 
samples by about 100%. In organised FA samples, calcium-activated PRP 
samples seem to have IGF-1 release (182.6±35 pg/mL) at about similar levels 
to that of non-activated (160.7±26 pg/mL) and thrombin-activated PRP samples 





































Figure 43: IGF-1 (mean ±SD) released between 2 hours post gelification and 1 
day post gelification. Samples from figure 42 were overlaid with fresh PBS and 
concentration of IGF-1 diffusing into the PBS was measured by ELISA one day 
later. The mean data for two blood donors were plotted. Calcium induced a 
greater release of IGF-1 over that of the control (non-activated PRP) in SS and 
disorganised FA substrate groups in both donors. While in organised FA groups, 
the non-activated PRP showed amounts of IGF-1 comparable to that of calcium-
activated PRP. DS, Disorganised FA; OR, organised FA; SS, stainless steel; PRP, 
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Time point 3: IGF-1 released between 1 day post gelification and 3 days 
post gelification 
In the period between 1 day post gelification and 3 days post gelifiction of PRP 
derived from donor 1 (Figure 44A), all FA coatings showed enhanced release of 
IGF-1 compared to uncoated SS corresponding groups. Calcium was the most 
potent activator to release IGF-1 from PRP combined with uncoated SS and FA 
coated substrates compared to non-activated PRP and thrombin. Nevertheless, 
organised FA increased the release of IGF-1 from calcium-activated PRP 
(200±42 pg/mL) compared to uncoated SS (72.6±56 pg/mL) and disorganised 
FA (101.5±10 pg/mL). 
In the case of donor 2 (Figure 44B), both non-activated PRP and thrombin- 
activated PRP exhibited comparable concentrations in all substrate groups. In 
uncoated SS and disorganised FA samples, 100% and 67% respectively more 
IGF-1 was released from calcium-activated PRP compared to the non-activated 
PRP. In contrast, in organised FA samples, non-activated PRP yielded a 
comparable amount of IGF-1 (97.6±29 pg/mL) to that of calcium-activated PRP 
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Figure 44: IGF-1 (mean ±SD) released between 1 day post gelification and 3 days 
post gelification. Samples from figure 43 were overlaid with fresh PBS and the 
concentration of IGF-1 diffusing into the PBS was measured by ELISA at 3 days 
post gelification. The mean data for the two donors were plotted. All FA coatings 
showed enhanced release of IGF-1 compared to uncoated SS. Calcium was the 
most potent activator to release IGF-1 from PRP in uncoated and FA coated 
samples with one exception that organised FA coatings stimulated the release of 
IGF-1 from non-activated PRP of donor 2 in a comparable amount to that of 
calcium-activated PRP. DS, Disorganised FA; OR, organised FA; SS, stainless 









Time point 4: IGF-1 released between 3 days post gelification and 7 days 
post gelification  
At the last time point (Figure 45A), both of the FA coatings continued to induce 
a greater release of IGF-1 from non-activated and activated PRP of donor 1 
compared to uncoated SS. Calcium raised the release of IGF-1 above that of 
the control by about 49% disorganised FA. However, organised FA displayed a 
greater amount of IGF-1 in calcium-activated PRP samples (116.8± 24 pg/mL) 
compared to uncoated SS (34.6±4 pg/mL) and disorganised FA (88.3± 3 pg/mL) 
substrates.  
PRP data of donor 2 (Figure 45B) showed that both non-activated PRP and 






















































P R P (C o n tro l)
P R P /T h r
P R P /C a


























P R P (C o n tro l)
P R P /T h r






















Figure 45: IGF-1 (mean ±SD) released between 3 days post gelification and 7 
days post gelification. Samples from figure 44 were overlaid with fresh PBS and 
IGF-1 concentrations diffusing into the PBS was measured by ELISA at 7 days 
post gelification. The mean data for the two donors were plotted. All FA coatings 
showed enhanced release of IGF-1 from PRP of donor 1 compared to uncoated 
SS. Calcium induced the highest release of IGF-1 from PRP combined with 
organised FA. PRP samples of donor 2 showed similar amounts of IGF-1 in all 
substrate groups. DS, Disorganised FA; OR, organised FA; SS, stainless steel; 










Determination of PDGF-AB released from PRP when used in combination 
with disorganised and organised FA coatings   
The temporal release of PDGF-AB from SS/PRP and FA/PRP combinations into 
PBS was measured over a period of 7 days using ELISAs. PRP samples used 
were derived from two separate blood donors (the same donors of IGF-1 
samples). Complete individual data (mean ±SD) for donor 1 and donor 2 are 
presented in figure 46. Both donors exhibited higher levels of PDGF-AB 
compared to IGF-1. In addition, PRP from donor 1 showed higher levels of 
PDGF-AB release than PRP from donor 2. Most of the release of PDGF-AB 
appeared mostly within the first 24 hours after PRP gelification with the 
maximum release seen after 2 hours of PRP gelification in thrombin-activated 
PRP (~1980 pg/mL and 1730 pg/mL in donor 1 and 2 respectively). It was 
obvious that the major induction of PDGF-AB was achieved consistently 
following thrombin activation. A lower sustained release was seen at the later 
time points. The lowest concentrations for both growth factors were measured 
at day 7 post PRP gelification reaching about 25 pg/mL for IGF-1 and 50 pg/mL 
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Figure 46: Concentrations of PDGF-AB (mean ±SD pg/mL) in PBS supernatants 
released from PRP of 2 blood donors combined with FA coatings. PRP samples 
were activated with thrombin (Thr), CaCl2 (Ca) or left non-activated (control). PRP 
from donor 1 exhibited higher levels of PDGF-AB than PRP from donor 2. High 
concentrations of PDGF-AB were detected after 2 hours with a lower sustained 
release at the later time points. The major induction of PDGF-AB release from 
PRP was achieved consistently following thrombin activation. DS, Disorganised 
FA; OR, organised FA; SS, stainless steel; PRP, platelet-rich plasma; Thr, 






For further discussion and comparison here, PDGF-AB concentration of the 
experimental groups were plotted for each time point and the means of this data 
are presented below (mean ±SD) and analysed. 
 
 Time point 1: PDGF-AB released between PRP gelification and 2 hours 
post gelification 
Two hours after PRP gelification, low concentrations of released PDGF-AB 
were detected when calcium was used to activate PRP derived from donor 1 
(516.6±84 pg/mL) combined with uncoated SS samples compared to the control 
(non-activated PRP) (901.9±187 pg/mL) as shown in figure 47A. Similarly, 
calcium did not enhance PDGF-AB release from PRP (857.3±94 pg/mL) 
compared to the control (1214.7±107 pg/mL) when combined with organised FA 
coatings. While thrombin activation induced the highest release of PDGF-AB 
from PRP compared to the control and to calcium reaching 1813±79 pg/mL, 
1871.7±87 pg/mL and 1979±59 pg/mL when used in combination with uncoated 
SS, disorganised FA coatings and organised FA coatings respectively.  
Results of donor 2 (Figure 47B) showed that organised FA released a higher 
amounts of PDGF-AB from non-activated PRP and activated PRP compared to 
the uncoated and to disorganised FA coated substrates. Moreover, organised 
FA induced the highest release from thrombin-activated PRP (1732±539 pg/mL) 
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Figure 47: PDGF-AB (mean ±SD) released between PRP gelification and 2 hours 
post gelification. PRP samples were loaded on uncoated SS, disorganised FA 
(DS) and organised FA (OR) coatings. The loaded PRP samples were either left 
non-activated (PRP) or activated using thrombin (Thr) or calcium chloride (Ca) 
and the discs were overlaid with PBS. PDGF-AB concentrations diffusing into the 
PBS were measured using ELISA and mean data for the two donors were plotted. 
Both FA coatings stimulated the release of PDGF-AB in high amounts compared 
to the uncoated SS. However, thrombin activation induced the highest release of 










 Time point 2: PDGF-AB released between 2 hours post gelification and 
1 day post gelification  
 
Increased amounts of PDGF-AB were measured from PRP samples of donor 1 
combined with FA coatings after one day of PRP gelification compared to 
uncoated SS (Figure 48A). It seems that the non-activated PRP used in 
combination with SS released most of its PDGF-AB within the first 2 hours. 
Calcium showed a slight increase in PDGF-AB release in all substrates groups 
compared to the corresponding controls (non-activated PRP). While, thrombin 
enhanced PDGF-AB release in great amounts above that of the control by 
about 600%, 120% and 300% when PRP used in combination with SS, 
disorganised FA and organised FA respectively. However, the highest release 
was triggered by organised FA from thrombin-activated PRP (1705 ±153 pg/mL) 
compared to SS (646.6 ±271 pg/mL) and disorganised FA (1143.6±423 pg/mL). 
Similarly, thrombin demonstrated higher release compared to non-activated 
PRP of donor 2 in all substrate groups (Figure 48B). In contrast to donor 1, the 
highest amount of PDGF-AB was seen in thrombin-activated PRP of uncoated 
SS group (1068.4±113 pg/mL) compared to disorganised FA (453.5±20 pg/mL) 











1 0 0 0
1 2 5 0
1 5 0 0
1 7 5 0
2 0 0 0
























P R P (C o n tro l)
P R P /T h r
P R P /C a





1 0 0 0
1 2 5 0
1 5 0 0
1 7 5 0
2 0 0 0
























P R P (C o n tro l)
P R P /T h r





















Figure 48: PDGF-AB (mean ±SD) released between 2 hours post gelification and 
1 day post gelification. Samples from figure 47 were overlaid with fresh PBS and 
concentration of PDGF-AB diffusing into the PBS was measured by ELISA and 
mean data for two blood donors were plotted. Thrombin enhanced PDGF-AB 
release above that of calcium and non-activated PRP in all the substrate groups. 
DS, Disorganised FA; OR, organised FA; SS, stainless steel; PRP, platelet-rich 












Time point 3: PDGF-AB released between 1 day post gelification and 3 
days post gelification 
At day 3, results of PRP samples of donor 1 showed that all FA experimental 
groups continued to show a high amount of PDGF-AB compared to the 
uncoated SS groups (Figure 49A). Thrombin burst PDGF-AB release from PRP 
combined with organised FA compared to non-activated PRP and calcium –
activated PRP. There was greater amount of PDGF-AB in thrombin-activated 
PRP samples of the organised FA coatings (565.4±104 pg/mL) than 
disorganised FA coatings (237.5±124 pg/mL) and SS uncoated discs (111±40 
pg/mL)  
Data of donor 2 (Figure 49B) showed the same trend where thrombin stimulated 
a higher release of PDGF-AB from PRP compared to the control (non-activated 
PRP) and to calcium in FA substrate groups. Nevertheless, the highest release 
of PDGF-AB in thrombin-activated PRP samples was induced by organised FA 
coatings (695.2±85 pg/mL) compared to disorganised FA coatings (493.3±221 
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Figure 49: PDGF-AB (mean ±SD) released between 1 day post gelification and 3 
days post gelification. Samples from figure 48 were overlaid with fresh PBS and 
the concentration of PDGF-AB diffusing into the PBS was measured by ELISA 2 
days later at 3 days post gelification. The mean data for two blood donors were 
plotted. Thrombin burst the release of PDGF-AB compared to non-activated PRP 
and calcium –activated PRP with a greater amount triggered by the organised FA 
coatings than disorganised FA coatings and SS uncoated discs. DS, 
Disorganised FA; OR, organised FA; SS, stainless steel; PRP, platelet-rich 









Time point 4: PDGF-AB released between 3 days post gelification and 7 
days post gelification 
Data obtained at day 7 showed that thrombin and calcium induced the release 
of PDGF-AB from PRP of donor 1 at a comparable levels to that of the control 
(non-activated PRP) when combined with uncoated SS (Figure 50A).rr This was 
not the case in FA coating groups where the highest release was induced by 
calcium in disorganised FA and by thrombin in organised FA groups. However, 
the thrombin-activated PRP of organised FA showed a greater release of 
PDGF-AB (232.9±26 pg/mL) than the calcium-activated PRP of disorganised 
FA (151±28 pg/mL).      
In PRP samples data of donor 2, thrombin and calcium activation triggered a 
greater release of PDGF-AB compared to non-activated PRP in all substrate 
groups (Figure 50B). PDGF-AB released from thrombin-activated PRP used in 
combination with organised FA coatings (431.7±117 pg/mL) was higher than 
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Figure 50: PDGF-AB (mean ±SD) released between 3 days post gelification and 7 
days post gelification. Samples from figure 49 were overlaid with fresh PBS and 
the concentration of PDGF-AB diffusing into the PBS was measured by ELISA at 
7 days post gelification. The mean data for two blood donors were plotted. 
Thrombin activation triggered the greatest release of PDGF-AB compared to 
calcium- activated and non-activated PRP groups from organised FA coatings. 
DS, Disorganised FA; OR, organised FA; SS, stainless steel; PRP, platelet-rich 







6.2.2 Growth factor released from PRP gel and PRP releasate when 
combined with uncoated SS and organised FA coatings  
In the previous section, growth factor release from PRP gel used in combination 
with uncoated SS, disorganised FA and organised FA was determined at 
different time points. In this section, growth factor release from PRP gel was 
compared to growth factor release from PRP releasate (obtained by extracting 
the soluble components from thrombin-activated PRP) when both were 
combined with uncoated SS and organised FA coated surfaces after being 
incubated 3 days in PBS. The accumulative amounts of IGF-1 and PDGF-AB 
released into PBS supernatants were measured using ELISA. The experiment 
was repeated twice using 2 blood donors and the results are presented below. 
 
IGF-1 released from PRP gels and PRP releasate when combined with 
organised FA coatings and uncoated SS 
The results based on PRP obtained from donor 1 (Figure 51) showed that the 
mean IGF-1 level released from PRP gel when combined with uncoated SS 
(117 ± 17 pg/mL) was lower than that of PRP releasate combined with uncoated 
SS (409 ± 48 pg/mL). Similarly, the mean IGF-1 level released from PRP gel 
when combined with organised FA coatings (125 pg/mL ± 42) was lower than 
that of PRP releasate when combined with organised FA coatings (447 pg/mL 
±53). Apparently, the underlying substrate, whether uncoated SS or organised 
FA had no effect on IGF-1 released from either PRP gel or PRP releasate.   
A broadly similar pattern of IGF-1 release was observed when PRP gel and 
PRP releasate derived from donor 2 (Figure 51) were used in combination with 
uncoated SS or organised FA surfaces though the absolute amounts of IGF-1 









Figure 51: Concentrations of IGF-1 (mean ±SD pg/mL) released into PBS from 
PRP gel and PRP releasates derived from 2 blood donors and combined with 
either uncoated SS or organised FA coatings. PRP releasate in both donors 
exhibited greater release of IGF-1 compared to PRP gel. The underlying 
substrate (SS or FA) did not affect the release in in either the PRP gel and 




PDGF-AB released from PRP gel and PRP releasate when combined with 
organised FA coatings and uncoated SS 
The PDGF-AB release profile from PRP extracted from 2 blood donors is 
illustrated in Figure 52.  
For donor 1, PRP gel samples showed a higher level of PDGF-AB release when 
combined with uncoated SS (1219.6 ±238 pg/mL) compared to PRP releasate 
loaded on uncoated SS (692.7 ±140 pg/mL). In the same way, PRP gel 
combined with organised FA coated discs exhibited a higher concentrations of 
PDGF-AB (1227.5 ±199 pg/mL) compared to PRP releasate loaded on 
organised FA coated discs (628 ±125 pg/mL). Additionally, no difference was 
seen in PDGF-AB release between SS and organised FA coatings for both of 
PRP gel groups and PRP releasate groups.  
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Sample derived from donor 2 (Figure 52) seemed to have the same release 
profile as samples derived from donor 1. PRP gel amplified the release of 
PDGF-AB in the SS group (886 ±130 pg/mL) and organised FA group (834.5 
±178 pg/mL) compared to the PRP releasate corresponding groups of SS (294 
± 67 pg/mL) and organised FA (245 ±63 pg/mL). Similar to donor 1, PDGF-AB 
concentrations in donor 2 didnot differ between SS and FA coatings for both of 
PRP gel groups and PRP releasate groups. 
Figure 52: Concentrations of PDGF-AB (mean ±SD pg/mL) in PBS supernatants 
released from PRP gel and releasate combined with uncoated SS or organised 
(OR) FA coatings. PRP gel released higher concentrations of PDGF-AB 
compared to PRP releasate. The underlying substrate (SS or FA) did not affect 
the release in either the gel or releasate groups. The results were consistent in 
both donors. OR, organised FA; SS, stainless steel; PRP, platelet-rich plasma.  
 
 
6.2.3 Release of Ca2+ from disorganised FA and organised FA coatings 
when combined with PRP gel 
The release of Ca2+ from disorganised  and organised FA coatings in presence 
of PRP gel was investigated by measuring the concentrations of Ca2+ ions 
diffusing into PBS at different time points for up to 14 days using inductively 
coupled plasma optical emission spectrometry (Figure 53). The PRP samples, 
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applied to the FA coatings were treated with 20 IU/mL thrombin to activate the 
platelets and trigger PRP gelification. At 2 hour time point, the concentrations of 
Ca2+ released from disorganised FA (0.07 ±0.01 mg/L) and organised FA (0.07 
±0.009 mg/L) coatings were similar when FA used alone without PRP gel and 
this was consistently seen at all time points. However, at the 2 hour time point 
and in the presence of PRP gel, the release of Ca2+ ions was increased for 
organised FA (0.95 ±0.03 mg/L) and disorganised FA coatings (0.68 ± 0.16 
mg/L) with the value for the organised FA coating being greater than that of the 
disorganised coating.  
At the one day time point (Figure 53), the absolute amounts released are clearly 
reduced compared to the 2 hour time point. However, the general pattern of 
Ca2+ release is similar to the data obtained for the 2 hour point described above 
where Ca2+ released from disorganised FA combined with PRP gel (0.118 
±0.01 mg/L) being higher than Ca2+ released from disorganised FA alone (0.078 
±0.02 mg/L) and Ca2+ released from organised FA combined with PRP gel 
(0.313 ±0.06 mg/L) being greater than the amount released by organised FA 
alone (0.055 ±0.001 mg/L). The organised FA combined with PRP gel induced 
a higher Ca2+ (0.313 ±0.06 mg/L) than the disorganised FA combined with PRP 
gel (0.118 ±0.01 mg/L). 
At day 3, the calcium release dropped. As can be seen from figure 53, the 
difference between disorganised FA and organised FA samples was small. 
Over the remaining 14 days of the test, the amounts of Ca2+ released remained 
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Figure 53: Concentrations of Ca2+ (mean ±SD) released from FA and FA/PRP 
combinations in PBS samples. No difference was seen between the 
concentrations of Ca2+ released from disorganised FA and organised FA 
coatings when used alone without PRP gel at all time points. Samples with PRP 
gel released more calcium than samples lacking PRP for over 3 days. OR/PRP 
gel had increased calcium concentrations compared to DS/PRP gel within the 
first 24 hours. DS, Disorganised FA; OR, organised FA; SS, stainless steel; PRP, 
platelet-rich plasma.  
 
6.2.4 Cytotoxicity of FA/PRP combinations  
Previously in Chapter 4, it was shown that media preconditioned with FA was 
non-cytotoxic against G292 cells when grown in culture supplemented with 10% 
FBS. In Chapter 5, it was shown that media supplemented with activated 10% 
PRP was also non-cytotoxic against G292 cells. The aim of this section was to 
discover the effect of FA preconditioned media combined with PRP on cell 
viability. In this test, G292 cells were grown in media supplemented with 10% 
PRP (activated with CaCl2) and compared to cells grown in FA preconditioned 
media supplemented with 10% activated PRP. As controls, the cells were grown 
in media supplemented with 10% FBS providing idealised conditions for cell 
viability (i.e. the negative control for cell death) and the cells were grown in FA 
preconditioned media supplemented with 10% FBS. Cell viability was 
determined by measuring LDH released into the media by the dead cells. The 

































donors. Cell death was expressed by normalising the amount of LDH released 
to a positive control (the cells were killed by adding the detergent Triton- X100) 
and mean data of the 2 blood donors were presented in figure 54.  
Relative to the positive control (representing 100% cell death), none of the 
treatment options were cytotoxic. LDH measurements were similar in the 10% 
FBS negative control (9.2%±0.6) and 10% FBS combined with FA 
preconditioned media (9.5%±0.4) which means FA has no cytotoxic effect 
(confirming the data presented in Chapter 4). Similarly, cells grown in media 
supplemented with 10% PRP are perfectly viable in that LDH release is not 
greatly different to the negative control (10% FBS) (10.7%±3.6 versus 9.2%±0.6 
respectively). Interestingly, using FA preconditioned media supplemented with 
10% PRP (6.3%±1) appeared to reduce the release of LDH compared to using 
media containing 10% PRP alone (10.7%±3.6). Likewise, FA preconditioned 
media supplemented with 10% PRP showed less LDH amount compared to FA-













Figure 54: Cytotoxicity (%LDH release mean ±SD) of FA&/or PRP combination on 
G292 cells after cell culturing for 3 days using PRP samples extracted from 2 
blood donors. All the tested groups were normalised to the positive control 
(100% cell death). The mean data of the 2 donors showed that all the tested 
groups showed no cytotoxicity. The negative control and FA preconditioned 
media and PRP groups showed similar amounts of LDH. However, combination 






6.2.5 Protein adsorption of PRP on FA coatings  
Adsorption of PRP and FBS proteins on substrates comprised of disorganised 
FA coatings, organised FA coatings and uncoated SS was investigated using 
gel electrophoresis (8-16% SDS-PAGE gel).  PRP was activated with thrombin 
to generate PRP gel and PRP-releasate. PRP and FBS samples were loaded 
on the substrates for an overnight period and competitively desorbed using 
phosphate buffer. Equal portions of each extract were subjected to SDS-PAGE 
analysis and the total protein was visualised using silver staining. The 
experiment was performed using PRP obtained from 2 blood donors and was 
repeated in triplicate for each donor. Representative data is shown in figure 55. 
Molecular weight calibrators are shown in the lane labelled Mwt and these 
indicate that proteins ranging from less than 15kDa to over 250KDa were 
evident in samples desorbed from the substrates.  
For donor 1, PRP gel proteins desorbed from disorganised and organised FA 
substrates are shown in lanes 1 and 2 respectively. Interestingly, PRP gel 
proteins appeared to be differentially adsorbed to the disorganised and 
organised coatings as indicated by the asterisks between the lanes. In contrast, 
no detectable PRP gel proteins was recovered from the uncoated SS (lane 3). 
Proteins comprising the PRP releasate from donor 1 appeared to adsorb to the 
disorganised and organised FA substrates as shown in lanes 4 and 5 
respectively with more protein being recovered from the organised FA. Again 
there was a very clear differential adsorption between the two coatings as 
indicated by the asterisks between the lanes. No detectable protein was 
recovered from the uncoated SS (lane 6). The protein comprising the FBS 
control were also differentially adsorbed to the disorganised and organised FA 
substrates as indicated by the asterisks in lanes 7 and 8 respectively. With 
more protein being recovered from the organised FA substrate. As with PRP gel 
and PRP releasate, no detectable FBS protein was recovered from the 







Figure 55: SDS-PAGE of PRP and FBS proteins that were adsorbed overnight on 
disorganised FA, organised FA and uncoated SS. Disorganised and organised 
FA appeared to adsorb proteins from PRP and FBS in a differential manner 
(indicated by the asterisks). Protein recovery was generally greater from 
organised FA compared to disorganised FA. Variability in the protein banding 
pattern between donors 1 and 2 demonstrates donor variability. Mwt, molecular 
weight calibrators; DS, Disorganised FA; OR, organised FA; SS, stainless steel; 






In the case of donor 2 (Figure 55), a range of proteins were again present 
ranging from less than 15kDa to over 250KDa. However, there are inter donor 
differences between donor 1 and 2. For example, lane 1 (PRP gel adsorbed to 
disorganised FA) when compared between donors 1 and 2. Asterisks indicate 
where there is a differential recovery of proteins from disorganised and 
organised FA coatings in each group. Special attention is drawn to lane 3 of 
donor 2 which shows that significant proteins were recovered from uncoated SS 
which is in complete contrast to donor 1 and further indicates the effect of donor 
variability on PRP composition and behaviour. PRP gel, PRP releasate proteins 
of donor 2 and FBS control proteins were also recovered in greater amounts 
from organised FA substrates compared to disorganised FA substrates.  
 
6.2.6 Microscopic analysis of cell morphology and attachment on FA 
coatings in combination with PRP gel or PRP releasate  
The attachment, morphology and distribution of G292 cells cultured for 2 days 
on discs coated with disorganised FA or organised FA in combination with PRP 
gel or PRP releasate were examined using SEM and fluorescence confocal 
laser microscopy.  
 
 Microscopic analysis of cell growth on FA/PRP gel combinations 
The SEM and fluorescence confocal images of G292 cells growing on both 
organised and disorganised FA crystal surfaces when combined with PRP gel 
are shown in figure 56. The analysis of disorganised FA images revealed 
clumps of small rounded structures that most likely represent platelets 
embedded within and surrounding the cells and PRP gel. The cells were 
clustered in groups spreading over the crystals (Figure 56a and 56b). 
In the case of organised FA, PRP gel appeared to form a large sheet that 
spread over the coating surface (Figure 56c and 56d), and was associated with 
a large number of cells laying down and adhering within PRP gel as seen 








Figure 56: SEM and confocal images of G292 cells attached and grown on 
FA/PRP gel combinations for 2 days. Cells grown on disorganised coatings were 
clustered in groups and were surrounded by small round structures which are 
most likely platelets. PRP gel of organised FA was seen as a big sheet 
incorporated with many cells. 
 
 
 Microscopic analysis of cell growth on FA/PRP releasate combinations 
The SEM and fluorescence confocal images of G292 cells growing on both 
disorganised and organised FA surfaces combined with PRP releasate are 
shown in figure 57. Cells colonising disorganised FA in combination with PRP 
releasate adopted a cellular morphology and distribution similar to that 
observed in disorganised FA coatings in combination with FBS (see figure 31, 
chapter 4). As shown in figure 57a and 57b, the cells tend to grow as groups of 






crystals indicating cell spreading and growth. In organised FA coatings (Figure 
57c and 57d), PRP releasate promoted the cellular attachment and growth but 
the cellular organisation and structure was not similar to that observed in 
organised FA combined with FBS in that the cells were polygonal but did not 
have a stellate-like shape and had less prominent cytoplasmic extensions 
compared to cells grown with FBS. 
 
 
Figure 57: SEM and confocal images of G292 cells attached and grown on 
FA/PRP releasate combinations for 2 days. The cells grew as groups of cells on 
disorganised FA with cell processes stretching between the crystals. On 
organised FA, the cells were polygonal and were spreading with less prominent 








6.2.7 Quantitative analysis of cell attachment and proliferation on FA 
coatings combined with PRP gel, PRP releasate or FBS 
G292 osteoblast-like cells were grown on uncoated stainless steel, disorganised 
FA coated discs and organised FA coated discs combined with either FBS 
(control), PRP gel or PRP releasate (obtained by extracting the soluble 
components from thrombin-activated PRP). In order to examine cell attachment, 
the DNA content of the grown cells was measured after 5 hours and one day of 
cell culture and in order to examine cell proliferation, DNA content was detected 
after 3 and 7 days. The experiment was repeated twice using PRP samples 
extracted from 2 blood donors. The complete individual data sets for donor 1 
and donor 2 are presented in appendix 3 and 4 respectively. The data in each 
experimental group was normalised to the mean value obtained from the control 
(uncoated SS combined with FBS) and the mean of the two donors data was 
plotted for each time point. 
 
 Quantitative analysis of cell attachment 
The assessment of cell attachment after 5 hours (figure 58) showed that under 
standard culture condition (cell culture using FBS), no difference was observed 
between FA coatings and uncoated discs (SS). PRP releasate seemed to have 
the same effect on cell attachment as FBS in all groups tested. However, 
compared to FBS, PRP gel increased the cell attachment and the DNA content 
(as a proxy for cell number) was increased by about 174%, 157% and 149% in 
SS, disorganised FA and organised FA respectively. 
After one day of cell culture (Figure 58), there was no difference between FA 
coatings and uncoated SS when combined with FBS. However, increase in 
DNA content was observed when PRP gel was added to the uncoated SS, 
disorganised FA and organised FA coatings compared to the FBS by about 
50%, 40% and 90% respectively. PRP gel promoted cellular attachment on 
organised FA (191%±56) compared to disorganised FA (140%±40) and 
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Figure 58: Cell attachment of G292 osteoblast-like cells on FA/PRP (PRP from 2 
blood donors) after 5 hours and one day of cell culture, assessed by DNA 
quantification. All the experimental groups of each donor were normalised to the 
relative control group (SS/FBS) and mean data of the 2 PRP donors were plotted 
for each time point. Under standard culture conditions (FBS), FA coatings did 
not show a different effect on initial cell attachment when compared to uncoated 
discs. However, addition of PRP gel to FA coatings seemed to enhance cell 
attachment within the first 24 hours as compared to the control. DS, 
Disorganised FA; OR, organised FA; SS, stainless steel; PRP, platelet-rich 
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 Quantitative analysis of cell proliferation  
DNA content was determined after 3 days as a measure of cell number and 
proliferative rate. A similar trend was observed at day 3 (Figure 59) where PRP 
gel increased the cellular proliferation on both FA coatings above that of the 
control (uncoated SS/FBS) by 50% and 90% in disorganised and organised FA 
coatings respectively. A higher amount of DNA was detected in organised FA 
compared to disorganised FA when the coatings combined with PRP gel .  
At day 7 (Figure 59), neither FA coatings enhanced cell proliferation when 
combined with FBS compared to the control. However, organised FA coatings 
combined with PRP gel showed increase in DNA content compared to the 
control (uncoated SS/FBS) by about 30%. Moreover, the increase of cell 
proliferation induced by organised FA combined with PRP gel was higher than 















































Figure 59: Cell proliferation of G292 osteoblast-like cells on FA/PRP 
combinations after 3 days and 7 days of cell culture, assessed by DNA 
quantification. All the experimental groups of PRP obtained from two donors 
were normalised to the relative control group (SS/FBS) and mean data of the 2 
PRP donors were plotted for each time point and statistically analysed. Under 
standard culture conditions (FBS), FA coatings did not show a significant effect 
on cell proliferation when compared to uncoated discs. However, addition of 
PRP gel and releasate to FA coatings seemed to enhance cell proliferation in a 
consistent manner over the 7 days as compared to the control. DS, Disorganised 
FA; OR, organised FA; SS, stainless steel; PRP, platelet-rich plasma; FBS, fetal 
bovine serum.  
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6.2.8 Osteogenic differentiation of human dental pulp stem cells (hDPSCs) 
cultured on FA/PRP combinations 
6.2.8.1 Determination of expression of osteogenic marker genes by 
hDPSCs cultured on FA/PRP combinations using qRt-PCR  
6.2.8.1.1 Validation of using GAPDH as a housekeeping gene 
Changes in gene expression are measured relative to the expression of a 
specific gene whose expression is thought to be constant during the course of 
the experiment. GAPDH is an example of a so called “housekeeping gene” 
which codes for a glycolytic enzyme and is expressed at a constant rate in 
many cell types as its function is essential to energy metabolism in the cell. In 
addition, the expression level of a suitable house-keeping gene should not vary 
significantly between different samples. The suitability of GAPDH to act as a 
reference housekeeping gene under the experimental condition used here was 
tested. hDPSCs were cultured for 3 days under osteogenic conditions on 
uncoated and organised FA coated discs combined with either PRP gel, PRP 
releasate or FBS. Expression of GAPDH by hDPSCs was investigated using 
qRT-PCR. Examples of the resulting amplification curves are shown in figure 
60. The results showed a constant expression of GAPDH irrespective of the cell 
culture conditions used with no differences between expression levels across 
samples. This indicated that GAPDH was suitable to use as a reference gene 










Figure 60: Amplification curves of the qRt-PCR assay using the house-keeping 
gene (GAPDH) showing a constant expression irrespective of changes of 






6.2.8.1.2 Effect of FA/PRP combinations on levels of osteogenic gene 
expression in hDPSCs under osteogenic culture conditions 
hDPSCs were grown on uncoated stainless steel and organised FA coated 
discs loaded with either FBS (control), PRP gel or PRP releasate (soluble 
components extracted from thrombin-activated PRP) in osteogenic media 
containing dexamethasone and L-ascorbic acid. After 3 days, the level of 
expression of osteogenic marker genes (ALP, RUNX-2, OCN and OPN) by 
hDPSCs was determined using qRT-PCR. The effects of PRP extracted from 2 
donors on gene expression was investigated. The relative change in gene 
expression was calculated using the delta Ct (ΔCt) method. By using this 
method, ΔCt was first calculated by normalising the Ct value of each gene of 
interest to that of the house keeping gene (GAPDH, see the previous section) 
determined for the same sample. Then, the relative change in gene expression 
was calculated using 2-Δct. Finally, the ratio of gene expression in FA/PRP 
cultures compared to the control (uncoated SS/FBS) was calculated by 
normalising 2-Δct value for each sample to the mean value of 2-Δct of the control 
sample. The results of the mean of ratio of expression (fold change) ±SD were 
plotted. 
  
Effect of FA/PRP combinations on expression of ALPL in hDPSCs 
PRP gel and PRP releasate derived from blood donor 1 (Figure 61), caused an 
up regulation in ALPL expression when used in combination with uncoated SS 
by about 4.6 fold relative to the control (uncoated SS loaded with FBS). PRP gel 
showed a slight upregulation in ALPL expression of about 1.7 fold above that of 
the control when combined with organised FA. In contrast, organised FA failed 
to cause any significant change in ALP expression compared to the control 
when used in combination with FBS or PRP releasate. However, both of PRP 
gel and PRP releasate showed an increase in ALPL expression compared to 
FBS when combined with organised FA.  
In the case of the second donor, all SS and organised FA samples had no 
effects on ALPL expression compared to the control (Figure 61). However, PRP 
gel and releasate from both donors showed higher ratios of expression when 







Figure 61: Ratio of ALPL gene expression to SS/FBS control (mean ±SD) in 
hDPSCs cultured on uncoated and organised FA coated discs combined with 
FBS, PRP gel or PRP releasate. Compared to the control, PRP extracted from 2 
blood donors did not increase the level of ALPL gene expression when 
combined with organised FA except PRP gel derived from donor 1. PRP of donor 
1 showed a high ALPL expression when combined with SS compared to the 
control. PRP gel and releasate of both donors showed high expression when 
combined with SS compared to when combined with organised FA. OR, 
organised FA; SS, stainless steel; PRP, platelet-rich plasma; FBS, fetal bovine 
serum; ALPL, alkaline phosphatase gene. 
 
 
Effect of FA/PRP combinations on expression of RUNX-2 in hDPSCs 
After 3 days in osteogenic culture, PRP gel and PRP releasate from donor 1 
showed upregulation in RUNX-2 expression when combined with uncoated SS 
(3 fold difference) and organised FA (2 fold difference) compared to the control 
(uncoated SS loaded with FBS) (Figure 62). Whereas organised FA displayed a 
lower level of RUNX-2 expression when loaded with FBS by about two times 
compared to the control.  
In donor 2, RUNX-2 expression was not changed when comparing the levels of 
all the samples to that of the control (Figure 62). Similar to donor 1, PRP 
releasate and FBS showed high RUNX-2 expression when combined with SS 
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compared to organised FA. Nevertheless, and in contrast to donor 1, hDPSCs 
showed an increase in RUNX-2 expression in organised FA when loaded with 














Figure 62: Ratio of RUNX-2 gene expression to the control (SS/FBS) (mean ±SD) 
in hDPSCs cultured on uncoated and organised FA coated discs combined with 
FBS, PRP gel or PRP releasate. Compared to the control, PRP gel and releasate 
of donor 1 showed a high RUNX-2 expression when combined with SS and FA 
compared to the control. While in donor 2, low RUNX-2 expression was showed 
by all the samples compared to the control. PRP gel and releasate of both 
donors showed high expression when combined with SS compared to organised 





Effect of FA/PRP combinations on expression of OCN in hDPSCs  
The levels of OCN expression of FA coated sample groups were not different to 








Figure 63: Effects of FA and PRP on levels of OCN gene expression (mean ±SD) 
in hDPSCs cultured on uncoated and organised FA coated discs combined with 
FBS, PRP gel or PRP releasate. The levels of OCN expression of organised FA 
sample groups were almost similar to those of the control in both blood donors’ 
cases. OR, organised FA; SS, stainless steel; PRP, platelet-rich plasma; FBS, 




Effect of FA/PRP combinations on expression of OPN in hDPSCs  
Compared to uncoated SS loaded with FBS control, OPN expression in 
hDPSCs was down regulated in PRP releasate of donor 1 when combined with 
uncoated SS. When SS was coated with organised FA, the level of OPN gene 
expression was upregulated under standard culture condition (FBS) by about 4 
times compared to the control, and was upregulated when organised FA was 
combined with PRP gel and PRP releasate by about 19 and 17 times 
respectively compared to the uncoated control (Figure 64).  
In the case of the donor 2 (Figure 64), OPN expression was comparable in PRP 
groups when combined with uncoated SS to that of the control. When PRP gel 
and releasate were combined with organised FA, they increased the expression 
levels of OPN compared to the control by 12 and 3 times respectively. The 
upregulation of OPN expression was higher in PRP gel when added to 
organised FA compared to PRP releasate. Organised FA showed also up-
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regulation in OPN expression under standard culture condition (FBS) compared 














Figure 64: Effects of FA and PRP on levels of OPN gene expression (mean ±SD) 
in hDPSCs cultured on uncoated and organised FA coated discs combined with 
FBS, PRP gel or PRP releasate. The levels of OPN gene expression were up 
regulated in organised FA when combined with FBS or PRP of 2 blood donors 
compared to the uncoated controls. OR, organised FA; SS, stainless steel; PRP, 
platelet-rich plasma; FBS, fetal bovine serum; OPN, osteopontin. 
 
 
6.2.8.2 ALP activity in hDPSCs cultured on FA/PRP combinations 
6.2.8.2.1 Quantitative analysis of ALP activity  
hDPSCs were grown on uncoated stainless steel and organised FA coated 
discs loaded with either FBS (control), PRP gel or PRP releasate (soluble 
components extracted from thrombin-activated PRP) in osteogenic media 
containing dexamethasone and L-ascorbic acid. After 2 weeks, ALP activity (an 
early osteoblast differentiation marker) of hDPSCs was determined. The levels 
of ALP activity was determined in two experiments using PRP samples 
extracted from blood of 2 donors. The data were first normalised to DNA 






deviation obtained using PRP from the 2 blood donors were plotted. The results 
presented in figure 65 showed that organised FA coatings reduced ALP activity 
under standard culture conditions (FBS), to around 10% relative to the control. 
The addition of PRP gel and PRP releasate to FA coatings did not restore ALP 
activity seen in uncoated SS/FBS samples (20% and 17% respectively).  
 
Figure 65: ALP activity normalised to DNA concentrations (mean ±SD) of 
hDPSCs cultured on uncoated and organised FA coated discs combined with 
FBS, PRP gel or PRP releasate under osteogenic culture conditions after at 2 
weeks of cell culture. ALP/DNA ratios were normalised to the control (uncoated 
SS/FBS) forming 100% and mean data of 2 blood donors was plotted. The 
highest level of ALP activity was detected in PRP groups when loaded on SS. In 
contrast, organised FA had a very low ALP activity compared to the control. OR, 
organised FA; SS, stainless steel; PRP, platelet-rich plasma; FBS, fetal bovine 
serum; ALP, alkaline phosphatase. 
 
 
6.2.8.2.2 Qualitative analysis of ALP deposition in hDPSCs culture 
hDPSCs were cultured for 2 weeks on monolayers under basal and osteogenic 
conditions in order to confirm the capability of hDPSCs for the osteogenic 
differentiation. The cells showed a transparent cell layer with sporadically 
distributed ALP positive areas. However, more intense ALP staining was seen 
visually in hDPSCs cultured under osteogenic conditions compared to cells 
cultured under basal conditions (Figure 66).   
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Figure 66: ALP staining for hDPSCs cultured in monolayer under basal and 
osteogenic conditions (OM). The cells showed positive ALP staining, but the 
stain was more intense for cells cultured under osteogenic conditions compared 
to basal conditions. 
 
Osteogenic differentiation of hDPSCs cultured for 2 weeks on SS and organised 
FA discs combined with FBS, PRP gel or PRP releasate under osteogenic 
conditions was determined by staining for ALP activity. All the samples showed 
evidence of positive staining for ALP (dark purple coloration) as shown in figure 
67. However, hDPSCs seeded with PRP gel and releasate showed a more 
intense widespread staining compared to cells seeded with FBS. Interestingly, 
ALP stain was more evident in SS uncoated discs compared to the 
corresponding organised FA coated discs. Control SS and organised FA discs 
(without cells) were also tested for ALP stain. As seen in figure 68, the controls 
were totally negative for the ALP stain when whether combined with FBS, PRP 










Figure 67: ALP staining (dark purple) of hDPSCs cultured on FA&/or PRP for 2 
weeks under osteogenic conditions. All the samples showed positive ALP stain. 
However, hDPSCs cultured with PRP had a more intense widespread staining 
compared to cells seeded with FBS. ALP stain was more evident in SS uncoated 
discs compared to the corresponding OR FA coated discs. OR, organised FA; 































Figure 68: ALP staining of control SS and FA discs cultured under the same 
conditions of the experimental samples but without cells. They were all negative 
for the ALP stain. OR, organised FA; SS, stainless steel; PRP, platelet-rich 
plasma; FBS, fetal bovine serum; ALP, alkaline phosphatase. 










6.2.8.3 Effect of FA/PRP combinations on mineralisation induced by 
hDPSCs 
Alizarin red stain (ARS) was used to evaluate calcium rich deposits 
(mineralisation) in hDPSCs grown in the presence of osteogenic media on 
FA/PRP combinations for 2 weeks. The results presented in figure 69 showed 
that all the SS and FA samples displayed positive red staining with Alizarin red. 
FA coatings themselves contain calcium, even though, it was still possible to 
distinguish Alizarin red positive calcium deposits within the attached cell layers. 
The cell layer of FA discs seemed to be more thickened compared to uncoated 
SS discs. Some calcifying deposits or clumps of mineralisation can be seen on 
FA coated discs, which was indicative of mineral nodule formation.  
Control SS and FA discs (without cells) were also tested with ARS. The results 
presented in figure 70 showed that the controls were totally negative for the 
ARS stain when combined with FBS and PRP releasate. However, PRP gel of 
both substrates had a red coloured stain but with different appearance from that 
of PRP gel-cell stain where the later was almost dissolved on the SS discs while 
in the control, the PRP gel was not dissolved. On organised FA discs, the PRP 
gel of the control took the stain but did not show calcium deposits that were 












Figure 69: ARS staining (red) of hDPSCs cultured on FA/PRP for 2 weeks under 
osteogenic conditions. All the SS and FA samples showed positive red staining 
with Alizarin red. The cell layer of FA discs seemed to be more thickened 
compared to uncoated SS discs. OR, organised FA; SS, stainless steel; PRP, 






























Figure 70: ARS staining (red) of control SS and FA discs cultured under the 
same conditions of the cells but without cells. They were negative for the ARS 
stain when combined with FBS and PRP releasate while PRP gel had the stain 
but with different appearance from that of the cell-seeded discs. OR, organised 
FA; SS, stainless steel; PRP, platelet-rich plasma; FBS, fetal bovine serum; ARS, 









6.3 Discussion  
FA coatings were synthesised successfully on stainless steel (SS) discs via a 
hydrothermal method described earlier (Chapter 4, FA results). Deposited FA 
crystals were arranged in a disordered manner on upper disc surfaces 
(disorganised FA coatings) and were ordered on the under surfaces (organised 
FA coatings). Both FA coatings were biocompatible and not cytotoxic. PRP 
containing high concentration of platelets (5-8 times higher than total blood) was 
prepared using a simple protocol (chapter 5, PRP results). PRP had a better 
effect on cell viability when added to culture medium at 10 % (v/v) compared to 
5% (v/v). Furthermore, PRP when used in cell culture as either PRP gel or PRP 
releasate (obtained by extracting the soluble components from activated PRP) 
enhanced significantly G292 osteoblast-like cell attachment and proliferation 
compared to the standard culture conditions (FBS).  
 
6.3.1 Temporal release of growth factors from PRP into PBS when used in 
combination with disorganised and organised FA coatings 
It is known that platelets upon activation release a large variety of growth 
factors (GFs) after they adhere, aggregate and form fibrin mesh (Albanese et 
al., 2013). IGF-1 and PDGF-AB growth factors are potent mitogens and 
chemotactic agents for marrow cells and are believed to trigger osteoblast 
differentiation (Zhang et al., 2013). The ability of FA coatings to influence the 
temporal release of IGF-1 and PDGF-AB from activated and non-activated PRP 
into PBS was examined in this study in order to model the release of growth 
factors (GFs) from FA/PRP implant coatings as they might be used in vivo. 
Calcium chloride (CaCl2) and thrombin were used to activate PRP. They are 
commonly used activators to stimulate the release of GFs from platelets. 
Extracellular ionised calcium serves as a cofactor for the activation of almost 
every protein factor of the coagulation cascade resulting in indirect platelet 
activation and the triggering of the prothrombinase catalysed reaction that 
generates thrombin. Thrombin triggers the conversion of fibrinogen contained in 
PRP to an insoluble network of fibrin. Activation by CaCl2 is therefore slower 
than that achieved by the direct addition of externally provided thrombin (Textor 






Several observations were made during this study:  
1) After 2 hours of PRP gelification derived from 2 blood donors, a high release 
of IGF-1 growth factor was observed in the non-activated PRP loaded on FA 
coatings. Interestingly, the elution of IGF-1 from non-activated PRP increased in 
FA samples compared to uncoated SS loaded with non-activated PRP (Section 
6.2.1). The loosely bound Ca2+ ions released from the Stern layer associated 
with FA coatings might induce this release.  
2) At day 1 after PRP gelification, the IGF-1 results indicated that there is a 
burst-like release of IGF-1 from PRP gel of donor 1 loaded on FA coatings. This 
might be a consequence of release of IGF-1 bound loosely to FA/PRP surfaces, 
diffusion of incorporated growth factors out of the combinations and degradation 
of the PRP gel (Matsumoto et al., 2004).  
3) From day 1 to day 7, CaCl2 was the potent stimulator for IGF-1 release from 
PRP loaded on uncoated SS and FA coated discs. However, organised FA 
triggered IGF-1 release from the non-activated PRP at a comparable rate to that 
of calcium-activated PRP at all time points. This confirms that the organised 
coatings can trigger a sustained release of IGF-1 gradually over time. Moreover, 
according to the proteomic analysis of the current study, organised FA surfaces 
induced the adsorption of a larger amount of proteins from PRP gel compared 
to uncoated SS and to disorganised FA. The adsorbed proteins might facilitate 
IGF-1 entrapment within the fibrin network and facilitate their adsorption onto 
the underlying FA coatings for a sustained release later as hypothesised by 
Anitua et al., (2012) in their review about PRP usage in regenerative medicine.  
4) On the contrary to IGF-1 release which was triggered by calcium, thrombin 
showed a general trend when induced the highest release of PDGF-AB in both 
blood donors and at all time points. This was in agreement with previous studies 
(Lacoste et al., 2003, Fufa et al., 2008, Harrison et al., 2011). The use of 
thrombin resulted in immediate release of amount of PDGF-AB within one day 
compared to non-activated PRP and calcium-activated PRP loaded on 
uncoated and FA coated SS discs (see section 6.2.1). However, organised FA 
coatings increased the release of PDGF-AB and showed a sustained release 
over time compared to uncoated substrates and disorganised FA when 






5) Another interesting point in the present study, that IGF-1 was released at 
considerably lower levels than PDGF-AB. The maximum mean concentrations 
of IGF-1 occurred within 1 day after PRP gelification reaching around 620 
pg/mL in blood donor 1 and 266 pg/mL in donor 2, but the highest 
concentrations of PDGF-AB were recorded within 2 hours of PRP gelification 
(~1980 pg/mL and 1730 pg/mL in donor 1 and 2 respectively). The lowest 
concentrations for both growth factors were measured at day 7 post PRP 
gelification reaching about 25 pg/mL for IGF-1 and 50 pg/mL for PDGF-AB in 
both blood donors. The observation that IGF-1 and PDGF-AB are released at 
different levels was also reported by Rai et al. (2005) who investigated the 
release of IGF1 and PDGF from thrombin-activated PRP loaded onto 
polycaprolactone–20% tricalcium phosphate (PCL–TCP) composite and 
immersed in PBS. Rai et al. detected a sustained release of IGF1 and PDGF 
over 21 days and related the difference between IGF-1 and PDGF levels to the 
molecular size and the amounts of both growth factors stored in platelets. The 
platelet content of IGF-1 was found to be much lower than that of PDGF 
(Weibrich et al., 2002). IGF-1 is a basic, single chain peptide with a molecular 
weight of 7.5 kDa (Schliephake et al, 2002). PDGF-AB is a basic, heterodimeric 
protein of 30 kDa molecular weight (Pfeilschifter et al., 1990). A larger size 
growth factor released in high amounts from platelets would mean reduced 
surface area of the substrate to volume ratio, which implies that fewer proteins 
could adhere onto the substrates, resulting in more release over time into the 
PBS. In previous studies, PDGF-AB was also detected in higher levels 
compared to IGF1 when released from calcium- activated PRP mixed with 
alginate beads and capsules and immersed in culture media (Lu et al., 2008) 
and when released from thrombin- activated PRP into culture medium (Schär et 
al., 2015).  
In conclusion, these ELISA experiments demonstrated that the choice of 
platelet activator and the underlying substrate can influence the release kinetics 
of GFs from PRP. Thrombin used in association with FA may be a good choice 
for activation of PRP, as thrombin maximally promotes the release of PDGF-AB 
while FA alone ensures the release of IGF-1. However, there may be no need 






directly into the injured tissue and will become activated on contact with 
collagen. Collagen is one of the most potent physiological activators of platelet 
activation and leads to slower and more sustained release of GFs compared to 
thrombin (Fufa et al., 2008; Harrison et al., 2011). Therefore, further studies are 
needed to determine whether collagen will have a significant effect on GFs 
release, specifically PDGF-AB from PRP loaded on FA coatings compared to 
thrombin. 
 
6.3.2 Cumulative release of growth factors from PRP gel and PRP 
releasate when combined with uncoated SS and organised FA coatings 
In the current study, the release of IGF-1 and PDGF-AB from platelet- 
containing PRP gel and platelet- free PRP releasate (obtained by extracting the 
soluble components released within 30 minutes of PRP activation) were 
compared when the gel and releasate were loaded on uncoated SS and 
organised FA coated surfaces for 3 days.  
Results showed that IGF-1 release from PRP gel was lower than from PRP 
releasate on both SS and organised FA coated surfaces. In contrast, PDGF-AB 
release from PRP gel was higher than from PRP releasate on both SS and 
organised FA coated surfaces release.  
To explain this result, it is important to realise that PDGF-AB originates from α-
granules found within platelets (Kniess et al., 2003) while plasma IGF-1 is 
derived  mainly from the liver (Schmidmaier et al., 2006) and its level in plasma 
does not correlate with plasma platelet count (Rubin and Baserga, 1995). 
Intracellular IGF-1 concentration in platelets is much lower than that of PDGF 
(Weibrich et al., 2002). Therefore, PRP gel will be expected to have a higher 
amount of PDGF-AB regardless of the underlying substrates. The platelets in 
PRP gel act as a reservoir of PDGF-AB and its release from PRP gel meant 
that PDGF-AB can accumulate in the PBS overtime. In contrast, PDGF-AB 
levels in PRP releasate are already fixed at their maximum value as PRP 
releasate contains no platelets. The fixed maximum value being the amount 
released within 30 minutes of platelet activation prior to removal of the platelets 
during preparation of the releasate. In agreement to the present study, higher 






reported by Cho et al. (2011) who also found a positive correlation between 
PDGF-AB and PRP platelets count, supporting the contention that platelets in 
PRP gel are a reservoir of PDGF-AB.   
 
6.3.3 Release of Ca2+ from disorganised FA and organised FA coatings 
when combined with PRP gel 
FA is stable and has low dissolution rate. The dissolution studies related this 
stability to the high crystallinity of FA, orientation of the crystals and to the 
composition of FA (Bhadang and Gross, 2004, Kim et al., 2004). In this study, 
release of Ca2+ from disorganised and organised FA and FA/PRP gel 
combinations into PBS was monitored at different time points (see figure 53). 
This study showed that disorganised and organised FA had similarly low 
dissolution rate. A very low amount of Ca2+ ion was released into PBS by both 
types of FA coatings (~0.07 mg/L) at all the time points up to 14 days. However, 
adding PRP gel to FA coatings increased Ca2+ release over 24 hours (~0.1 
mg/L – 1 mg/L) compared to FA alone. The rate of release level then dropped 
between 3 and 14 days similar to that recorded in FA alone. The high Ca2+ 
concentrations detected when PRP gel is added to FA compared to FA alone 
might be a result of the platelet activation process triggered by the coating in 
addition to thrombin, stimulating intracellular calcium release from platelet 
dense granules (in addition to GFs from the α-granules) (Zucker-Franklin et al., 
1998). Ca2+ may also be associated with PRP gel as serum albumin is the major 
Ca2+ binding protein in the blood (Eatough et al., 1978). Interestingly, PRP gel 
showed higher Ca2+ release over the first 24 hours when combined with 
organised FA compared to disorganised FA. The reason for this is unclear but 
may be related to the larger specific area of the disorganised FA crystals (which 
as described previously exhibit a greater surface roughness) being able to bind 
and immobilise more Ca2+.  
 
6.3.4 Cytotoxicity of FA/PRP combinations 
Biocompatibility is very important for dental implant materials. The present study 
has shown that FA synthesised via a hydrothermal method was not cytotoxic. 






suggests that the FA/PRP combination might play a critical role in influencing 
cell behaviour though the effect of GFs. The release of Ca2+ from the FA 
coatings and its role in inducing high and sustain GF release was explained 
earlier in this study (section 6.3.1).  
 
6.3.5 Protein adsorption of PRP on FA coatings 
The biological activity of a surface is determined by its surface properties 
(chemistry and topography), that influence protein adsorption and cell 
responses. In the current study, it was demonstrated that a wide range of 
proteins (15kDa to over 250KDa) adsorbed to FA substrates from PRP gel, 
PRP releasate and FBS control. In contrast, no detectable PRP proteins from 
donor 1 nor FBS proteins were recovered from the uncoated SS. However, 
significant proteins of PRP gel of donor 2 were recovered from uncoated SS 
which indicates the effect of donor variability on PRP composition and 
behaviour. The higher protein retention observed in FA samples compared to 
SS could be attributed to surface properties of the material including topography 
and heterogeneity, electrical potential, wettability and hydrophobicity. The 
crystals can interact with organic molecules (proteins) by electrostatic 
interaction between charged amino acid side chains and the negative and 
positive charges on the crystal surfaces. The uncoated SS samples might 
adsorb low amounts of proteins with low affinity that were readily removed while 
washing the discs. In addition, though phosphate buffer is well known for its 
ability to desorb proteins from apatite, its ability to desorb proteins from SS is 
not clear, it may be that the phosphate desorption was less effective in the case 
of desorbing donor 1 PRP protein from SS.  
Interestingly, there was a very clear differential adsorption between the 
organised and disorganised FA coatings. Furthermore, organised FA adsorbed 
higher amounts of protein from PRP and FBS compared to the disorganised FA. 
It was  reported in an early study that proteins are adsorbed onto different 
surfaces in different quantities, conformations and orientations depending on 
the chemical and physical properties of the surfaces (e.g. van der Waals forces 







6.3.6 Comparing cell morphology and attachment on disorganised FA and 
organised FA coatings in combination with PRP 
The protein adsorption analysis of PRP on FA coatings was complimented by 
investigating the biologic activity of FA/PRP combination on cell adhesion and 
proliferation using osteoblast-like cells (G292). In the current study, PRP 
releasate had the same effect as FBS on cell morphology (see chapter 4, 
section 4.2.2.2) in which the cells formed isolated clusters attached to individual 
patches of disorganised FA crystals through cytoplasmic extensions. While on 
organised FA, the cells were more spindle-shaped and were spread on the 
surfaces via long, more prominent cytoplasmic extensions compared to 
disorganised FA. However, the cells of the organised coating combined with 
PRP releasate had less prominent cytoplasmic extensions compared to cells of 
FBS probably due to the presence of higher number of cells compared to FBS. 
The difference of cells morphology observed between organised and 
disorganised FA surfaces is related in part to the difference in the crystal 
organisation in both coatings. Indeed, it has been reported that the cell 
behaviour is highly influenced by topographically different microenvironments 
and the intrinsic characteristics of a substrate (e.g. chemical composition, 
charge and hydrophobicity) (Liu et al., 2010, 2011 and 2102). The capability of 
the cells in sensing the substrate geometry, rigidity and microstructure was also 
reported previously (Vogel and Sheetz, 2006). They stated that the cells 
transfer the geometrical and physical cues provides by the surface on which 
they are adsorbed into cellular biochemical signals that regulate various cellular 
events. Cell morphological changes to varied geometric microenvironments 
were also recorded (Poellmann et al., 2010). PRP gel seemed to provide a 
favourable extracellular environment for the cells as it was seen under the SEM 
and confocal microscopy as a sheet of protein matrix populated with a high 








6.3.7 Assessment of cell attachment and proliferation on FA/PRP 
combinations quantitatively  
The synergistic effect of FA and PRP on improving cell attachment and growth 
was demonstrated quantitatively in the present study. Both FA coatings under 
standard cell culture conditions (FBS) induced no changes to the proliferation 
rate compared to uncoated SS discs. This was in agreement with a previous 
study, in which no significant difference was found between the number of 
dermal-derived human microvascular endothelial cells grown on SS and 
organised FA surfaces for 1, 7 and 14 day (Wang et al., 2013). In contrast, Liu 
et al. (2010 and 2012) reported that FA coatings showed low rates of cell 
proliferation of MG-63 osteoblast-like cells and adipose -derived stem cells 
compared to uncoated SS surfaces after 3 days in cell culture. This difference in 
cell proliferation results between different studies using the same FA coating 
could be attributed to differences in the adhesion abilities of the different cells 
grown on the two surfaces (SS and FA coated) which precede cell proliferation. 
It might also be related to cell harvesting technique utilised in the above studies 
which was trypsin-EDTA. The presence of Ca2+ associated with FA samples 
may inhibit trypsin enzyme activity used for detachment of the cells prior to cell 
counting. In addition, the 3D structure of the FA coating could prevent the 
complete exposure of the cells to trypsin and even when released, cells could 
be mechanically trapped in the forest of crystals that could compromise the 
collection of the cells compared to the flat surfaces of SS discs and lead to 
artefactual low cell counts for the FA surfaces. Further to the above, Liu et al. 
(2010, 2011 and 2012) and Czajka-Jakubowska et al. (2011) reported that initial 
cellular attachment in vitro was significantly higher on organised FA compared 
to disorganised FA surfaces, although both surfaces showed excellent 
biocompatibility. This was also evident in the present study at day 3 and 7 of 
cell culture presumably due to the difference in proteins adsorbed to both 
surfaces as shown and explained in the proteomic analysis (section 6.3.5). It is 
believed that proteins are adsorbed onto different surfaces depending on the 
chemical and physical properties of the surfaces (e.g. van der Waals forces and 
hydrophobic forces) and that the adsorbed proteins may act as mediators for 






composition and conformation of the protein adsorbed to FA might account for 
the enhanced cellular response on the organised FA surfaces. 
As stated before, several advantages have been reported on the potential use 
of platelet-rich plasma (PRP) as a 3D gel scaffold for cell support. Among these 
advantages, the capacity of fibrin (one of the main components of PRP gel) to 
interact with the extracellular matrix and cellular components mediating cell 
attachment and the abundance of growth factors inducing cell proliferation 
(Anitua el al., 2012). G292 cell attachment and proliferation was increased in a 
constant manner upon the addition of PRP gel to both FA coatings compared to 
the addition of FBS or PRP-releasate. This synergistic effect might reasonably 
be expected due to the presence of the osteoconductive fibrin scaffold and 
osteoinductive growth factors released from PRP gel and the FA coatings which 
enhanced protein adsorption and sustained release of PRP growth factors (see 
section 6.3.5 and 6.3.1). It was thought that the major effect of PRP is derived 
from the effect of PDGF which has a key role in hard- and soft-tissue healing. 
PDGF has been shown to stimulate, in addition to chemotaxis and mitogenesis, 
the production of fibronectin which is an important extracellular cell adhesion 
protein (Yang et al., 2000). Fibronectin is known to mediate the specific 
interaction of the cells to underlying surfaces via cell integrin receptors, along 
with vitronectin, fibrinogen, collagens, laminin, osteopontin, and other trace 
proteins (Steele et al., 1995). The finding of the present study that PRP gel 
enhanced cell proliferation on FA coatings was supported by in vitro study of 
Kasten et al. (2008) who found that mesenchymal stem cells (MSCs) 
proliferation was significantly improved by adding PRP gel on calcium 
phosphate scaffolds. In another study, non- activated PRP significantly 
stimulated the cell growth of MSCs for 28 day on HA scaffolds when calcium 
element of HA induced platelets aggregation and growth factor release (Nair et 
al., 2009). Furthermore, the synergistic effect of PRP with calcium phosphates 
to promote cell proliferation of MSCs for more than 7 days was reported as well 
by other in vitro studies (Bi et al., 2010; Qi et al., 2015). 
In addition to the above, the synergistic effect of FA and PRP on cell 
proliferation may be attributed to the combined effect of fluoride and PRP 






coatings was detected by Clark (2013) at pH 7.0 and 6.0 within 30 minutes and 
related this initial release to the loosely bound fluoride remaining from the 
synthesis process and/or to soluble fluoride containing non-apatitic phases 
generated as by product during FA synthesis. The possible molecular 
mechanism of the osteogenic action of fluoride ions was suggested in previous 
studies through the tyrosyl phosphorylation level of cellular proteins (Lau et al., 
1989; Lau et al., 1998; Lau and Baylink, 1998). Protein phosphorylation serves 
to control the activity of the target protein and is a central feature of cell 
signalling pathways. The overall tyrosyl phosphorylation level of cellular proteins 
is determined by two important and opposing enzymatic reactions (Figure 71A), 
Tyrosyl phosphorylation which is catalyzed by protein tyrosine kinases (PTKs) 
and the tyrosyl dephosphorylation which is mediated by phosphotyrosine 
phosphatase enzymes (PTPs). It is believed that the binding of a growth factor 
to its corresponding cell surface receptor promotes the receptor’s intrinsic PTKs 
activity (Figure 71B), and consequently triggers a cascade of tyrosine 
phosphorylation reactions targeting a number of cellular signalling proteins 
(Fantl et al., 1993). Signalling pathways are controlled by the action of PTPs 
which dephosphorylate the phosphorylated target proteins returning them to a 
resting state. However, some PTPs are inhibited by fluoride (Figure 71B). When 
fluoride enters the bone cells, it inhibits the activity of fluoride-sensitive PTPs 
and as a result signalling proteins remain phosphorylated for longer which 
potentiates the impact of the signalling pathway leading eventually to potential 





























Figure 71: A, Schematic diagram showing the overall tyrosyl phosphorylation 
level of cellular proteins. It is controlled by 2 opposing enzymatic reaction: 
protein tyrosine kinases (PTKs) and phosphotyrosine phosphatase enzymes 
(PTPs). B, Schematic diagram showing the stimulation of PTKs activity by 
growth factors and inhibition of PTPs by fluoride leading eventually to an 
increase in the overall level of tyrosyl phosphorylation of cellular signalling 
proteins (https://onlinelibrary. wiley.com/doi/epdf/10.1359/ jbmr. 1998. 13. 11. 
1660).    
 
6.3.8 Osteogenic differentiation of human dental pulp stem cells (hDPSCs) 
on FA/PRP combinations 
For tissue engineering purposes, in addition to its potential to promote cell 
attachment and proliferation, the ability of the implant surface to stimulate the 
osteogenic differentiation of mesenchymal stem cells is important for a 
successful osseointegration between the implant and the surrounding bone 
(Lavenus et al., 2011). Very few studies have investigated the osteogenic 






Wang et al., 2012; Wang et al., 2013), and none have investigated their 
behaviour on FA/PRP combinations specifically. The present study was the first 
attempt to examine the osteogenic differentiation of human dental pulp stem 
cells (hDPSCs) cultured under osteogenic conditions on FA/PRP combinations. 
hDPSCs were chosen for this study because they are readily available and 
were proved to be a generic source of mesenchymal stem cells, showing 
characteristic stem cell features of high proliferative ability after prolonged 
culture (Papaccio et al., 2006, Govindasamy et al., 2010). Moreover, hDPSCs 
showed in earlier studies positive expression for mesenchymal stem cell 
markers including CD29, CD44, CD146, CD90, CD105, STRO-1, CD106, and 
OCT4 (Gronthos et al., 2002; Lindroos et al., 2008). Many previous studies 
have reported the ability of hDPSCs to differentiate into functional osteoblasts 
and produce mineralised matrix (Pisciotta et al., 2012, Riccio et al., 2010). 
Furthermore, the ability of hDPSCs to reconstruct bony structures were 
confirmed in some in vivo studies (d’Aquino et al., 2009, Giuliani et al., 2013, 
Sheth et al., 2017). hDPSCs were shown to have a comparable behaviour to 
human bone marrow stem cells (El-Gendy, 2010). However, DPSCs have 
higher osteogenic potential in vivo compared to BMSCs when implanted with 
platelet-rich plasma (PRP) into bone defects (Yamada et al., 2011) or in dental 
implant cavity (Ito et al., 2011).  
In order to accelerate and promote mineralisation of hDPSCs in culture, 
osteogenic induction has been successfully achieved in earlier studies by 
adding the inducing agents dexamethasone and ascorbic acid to the culture 
media (El-Gendy et al., 2012; Alkharobi, 2016). Such osteogenic induction was 
also tested and confirmed in this study where alkaline phosphatase stain (early 
osteoblast marker) was more positive in hDPSCs cultured on monolayer under 
osteogenic conditions compared with basal culture (no osteogenic induction). It 
must be pointed out that the present study did not aim to examine the 
osteoinductive properties of FA/PRP combination but focused on the 
osteoconductive ability of this combination to support the differentiation of 
hDPSCs which were already induced toward osteogenic differentiation by 






hDPSCs (derived from single human donor) cultured for 3 days on FA/PRP was 
examined using quantitative and qualitative analyses.  
 
6.3.8.1 Determination of expression of osteogenic marker genes by 
hDPSCs cultured on FA/PRP combinations using qRt-PCR 
ALPL, RUNX-2, OCN and OPN are markers indicative of active osteogenic 
differentiation (d'Aquino et al., 2007; d’Aquino et al., 2008; Lindroos et al., 
2008).  
 
 ALPL gene expression 
ALPL is considered an early osteoblast differentiation marker (Jaiswal et al., 
1997) and is useful osteogenic marker for in vitro cell cultures (Gronthos et al., 
2000). Several results were made during this study: 
1) ALPL results obtained using PRP from 2 donors clearly demonstrated that 
when cells were grown on organised FA showed no increase in ALPL 
expression whether the coatings were used with standard culture (FBS) or in 
combination with PRP gel or releasate compared to the control (uncoated SS 
combined with FBS). This might indicate that the cells grown on organised FA 
were still in an active proliferation stage which could take longer time for the 
cells to reach confluency on 3-D surface before starting the differentiation stage 
compared to cells growing on 2-D flat surface of SS. Interestingly, PRP gel and 
releasate obtained from the 2 blood donors confirmed this hypothesis when 
they showed higher levels of ALPL gene expression when used on SS 
compared to when used in combination with organised FA.  Cell proliferation 
and differentiation are both essential for bone regeneration. However, these two 
processes cannot happen in the cell at the same time. Cell proliferation is 
essential in the early phases of regenerative wound healing and must occur 
before differentiation is initiated (Graziani et al., 2006). Therefore, using 
hDPSCs at higher cell density would have been helpful in disentangling the data 
of this study. Li et al. (2013) observed an increase in cell proliferation and a 
reduction in the expression of lineage specific markers by PRP-expanded 






cycle was responsible for preventing the cells from entering a differentiation 
phase.   
2) It was reported in previous studies that increased dental pulp cell density and 
longer culture times of 3 or 4 weeks established higher levels of ALPL 
expression associated with lower proliferation of the cells as they reach 
confluency (Shiba et al., 1995; Tomlinson et al., 2015; Alkharobi, 2016). 
Therefore, it is worthwhile in the future to evaluate the gene expression using 
longer time durations than 3 days as used in the present study.  
3) Data of ALPL expression obtained in PRP groups can depend heavily on the 
blood donor. ALPL results associated with one of the donors showed that 
loading PRP gel or releasate on uncoated SS and organised FA stimulated high 
ALPL expression of hDPSCs compared to FBS. This suggests that both PRP 
types supported the osteogenic differentiation of hDPSCs at higher levels 
compared to FBS regardless of the underlying substrate. This result was similar 
to that published recently in which the expression of ALPL by hDPSCs cultured 
on PRP gel combined with 3D-printed polycaprolactone scaffolds for 7 days and 
14 days was significantly higher than those cultured on bare scaffolds (+FBS) 
(Li et al., 2017). Whereas, data of another blood donor used in the present 
study displayed no effect of PRP on ALPL expression compared to FBS when 
combined with uncoated SS or organised FA and this in agreement with an 
observation in which no significant difference was detected in ALPL expression 
of goat bone marrow stem cells between bare HA (+FBS) and PRP-coated HA 
at 7,14, 21 and 28 day in culture (Nair et al., 2008). The efficacy of PRP is 
based on the release of multiple growth factors (GFs) when platelets are 
activated. The GF concentrations varied among donors and the varying GF 
concentrations in turn may result in different biologic effects including cell 
proliferation and differentiation (Cho et al., 2011). 
 
 Runx-2 gene expression 
Runx-2 is a master transcription factor of the bone that is required in 
maintaining fully functional cells and is essential in early stages of the 
differentiation of pluripotent mesenchymal cells to osteoblasts (Ducy et al., 






1) RUNX-2 expression of hDPSCs was upregulated in cells grown on PRP gel 
and releasate of donor 1 when loaded on uncoated SS and when used in 
combination with organised FA compared to the control (uncoated SS loaded 
with FBS). This suggests that hDPSCs might be still in an active differentiation 
stage, as RUNX-2 expression is known to be up-regulated until complete 
maturation of functioning osteoblasts (Nakashima and de Crombrugghe, 2003). 
However, RUNX-2 findings demonstrated a clear donor variability where using 
PRP of second blood donor showed a decrease in RUNX-2 expression in SS 
and FA groups compared to the control (uncoated SS loaded with FBS). The 
difference in RUNX-2 expression between the 2 PRP donors might mean that 
the cells cultured on PRP samples from the two donors were at different stages 
of osteoblastic differentiation. PRP donors’ variability is a possible reason for 
that when affects cell proliferation and the subsequent cell differentiation rate. 
2) Interestingly, the upregulation of RUNX-2 by cells grown on PRP releasate 
and FBS of both donors was higher when loaded on uncoated SS compared to 
when combined with organised FA. A possible explanation for that is because 
the cells growing on a high specific surface area scaffold (organised FA), they 
theoretically take longer time to reach confluency compared to SS surface. 
Similarly, Kanno et al. (2005) observed that RUNX-2 was expressed only in the 
confluent samples of osteoblast-like cells cultured in 10% PRP. They found that 
when the cells underwent proliferation, cell differentiation was suppressed and 
once the cells had grown to confluence, PRP effectively enhanced ALP 
production and bone marker expression including RUNX-2 and OPN.  
3) RUNX-2 expression of hDPSCs grown on organised FA groups showed 
variability of expression between the 2 blood donors when comparing PRP and 
FBS. RUNX-2 results of one blood donor showed that loading PRP gel or 
releasate on organised FA stimulated high RUNX-2 expression compared to 
FBS. This result was similar to that published recently by Li et al. (2017) in 
which the expression of RUNX-2 by hDPSCs cultured on a combination of PRP 
gel and 3D-printed polycaprolactone scaffolds for 7 days and 14 days was 
significantly higher than those cultured on bare scaffolds (+FBS) (Li et al., 
2017). In contrast to donor 1, cells grown on PRP gel and releasate of donor 2 






Therefore the results of FA were confusing and more PRP donors would have 
been helpful to draw a final conclusion. 
4) Organised FA under standard conditions (FBS) inhibited RUNX-2 expression 
in both donors compared to the control (SS combined with FBS). This finding is 
different from that of Wang et al. (2012) who studied the osteogenesis gene 
profile of hDPSCs cultured on FA coatings for 4 weeks under standard 
osteogenic culture condition (FBS). They found that RUNX -2 was significantly 
upregulated in cells grown on organised FA surfaces relative to SS surfaces. 
This variation might be related to the difference in cell density and culture 
duration which might allow more time for the cells to stop proliferation on both 
substrates (SS and FA) and start the differentiation process.  
  
 OCN gene expression 
OCN is a convenient marker of fully differentiated osteoblasts and matrix 
mineralisation (Zur Nieden et al., 2003). OCN gene encodes osteocalcin protein 
which is a non-collagenous highly abundant bone matrix protein synthesised 
and secreted exclusively by osteoblasts in the late stage of maturation. It 
regulates bone mineralisation and the differentiation of osteoclast progenitors 
and hence promotes bone remodelling activity (Boskey et al., 1998).  
The results of OCN expression herein showed similar levels of expression in FA 
coating groups to that of the controls in both donors. It seems that all the 
different construct were in active stage of differentiation but none consistently 
promoted OCN expression compared to the control. It was reported earlier that 
OCN expression is increased with time and this increase may be associated 
with elevated levels of matrix mineralisation and lower osteoblast proliferation 
(Candeliere et al., 2001). A time dependant rise of OCN expression has been 
previously observed in hDPSCs (Wei et al., 2007). This was also reported by 
Nair et al. (2008) who found no significant difference in OCN expression of goat 
bone marrow stem cells when grown on  HA (+FBS) and PRP-coated HA after 7 
days in culture but OCN expression increased significantly with PRP-coated HA 
after 14, 21 and 28 days in culture. Another study has recently reported high 
OCN gene expression in bone mesenchymal stem cells cultured with calcium 






particles alone (Qi et al., 2015). The difference in OCN expression between the 
above studies and the present study might also reflect the controversial reports 
on the potential of PRP in stem cells osteogenic differentiation in vitro 
depending on donor variability and PRP preparation technique where each 
method generates a different PRP product with different biological properties 
and uses. 
 
 OPN gene expression 
OPN is a marker of mature osteoblast cells and is produced by osteoblastic 
cells at various stages of differentiation (Zohar et al., 1997).  
1) In the current study, the results obtained using PRP from 2 donors showed 
that OPN expression of hDPSCs was promoted by organised FA when 
combined with FBS, PRP gel or PRP releasate compared to the control 
(SS/FBS), however, both PRP types induced a greater expression of OPN 
compared to FBS. This was in accordance with a previous report in which OPN 
expression of goat bone marrow stem cells was significantly better on PRP-
coated HA than bare HA (+FBS) after 7, 14, 21 and 28 days in culture (Nair et 
al., 2008). Moreover, a recent study showed that OPN expressed by hDPSCs 
was significantly higher in cells cultured for 7 days and 14 days on scaffolds of 
PRP gel and 3D-printed polycaprolactone compared to cells cultured on 
scaffolds alone without PRP (+FBS) (Li et al., 2017).  
2) In contrast to organised FA, uncoated SS when loaded with PRP gel and 
PRP releasate of one donor showed low OPN expression compared to the 
control and PRP of a second donor exhibited slightly higher degree of OPN 
expression. This could illustrate that PRP loaded on uncoated SS might 
upregulate early bone markers (ALP and RUNX-2) but organised FA might 
upregulate late bone marker OPN.   
3) OPN expression by hDPSCs was stimulated by organised FA coated discs 
compared to uncoated SS discs under standard culture condition (FBS) for 3 
days. This result was comparable to that of Liu et al. (2011) who have grown 
hDPSCs on FA surfaces for 3 days and investigated the expression of human 
pathway-focused matrix and adhesion molecules using PCR array. They 






coatings under standard culture condition (FBS). Investigating the gene 
expression after 3 days in culture is important for studying gene regulation 
responsible for cell adhesion selectivity in cell-surface interactions and thus to 
obtain accurate cell adhesion information. Moreover, OPN is regarded as a cell-
matrix adhesion molecule that has the potential to serve as a bridge between 
cells and hydroxyapatite through its RGD amino acid sequence (Oldberg et al., 
1986). Therefore, OPN was highly upregulated on organised FA crystals 
compared to uncoated SS surfaces in the present study and this differential 
expression of OPN may play important role in enhancing the initial cellular 
response of hDPSCs to the coatings including cell adhesion. The surface 
characteristics was suggested to affect the first stage of cell-surface interaction 
(cell attachment, adhesion and spreading) which may in turn influence the 
second stage of the interaction involving proliferation and differentiation of the 
mesenchymal stem cells (Curran et al., 2006). 
 
6.3.8.2 ALP activity in hDPSCs cultured on FA/PRP combinations 
In the light of above cell culture conditions, alkaline phosphatase activity (ALP) 
was also evaluated quantitatively in hDPSCs after 2 weeks in culture under 
osteogenic conditions. ALP is the most widely recognized biochemical marker 
for osteogenic activity and hard tissue cell differentiation (Sharma et al., 2014). 
ALP is involved in skeletal mineralisation by acting both to increase the local 
concentration of inorganic phosphate and to decrease the concentration of 
extracellular pyrophosphate (an inhibitor of mineral formation) (Golub and 
Boesze-Battaglia, 2007).  
In the present study, PRP gel and releasate when loaded on uncoated SS 
enhanced ALP activity of hDPSCs compared to the control (SS/FBS). In 
contrast, they inhibited ALP activity of hDPSCs when combined with organised 
FA compared to the control. Interestingly, Arpornmaeklong et al., (2004) 
reported that PRP gel increased cell proliferation but reduced ALP activity in a 
dose dependant manner in rat bone marrow stromal cells cultured on porous 
collagenous scaffold for 21 days. They found that high PRP concentrations 
containing 2.5 x 108 platelet/scaffold had the strongest inhibitory effect on ALP 






high concentrations of growth factors released from PRP and adsorbed on the 
collagenous scaffold fibres for slow release later (Arpornmaeklong et al., 2004). 
Taking this study into account, the influence of PRP when combined with 
organised FA should rather be correlated to the observations in the PRP groups 
loaded on uncoated SS as it is possible that the released growth factors of PRP 
gel and PRP releasate were rapidly adsorbed on the FA coating behaving as a 
carrier, and later slowly released into culture medium, resulting in high cell 
proliferation and low ALP activity. However, it was reported previously that 
thrombin- activated PRP decreased ALP activity compared to non-activated 
PRP in vivo (Han et al., 2009). Therefore, it is worthy to investigate FA/PRP 
combination in vivo without activating the PRP and will become activated on 
contact with collagen or in vitro with using collagen as an activator. Collagen is 
one of the most potent physiological activators of platelet activation and leads to 
slower and more sustained release of GFs compared to thrombin (Fufa et al., 
2008; Harrison et al., 2011). Cho et al. (2011) also documented that using 10% 
PRP releasate in MSCs culture induced marked cell proliferation but reduced 
ALP activity compared to the control (10%FBS). Additionally, they noted that 
PRP releasate stimulated cell proliferation in a dose dependant manner and 
that this proliferation was positively correlated with TGF-β1 and PDGF 
concentrations while ALP activity was negatively correlated with PDGF-BB 
concentration. A previous report has also suggested that PDGF-BB induced 
bone formation in a dose dependant manner (Ranly et al., 2005). Therefore, 
these remarkable findings, coupled with the current study results, indicate that 
individual differences in growth factors should be taken into consideration in 
order to ensure standardised application of PRP. For example, PDGF which is a 
strong mitogen and responsible for the major effects of PRP (Ross et al., 1986), 
its content in PRP gel was very high according to the ELISA data and was 
enhanced by FA coatings (see section 6.3.1). PDGF has been found to 
increase DNA synthesis and decrease ALP activity in a dose dependent 
manner in cultured foetal rat calvaria osteoblasts (Graves et al., 1989; Hsieh 
and Graves, 1998). A similar effect was reported for PDGF growth factor 
impregnated in an inorganic bovine collagen matrix (Stephan et al., 2000), or a 






In the present study, hDPSCs showed low ALP activity when grown on 
organised FA when combined with either FBS or PRP compared to the control 
(SS/FBS) but with a higher ALP activity shown by PRP gel and PRP releasate 
compared to FBS. This result was in contrast to an earlier study which showed 
that ALP activity of MSCs was unaffected by the addition of PRP to tricalcium 
phosphate scaffold compared to the scaffold alone although PRP enhanced the 
cellular proliferation (Kasten et al., 2008). While ALP activity of goat bone 
marrow stem cells was much higher in tricalcium phosphate/chitosan and PRP 
gel combination than that of tricalcium phosphate/chitosan/FBS on days 7 and 
14 of cell culture (Bi et al., 2010). Similarly, Qi et al. (2015) indicated a higher 
ALP activity, alizarin red stain and bone markers gene expression of bone 
MSCs treated with PRP gel and calcium phosphate (CaP) particles compared to 
CaP alone (+FBS). They related this potential to the growth factors of the PRP 
assuming that the release was enhanced by contact of PRP with CaP particles.  
Low ALP activity of cells grown on organised FA could also be detected 
because more cells were retained in the more densely deposited mineral 
nodules and matrix layers on the organised FA crystal surfaces; thus, less 
amount of cells was being retrieved leading consequently to low ALP activity. 
The biochemical finding of ALP activity of the present study was confirmed by 
histochemical stain (ALP stain) of hDPSCs after 2 weeks in culture under 
osteogenic conditions. It was previously demonstrated that ALP expression is 
detectable between days 12 and 18 in monolayer culture using the 
histochemical methods (Wessinger and Owens, 1990, Jaiswal et al., 1997). The 
finding of the present study showed that alkaline phosphatase was positive in all 
uncoated SS groups, however coating SS discs with organised FA coating 
seemed to reduce ALP expression when combined with FBS. This finding was 
in contrast to Wang et al. (2012) who found stronger ALP staining displayed by 
hDPSCs grown under standard conditions (FBS) on organised FA compared to 
cells grown on uncoated SS after 1 week in culture with and without osteogenic 
induction. They related this effect to the intrinsic properties and surface 
characteristics of the FA coating (chemical compositions, charge, 
hydrophobicities and the topographical features). The difference between ALP 






variability among the cells of different donors which was demonstrated earlier 
by El-Gendy (2010) who investigated the osteogenic potential of hDPSCS of 3 
cell donors when seeded on 3D bioglass construct under osteogenic conditions 
for 2 weeks and 4 weeks. Alkharobi (2016) also found such cell donor variability 
in osteogenic differentiation of hDPSCs when cultured in monolayer for 1 and 3 
weeks. Moreover, Kasten et al. (2008) detected large differences in ALP activity 
between individual donors’ bone marrow stem cells. Therefore, using hDPSCs 
obtained from more than one donor would have been helpful in confirming the 
data. 
In addition to the above, the substitution of FBS by PRP gel and releasate on 
SS and FA seemed to increase ALP deposition to a greater level. Interestingly, 
the ALP stain results were in keeping with ALP activity and ALPL gene 
expression results. This suggests that the combination of PRP and FA might 
have a strong proliferative effect on the cells but at the cost of cell differentiation 
which is clear evidence that PRP maintained the cells on FA in a less 
differentiated state. Whereas, PRP had a constant and a strong effect on cell 
proliferation and differentiation compared to FBS, irrespective of the underlying 
substrate (SS or FA).  
 
6.3.8.3 Effect of FA/PRP combinations on mineralisation induced by 
hDPSCs 
 Mineralisation of hDPSCs cultured for 2 weeks on SS and organised FA coated 
discs under osteogenic conditions was also investigated to identify calcium 
deposits and nodules using alizarin red stain. In vitro mineralization was 
considered as a parameter of osteoblastic differentiation in the mature stage 
and calcium nodules are regarded as a marker for the late stage of mineralized 
tissue formation (Aubin, 1998a). In accordance with OCN gene expression 
which regulates bone mineralisation, all uncoated and organised FA coated 
discs showed positive alizarin stain when combined with FBS, PRP gel or PRP 
releasate. This result demonstrated an extensive osteogenic mineralisation 
potential of hDPSCs and suggested that hDPSCs grown on organised FA 
surfaces were capable of differentiating into mineralised tissue forming cells and 






The present finding of low ALP and high calcium deposition showed by FA/PRP 
combination was similar to that of Dolder et al. (2006) who investigated PRP gel 
as a coating for the tissue culture wells 75µL/cm2 before rat bone marrow cells 
were cultured. They observed that PRP showed a downregulation in ALPL gene 
expression, a decrease in ALP activity and increased calcium content compared 
to standard culture (FBS) (Dolder et al., 2006) and they related this effect to the 
high growth factor content. 
The ability of hDPSCs to produce mineralised nodules on FA coatings suggests 
the suitability of FA as a bone engineering material. This finding is supported by 
earlier studies which demonstrated that organised FA induced much stronger 
intensity alizarin stain compared to SS under standard conditions (FBS) when 
colonised by either adipose-derived stem cells (Liu et al., 2012), hDPSCs 
(Wang et al., 2012) or mesenchymal/endothelial co-cultures (Wang et al., 
2014). Bi et al. (2010) found that PRP promoted the osteogenic mineralisation 
of MSCs on TCP/chitosan composite and showed high alizarin red positive 
nodules. Moreover, Qi et al (2015) showed that alizarin red stain and calcified 
nodes were increased in bone marrow stem cells co-cultured with CaP 
particles/PRP compared to CaP alone.  
 
Summary 
In summary, this study demonstrated that organised FA and PRP combinations 
provided a favourable extracellular environment for the cells in regards of high 
and sustained growth factor release (see section 6.3.1), protein adhesion 
(section 6.3.5) and osteoblast-like cell attachment and proliferation (see section 
6.3.6 and 6.3.7). PRP induced and stimulated cell proliferation and 
differentiation regardless of the underlying substrates (see section 6.3.7). PRP 
gel had better effect than PRP releasate on osteoblast-like cell proliferation 
especially when combined with organised FA but showed almost similar effect 
to PRP releasate on the differentiation of hDPSCs into osteoblasts (See section 
6.3.8). Furthermore, FA/PRP combination increased the mineralisation process 
and enhanced the osteogenic differentiation of hDPSCs but not in a constant 







Chapter 7: General Discussion 
 
7.1 General Discussion 
The use of dental implants for correction of tooth and tissue loss has increased 
exponentially around the world with high success rates. However, using 
implants to treat some conditions remains a challenge. For example, poor bone 
quality in the implantation site associated with systemic diseases such as 
osteoporosis and diabetes compromises the peri-implant healing process 
(Elsubeihi and Zarb, 2002). Another challenge is the strategy of immediate 
implant loading to reduce the patient anxiety and social inconvenience 
associated with the long waiting time required between implant placement and 
loading with dental prosthesis (Gapski et al., 2003). Such conditions justified the 
necessity for this research to investigate the factors that can improve and 
accelerate the integration of the dental implant with the surrounding bone 
(Albrektsson and Lekholm, 1989). In this study, a strategy combining 
fluorapatite coatings (FA) with platelet-rich plasma (PRP) was tested. Implant 
failure usually occurs at relatively early stages after implantation surgery 
according to clinical studies (Esposito et al., 1998), indicating the necessity to 
understand the initial response of the surrounding tissues to the implant 
surface. Therefore, the initial cellular response to FA/PRP combinations was 
investigated including cell viability and proliferation of osteoblast-like cells and 
differentiation of human dental pulp stem cells into an osteogenic lineage.  
The present hypothesis was that FA/PRP combinations contain several 
components and qualities ideal for bone regeneration:  
1) High quantities of calcium and phosphate important for bone mineralisation 
 2) Physiologically high concentrations of platelet derived growth factors 
important for bone healing and formation (osteoinductive properties) 
 3) Physiologically high concentrations of adhesive plasma proteins important 
for cell attachment and migration e.g. fibrin (osteoconductive property) 
 4) Providing a time-dependent and sustained release of growth factors. 
 
For tissue regeneration purposes a biocompatible, bioactive scaffold with 






al., 2012). Fluorapatite was recently used as an osteoconductive implant 
coating due to its similarity to human bone and its favourable mechanical 
properties and high stability compared to other inorganic calcium phosphate 
materials (Bhadang and Gross, 2004; Kim et al., 2004). FA coatings have been 
applied to implants by plasma spraying, in which the implant surface is exposed 
to a stream of FA powder blown through a very high temperature plasma flame 
that melts the powder (Ranz et al., 1997). However, the rapid cooling process 
causes a change in the orientation of the FA crystals (Klein et al., 1994). In 
addition, all coating processes are likely to alter the composition of the coating 
materials, influence their microstructure and crystallinity as well as the biological 
responses (Yang et al., 1997, Sun et al., 2001). Therefore, Czajka-Jakubowska 
et al., (2009a) demonstrated a hydrothermal technique to grow a film of 
disorganised FA crystals on upper surfaces of metal plates and a film of 
compacted well-aligned FA crystals on under surfaces at 121oC and 2 atm for 
10 hours. They reported that the crystal structure was very similar in chemical 
composition and in structure to natural tooth enamel. In vitro studies have been 
conducted to investigate the initial cellular response to such FA coatings and 
have revealed that the well aligned FA crystals (organised) generated using the 
mild hydrothermal method appeared to promote the initial cellular attachment of 
the osteoblast-like cells and hDPSCs better than the disorganised crystals 
although both surfaces showed excellent biocompatibility (Liu et al., 2010; 
Czajka-Jakubowska et al., 2011). Moreover, Liu et al. (2011) found the same 
results when they succeeded in growing dental pulp stem cells (hDPSCs) on 
these FA coatings with an ambition to induce dentin and pulp formation in vitro 
with a view to creating an implantable tooth analogue.  
In the present study (Chapter 4), SS discs (medical grade 316) were used as 
substrates to grow disorganised FA coatings on the upper surfaces and 
organised FA coatings on the under surfaces. Both coatings had the same 
chemical composition and had Ca/P and Ca/F ratios close to the theoretical 
values of FA (1.67 and 5 respectively). Both coatings were not cytotoxic and 
they appeared to induce cell adherence and growth by stimulating the cells to 
attach to underlying crystals through long, thin and dynamic filopodia, 






cells grown on organised coatings were more spindle-like shaped and exhibited 
prominent cytoplasmic extensions which suggested good cell adhesion. Cell 
adhesion is usually preceded by protein adsorption which in turn determines 
cell–substrate contact and attachment and the consequent host response to the 
implant surface material. Therefore, correlations among surface properties, 
protein adsorption, and cell response have been of great interest to 
researchers. In the current study, cell proliferation was higher on organised FA 
compared to disorganised FA surfaces when FBS was used as growth 
supplement. The difference in cell morphology and proliferation rate between 
cells attached to and grown on disorganised and organised FA coatings was 
presumably due to the difference in the amount and type of proteins adsorbed 
onto both surfaces. Roach et al. (2005) believed that adsorbed proteins may act 
as mediators for cell adhesion if they have the correct geometry. The proteomic 
analysis in the present study showed a higher amount of FBS proteins 
adsorbed on organised FA compared to the disorganised coatings which could 
be attributed to surface properties of the coatings including topography and 
heterogeneity, electrical potential, wettability and hydrophobicity (Matsumoto et 
al., 2004). Proteins are charged molecules that change conformation (the 
protein’s three-dimensional shape) depending on their electrochemical 
environment. The conformation of the protein determines the availability of 
certain bioactive peptide sequences located within the protein for specific cells 
(Ratner, 1993). For example, the arginine-glycine-aspartic acid (RGD) amino 
acid sequence is a bioactive peptide sequence that is responsible for mediating 
cell binding and integrin-mediated signalling for many different types of cells 
(e.g. endothelial cells, osteoclasts and osteoblasts). Proteins like fibronectin and 
vitronectin contain peptide sequences that are responsible for mediating cell 
adhesion for many different kinds of cells (Kieswetter et al., 1996). Fibrinogen, 
complement and IgG proteins are important for platelet activation, coagulation 
and inflammatory response (Kuzyk and Schemitsch, 2011).  
The main aim of the present study was to improve the cell response to the FA 
coatings by introducing PRP. The biological function of fibrin provided by PRP is 
based on its capacity to interact with the surrounding tissue (extracellular matrix 






proliferation forming a conductive scaffold (Anitua el al., 2012). The successful 
use of PRP gel to replace fibrin glues in oral and maxillofacial surgery was first 
described by Whitman et al., (1997). In addition to fibrin, PRP also contains 
many growth factors (GFs) that can influence cell chemotaxis, proliferation and 
differentiation, thereby enhancing bone-implant contact (Kasten et al., 2008). 
Previously, commercial GFs were used in combination with bone scaffolds to 
obtain a favourable outcome in regard to bone regeneration. However, it was 
found that the biological effect of a single GF is less than that of multiple GFs 
and might represent an inefficient method in terms of time needed for bone 
healing and the inappropriate (non-physiological) amounts of GF required 
(Babensee et al., 2000; Raiche and Puleo, 2004). PRP from autologous blood 
was identified as a rich source of multiple GFs that poses no risk of any immune 
response or transmissible diseases (Marx, 2001). PRP usage has increased 
over the past decades in dental and oral surgeries since the1990s (Kao et al., 
2009). However, conflicting results were obtained on the use of PRP in 
combination with dental implants to improve osseointegration and bone 
formation. Some studies showed positive outcomes (Anitua, 2006; Gentile et 
al., 2010; Anand and Mehta, 2012) and others showed no significant results 
(Thor et al., 2005; Garcia et al., 2010). Such controversial results may be 
caused by biological variabilities between donors, the methods of PRP 
preparation and also the concentration of platelets used and the method by 
which they were activated. Early studies suggested that few folds of platelets (2- 
4 fold) above baseline levels in blood is enough to promote the proliferation and 
differentiation of primary osteoblast and fibroblasts (Anitua et al., 2009a, 
Graziani et al., 2006).  
In the present study (Chapter 5), PRP was prepared manually from whole blood 
using a two-step centrifugation procedure resulting in a platelet count within the 
recommended range of about 5 - 8 times greater than the physiological average 
count in healthy human adult (200 x103 Plt/µL). By activating the PRP with an 
exogenous activator such as calcium chloride or thrombin, two key processes 
may be initiated; degranulation of platelets to release GFs from their α-granules 
and fibrinogen cleavage into insoluble fibrin (Wasterlain et al., 2012). In the 






soluble components of activated PRP) used at 10% in culture medium showed 
better cell viability and proliferation compared to 10% FBS. The biological 
actions of GFs in cell proliferation and bone regeneration have been 
documented in many studies (Sporn and Roberts, 1993; Greenhalgh, 1996; 
Eppley et al., 2004). Cho et al. (2011) revealed that cell proliferation is positively 
correlated with transforming growth factor-beta1 (TGF-β1) and platelet-derived 
growth factors (PDGFs) concentrations. In addition, many studies have reported 
the successful culture of cells incorporated into PRP gels, suggesting that the 
gel environment enhances viability and proliferation of encapsulated cells (Ho et 
al., 2006; Kawasumi et al., 2008; Xie et al., 2012; Jalowiec et al., 2015). Thus, it 
was decided to focus on investigating and comparing PRP gel and PRP 
releasate on cell proliferation and differentiation when combined with FA 
coatings (Chapter 6). 
Some investigators have used PRP in combination with other biomaterials to 
create a microenvironment favourable for tissue healing including induction of 
chemotaxis, cell proliferation and differentiation stimulated by platelet GFs 
(Okuda et al., 2005; Yamamiya et al., 2008; Bi et al., 2010). PRP gel contains 
proteins such as fibrin, fibronectin and vitronectin which act as cell adhesion 
molecules, thus favouring osteoconduction as well as being essential in forming 
bone matrix (Anitua et al., 2004; Gandhi et al., 2006). The biomaterial can 
induce better protein adhesion and therefore can improve subsequent cell 
adhesion. Growth factors from PRP theoretically adsorb to PRP fibrin network 
and to the underlying biomaterial surfaces. Thus, the biomaterial can act as a 
carrier for the GFs allowing for a sustained release over a long period of time 
after diffusion of the incorporated growth factors out of the combinations and 
with degradation of the PRP gel. Studies have shown that activation of platelets 
with thrombin can cause immediate activation with surge of GFs release where 
70% of the GFs are released within 10 min of clotting and 100% are released 
within 1 hour (Foster et al., 2009). This rapid and high GFs release in addition to 
the fact that PRP has naturally a short half-life, limit the impact of the GFs on 
cell stimulation over time as most GFs are cleared before they can exert a 
therapeutic effect (Lu et al., 2008). Therefore, a controlled release strategy was 






hydrogels to temporarily regulate GF bioavailability and enhance the clinical 
efficiency of PRP (Lin et al., 2006; Lu et al., 2008; Kurita et al., 2011; Kakudo et 
al., 2017; Jain et al., 2017). Several biomaterials have been employed to 
prolong the release of GFs from PRP preparations e.g. gelatin, alginate, 
collagen and calcium sulphate (Chen et al., 2010). However, the use of natural 
polymers (alginate) is shown to have some disadvantages such as batch-to-
batch variability, non-specific polymer-protein interactions, immuno-toxicity and 
limited control over hydrogel properties (Malafaya et al., 2007). Thus, using 
synthetic scaffolds exhibiting well controlled and acceptable properties would be 
preferable. With this in mind, the release of 2 important osteogenic GFs (IGF-1 
and PDGF-AB) from PRP gel combined with FA coatings was monitored over 7 
days (Chapter 6). It was reported earlier that the combination of IGF-1 and 
PDGF-AB could increase bone formation on implant surfaces (Stefani, et al., 
2000). According to the findings of the present study, the addition of PRP gel to 
organised FA induced an enhancement and a sustained release of both GFs 
from the gels (IGF-1 and PDGF-AB). This could form a good strategy to 
coordinate GF release and to maximise the clinical efficiency of PRP, creating 
osteo-inductive, osteo-conductive tissue engineered constructs for rapid bone 
healing. Interestingly, the findings of this study indicated that the loosely bound 
Ca2+ ions of organised FA coatings were capable, without addition of 
exogenous agent, to trigger a high and sustained release of IGF-1 over 7 days 
from PRP. Nair et al. (2008) showed similar results when coated HA scaffolds 
with non-activated PRP with agitation for 1 hour. They proposed that HA can 
activate platelets without the addition of any triggering factors like calcium 
chloride or thrombin and can induce platelet aggregation and activation. Nair et 
al. confirmed platelets activation by identifying the activation markers: P-selectin 
adhesion molecules (which are expressed on activated platelets) and plasma 
factor-4 (released by aggregated platelets).  
The present study confirmed that the high Ca2+ content of the disorganised 
coatings triggered a burst release of IGF-1 over a short term while the 
organised coatings triggered a sustained release of IGF-1 over an extended 
period of time. This finding was supported by the proteomic analysis of the 






amounts of PRP proteins compared to disorganised FA. This probably result in 
entrapping more GFs within the fibrin network of the PRP gel and creating a 
reservoir of GFs for a sustained release later. However, in the current study, 
thrombin was required to ensure high release of PDGF-AB from PRP. Some 
researchers questioned the necessity of using thrombin in vivo, as commercially 
available thrombin derived from bovine plasma has been associated some 
years ago with the development of antibodies to some clotting factors (V, XI and 
thrombin) and sporadically caused life-threatening coagulopathies (Zehnder and 
Leung, 1990). In the same time, non-activated PRP liquid was reported to 
enhance bone formation (Anitua 1999; Dugrillon et al. 2002) and to improve 
bone apposition to roughened titanium implants during the early post 
implantation healing phase (Nikolidakis et al. (2006). It was suggested that non-
activated PRP can be injected directly into injured tissue to become activated by 
contact with collagen rather than by applying thrombin. Recently, collagen was 
demonstrated as one of the most potent activators of platelet activation leading 
to a slower and more sustained release of GFs compared to thrombin (Fufa et 
al., 2008; Harrison et al., 2011). 
In addition to the above, PRP gel containing platelets showed higher 
concentrations of PDGF-AB compared to platelet-free PRP releasate regardless 
of the underlying substrate ( uncoated or FA coated SS). While PRP releasate 
showed higher concentrations of IGF-1. Therefore, effect of both types of PRP 
was further investigated on cell proliferation. The major effect of PRP is derived 
from the effect of PDGF originating from the platelets which has a key role in 
hard- and soft-tissue healing (Rozman and Bolta, 2007). PDGF has been 
shown to stimulate cell chemotaxis and mitogenesis, and the production of 
fibronectin which is an important extracellular cell adhesion protein (Yang et al., 
2000). IGF-1 is an important osteogenic factor that can enhance bone formation 
when bound to a specific receptor on the cell membrane of preosteoblasts and 
can stimulate their proliferation and differentiation and the subsequent 
osteogenesis (Hock et al., 1988). It was shown to enhance cell proliferation of 
osteoblast-like cells and osteogenic differentiation by increasing ALP activity 
(Schmid et al., 1984). It increased type I collagen synthesis as well in foetal rat 






There is little information on the effect of PRP acting in synergy with other 
biomaterials on osteoblast cell proliferation. In the present study, under 
standard cell culture condition (FBS), FA coatings induced cell attachment and 
proliferation at a comparable rate to that of uncoated SS discs. However, cell 
attachment and proliferation was increased upon the addition of PRP gel to 
organised FA coatings. Organised FA adsorbed higher amounts of PRP gel 
proteins and induced higher growth factor release and cell proliferation 
compared to uncoated SS and disorganised FA. Thus, the composition and 
conformation of the adsorbed protein layer might be responsible for the 
enhanced G292 cellular response on the organised FA surfaces. FA/PRP 
combinations induced higher cell proliferation compared to PRP loaded on SS 
surfaces. This emphasised that the combined effect of PRP and FA can sustain 
cell viability and proliferation. In addition, the present study suggested that fibrin 
provided by PRP gel adsorbed very well to FA coatings minimising cell loss and 
leading to enhanced cell growth compared to PRP releasate and FBS. The 
synergistic effect of PRP with calcium phosphate to promote cell proliferation of 
mesenchymal stem cells for more than 7 days was reported by several in vitro 
studies (Kasten et al., 2008; Nair et al., 2009; Bi et al., 2010; Qi et al., 2015). 
Recent advances in stem cell biology and tissue engineering offer an attractive 
prospect for hard tissues healing (Yen and Sharpe, 2008). For tissue 
engineering purposes, three key ingredients are required; biocompatible and 
bioactive scaffolds, mesenchymal cells and inductive growth factors. Ideally, it is 
desirable that a scaffold should not only support the growth of specific cells but 
also direct the differentiation of these cells toward the creation of functional 
tissues (Wang et al., 2012). The interactions between stem cell and biomaterial 
can provide valuable information of the relationship of material characteristics 
with cell phenotypic behaviour (adherence, proliferation and differentiation) 
which are fundamental to the future application of these biomedical materials in 
the orthopedic and dental fields (Liu et al., 2010). It was thus essential to 
investigate the synergistic effect of FA and PRP on stem cells differentiation 
and mineralisation using hDPSCs. 
The findings of the current study concluded that FA and PRP supported 






clear PRP donor variability in ALPL and RUNX-2 gene expression while neither 
FA nor PRP promoted OCN expression compared to the control. In accordance 
with OCN gene expression (which regulates bone mineralisation), all uncoated 
and organised FA coated discs showed positive calcium deposition 
(mineralisation) when combined with FBS, PRP gel or PRP releasate. This 
result demonstrated the osteogenic mineralisation potential of hDPSCs and 
suggested that hDPSCs grown on organised FA surfaces combined with PRP 
were capable of differentiating into mineralised tissue forming cells and promote 
ECM mineralisation. OPN expression (cell-matrix adhesion molecule and late 
osteoblast marker) was highly induced by organised FA when combined with 
either FBS, PRP gel or releasate which demonstrates that organised FA had a 
strong effect on cell-substrate contact and on the late stage of cell 
differentiation. It can be concluded that the combination FA/PRP might have a 
potential for bone regeneration but further studies using more blood donors are 
need to fully prove this hypothesis and elucidate the mechanisms involved.  
Cell proliferation and differentiation are both essential for bone regeneration. 
However, these two processes cannot happen in the cell at the same time. Cell 
proliferation is essential in the early phases of regenerative wound healing and 
must occur before cell differentiation is initiated (Graziani et al., 2006). 
Therefore, using hDPSCs at higher cell density and over longer culture duration 
might allow more time for the cells to stop proliferation on both substrates (SS 
and FA) and start the differentiation process.  
ALP activity was enhanced by both PRP types but suppressed by organised FA 
when combined with either FBS or PRP. This result was also confirmed by ALP 
stain images. It is possible that the GFs released from PRP gel and PRP 
releasate were rapidly adsorbed on the FA coatings and were slowly released 
into the cell culture medium which in turn promoted the cell proliferation and 
reduced ALP activity. However, thrombin- activated PRP decreased ALP 
activity compared to non-activated PRP in vivo (Han et al., 2009). Therefore, it 
is worthy to investigate FA/PRP combinations in vivo without activating the PRP 
or in vitro using collagen to activate the PRP samples.  
The ability of PRP to enhance cell proliferation and reduce ALP activity has 






increased cell proliferation but reduced ALP activity in a dose dependant 
manner when cultured rat bone marrow stromal cells on porous collagenous 
scaffold for 21 days. Kasten et al. (2008) investigated the in vitro effect of PRP 
gel on MSCs seeded on calcium phosphate scaffolds and similar to the 
previous studies, they found that PRP improved cell proliferation on the scaffold 
but did not affect ALP activity compared to the scaffold alone and they related 
this result to inefficient preparation and storage of PRP. However, if their PRP 
was compromised in some way, it is questionable whether it could even 
enhance cell proliferation or affect ALP activity. Cho et al. (2011) documented 
that using 10% PRP releasate in MSCs culture induced marked cell proliferation 
but reduced ALP activity compared to the control (10%FBS). Further, Li et al. 
(2013) observed an increase in cell proliferation and a reduction in the 
expression of lineage specific markers by the PRP-expanded human muscle 
derived progenitor cells, suggesting that failure to exit the cell cycle was 
responsible for preventing the cells from entering differentiation phase.   
Organised FA in the present study inhibited ALP activity in standard culture 
(FBS) compared to uncoated SS. This finding might again be related to the fact 
that cells growing on 3-D constructs need longer time than cell growing on 2-D 
surface of SS to reach confluency, exit the cell proliferation cycle and start cell 
differentiation. In contrast, Wang et al. (2012) found higher ALP activity when 
hDPSCs were grown under standard conditions (FBS) on organised FA 
compared to cells grown on uncoated SS after 1 week in culture with and 
without osteogenic induction. They related this effect to the intrinsic properties 
and surface characteristics of the FA coating (chemical composition, charge, 
hydrophobicity and topographical features). The difference between ALP 
findings reported in the present study and Wang et al (2012) may be related to 
the variability among hDPSCs of different donors which was demonstrated 
earlier by El-Gendy (2010) and Alkharobi (2016). Therefore, using hDPSCs 
obtained from more than one donor would have been helpful in confirming this 
data. Variability of donated DPSCs response could be related to the patient’s 
dental health which could have an effect on the biological behaviour of the 
residing stem cells. For example, dental pulp inflammation was associated with 






2010). Deep tooth caries (decay) also affects the proliferation rate and 
differentiation potential of DPSCs (Ma et al., 2012). Pressure and tension 
caused by previous orthodontic tooth movement can also induce differentiation 
of residing DPSCs (Zainal Ariffin et al., 2011). Smoking affects the 
mineralization potential of DPSCs (Yanagita et al., 2008) and donors’ age 
decreases cell proliferation and differentiation of DPSCs (Ma et al., 2009). 
However, the expression of stem cell markers was observed in DPSCs from 
donors ranging from 14 to 60 years old (Atari et al., 2012). The age is not a 
crucial factor in the maximal division potential of DPSCs and cells derived from 
donors ranging from 12 to 30 years old are all suitable for stem cell banking 
(Kellner et al., 2014).  
In general, as long as organised FA/PRP gel combinations promoted a higher 
proliferation rate, enhanced expression of late osteoblast markers (OPN) and 
mineralisation potential, they might be of significant use in bone tissue 
engineering. Using PRP in combination with biomaterials for tissue engineering 
purposes is a controversial and interesting area to discuss. Some investigators 
reported that using PRP in combination with HA/tricalcium phosphate (TCP) 
scaffolds may hold some promise for tissue engineering purposes by enhancing 
in vivo bone regeneration compared to the use of scaffolds alone (Okuda et al., 
2005; Abhijit, 2006; Rai et al., 2007; Chevallier et al., 2010; Bi et al., 2010, Qi et 
al., 2015). Yamada et al. (2004), in an animal study, observed a well-formed 
mature bone in osseous defects when injected with PRP gel and MSCs 
compared to PRP alone or autogenous bone graft. They found a progressive 
and complete resorption of PRP gel and relatively mature remodelled bone. 
Another animal study showed that the bone regeneration around dental 
implants was promoted when the implants were placed simultaneously with a 
combination of MSCs, PRP and fibrin glue (a composite containing fibrinogen 
and thrombin) in areas with poor bone quality or low bone volume (Ito et al., 
2006). Fibrin glue was used as osteoconductive scaffold for stem cells and as a 
carrier for PRP growth factors. Another study evaluated the effect of PRP in the 
treatment of periodontal intrabony defects (Yamamiya et al., 2008) and reported 
a more favourable clinical improvement in the periodontal defects when treated 






osteoprogenitor cells and extracellular matrix) compared to HA and PRP 
combination. The result was attributed to the additional benefit of the osteogenic 
cells found in the periosteum sheet. Another study introduced a calcium 
sulphate and PRP combination as a novel biomaterial that is able to induce 
bone formation in the bone defects. They assumed that the exothermic reaction 
generated by the mixture of calcium sulphate with PRP activated the platelets 
contained within the PRP and this combination behaved as time-controlled 
releasing matrix for all the platelet GFs (Intini et al., 2007). 
In contrast to the above studies, it was concluded in previous animal studies 
that the use of PRP gel did not have any effect on the bone-implant contact of 
trabecular bone (Nikolidakis et al., 2006) and cortical bone (Nikolidakis et al., 
2008) compared to calcium phosphate coated implants, while non-activated 
PRP in a liquid form induced an increase in bone apposition to roughened 
titanium implants. They related this difference to the mechanical trauma caused 
by the pressure of the PRP gel on the walls of the already tightly fitted implant 
leading consequently to bone resorption and necrosis of interfacial bone. They 
supported their hypothesis by indicating remnants of PRP gel around the 
implant surfaces which couldn’t be seen around calcium phosphate coated 
implants, suggesting that calcium phosphate coating may enhance macrophage 
activation (Silva et al., 2003) and play a role in the faster degradation of PRP 
gel. Another recent animal study also suggested that treating bone defects with 
TCP/PRP did not have a significant effect compared to PRP alone (Sebben et 
al., 2012). The underlying reasons for these conflicting results are still unclear. 
However, as stated earlier, the major factors in PRP thought to be involved in 
the biological events are GFs. It was believed that the GFs have a complex 
synergistic effect that is not fully understood. Many different signalling pathways 
can be triggered from the synergistic interaction of GFs and can lead to either 
enhancement or inhibition of tissue healing depending on the mode of growth 
factor release, as well as the dynamics of the wound area (Border and 
Ruoslahti, 1992). Therefore, it is important in the future to correlate the effects 
of PRP derived GFs (acting singularly and together in concert) with cell 
proliferation and with the expression of specific osteogenic marker genes and 







1. Within the limits of the current study, it can be concluded that combinations 
of FA coatings and PRP were biocompatible. The PRP prepared had a 
platelet count in the accepted therapeutic range. All PRP concentrations and 
configurations used herein were not cytotoxic. In cell monolayer culture, 
PRP-releasate (10% in culture medium) promoted the highest rate of cell 
growth compared to PRP gel and FBS. While on FA coatings, especially the 
organised form, PRP gel induced the highest growth of osteoblast-like cells.  
2. FA stimulated high and sustained release of IGF-1 and PDGF-AB for up to 7 
days. However, thrombin was required to induce the highest release of 
PDGF-AB. Furthermore, FA coatings, especially organised FA, promoted 
high protein adsorption and high cell attachment when combined with PRP 
gel.  
3. There was a clear PRP donor variability in ALPL and RUNX-2 gene 
expression when combined with uncoated SS or FA while neither FA nor 
PRP promoted OCN expression compared to the control. Organised FA 
when used under standard culture conditions did not promote early bone 
markers ALPL and RUNX-2 and late marker OCN but increased late OPN 
bone marker expression and inhibited ALP activity compared to uncoated 
SS. PRP gel and releasate supported the osteogenic differentiation of 
hDPSCs on uncoated SS by inducing high ALP activity compared to when 
combined with organised FA. Organised FA/PRP combinations showed a 
high OPN osteoblast gene expression and mineralisation potential. Thus, 
such combinations might be of use in bone tissue engineering and may 
represent an effective approach to enhancing the osseointegration of dental 
implants but further investigations are necessary to confirm this. 
 
7.3 Limitations 
1. The variability between PRP results of 2 blood donors was considerable. 
Therefore, the effect of inter-donor variability could be averaged out by 
using PRP samples extracted from more blood donors. 
2. Variability of stem cell behaviour and their response to stimuli may again be 






impossible to isolate hDPSCs from different teeth and donors when 
studying the effect of FA/PRP on cell proliferation and osteogenic 
differentiation concurrently.  
3. The hDPSCs were extracted from samples obtained from the tissue bank 
and came with very limited information about the medical and dental history 
of the patients donating the samples. This information would be useful for a 
better understanding of the behaviour of the cells and how their behaviour 
might correlate to their past history.  
4. Another limitation of this study is that it did not investigate whether other 
platelet derived osteogenic GFs (e.g. TGF-B1) are secreted and affected by 
a specific activator when released from FA/PRP combinations. Platelets 
contain over 30 GFs and it would be preferable to investigate the effect of 
all these GFs on stem cell biology.  
5. Finally, due to time limits and the short time course (3 days) associated 
with gene expression differentiation assays, it would be worth performing 
more extensive time course studies to better observe any time-dependent 




7.4 Future work 
1. The work around PRP proteins and FA coatings and the effect they have on 
cell biology was the central theme of this thesis but further work is required 
to explore the molecular mechanisms involved in the cellular response to 
FA/and or PRP coated titanium samples.  
2. Further research is needed to fully understand the release pattern and 
kinetics of the full cocktail of GFs present in platelets when used 
synergistically with FA coatings.  
3. A key question remaining is how PRP/FA coatings would affect the 
osteogenic differentiation of stem cells in vitro and in vivo including, 
characterisation of osteoblastic cell phenotype using immunohistochemical 
staining/ Western Blotting against a range of bone markers such as alkaline 






sialoprotein so as to confirm protein expression related to gene expression 
data.   
4. The PRP and FBS proteins adsorbed to the coatings need to be better 
characterised and the role of specific components on cell attachment and 
behaviour need to be further investigated. This may involve testing the 
bioactive effects of purified components (or recombinant analogues) on 
stem cell differentiation and subsequent behaviour with regard to bone 
regeneration. 
5. Well designed and properly controlled studies are needed to provide solid 
evidence of the capacity of PRP alone or combined with FA to enhance 
osseointegration of dental implants. For example, clinical trials should 
include a sufficient number of patients and a proper design (randomized, 
controlled, clinical trials). Future studies should assess the ideal 
concentration of the various growth factors, characterise other 
physiochemical factors that may be present in the platelet concentrate, and 
explain the potential beneficial effects of PRP treatment in bone 
regeneration. 
6. Regarding the use of hDPSCs in in vitro studies, efforts should be made to 
restrict the variability of hDPSCs by extracting cells from only impacted 
wisdom teeth for example. However, donor variation would still be a 
concern. For example, age, gender and patient’s history may still affect 
hDPSCs.  
7. This study only used hDPSCs. Other dental tissues containing stem cells 
are readily accessible; e.g. periodontal ligament stem cells. It would be 
interesting to compare the behaviour of FA/PRP used in combination with 
hDPSCs, periodontal ligament stem cells and hBMSCs.  
8. It was stated earlier in this thesis that PDGF release from PRP gel 
combined on FA coatings required thrombin. As it has been reported that 
the use of thrombin has some drawbacks, it would be worth investigating 
the potential of collagen as an alternative platelet activator in bone 
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Chapter 9: Appendices 
Appendix 1: Growth of G292 cells seeded on PRP gel, encapsulated in PRP 
gel and PRP releasate supplemented medium for 7 days using 2 PRP samples 
donors. Cells were successfully cultured in all experimental groups compared 
to the controls. PRP releasate enhanced the cell proliferation as compared 
with the others. The maximum increase in DNA content was observed when 
cells where cultured with PRP releasate reaching 3423 ng ± 96 after 7 days 
and 4015 ng ± 41 for donors 1 and 2 respectively, followed by when cells were 
encapsulated in PRP gel (2902ng ± 634 and 2856ng ± 475 for donors 1 and 2 
respectively). 
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Appendix 2: Cell attachment and proliferation of G292 osteoblast-like cells on 
combinations of FA coatings and PRP extracted from blood donor 1 assessed 
by DNA quantification at 5 hours and 1, 3 and 7 days of cell culture. A gradual 
increase in DNA content was seen in all groups with a higher cell growth 
rates recorded for SS substrate compared to FA coatings. PRP gel induced 
the highest DNA content in all the substrate groups, followed by PRP 
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Appendix 3: Proliferation of G292 osteoblast-like cells on combinations of FA 
coatings and PRP extracted from blood donor 2 assessed by DNA 
quantification at 5 hours and 1, 3 and 7 days of cell culture. PRP of donor 2 
showed a boost in cell proliferation at day 3 and a comparative growth rates 
for all substrate groups. Overall, PRP gel induced the highest DNA content in 
all the substrate groups, followed by PRP releasate and FBS.   
 
 
 
